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Abstract
Inflammation is a major component of acute and chronic pathologies o f the central 
nervous system, including psychiatric disorders. Microglia respond to pathogens, injury, 
and toxins by secreting inflammatory mediators including pro-inflammatory cytokines in 
an event known as neuroinflammation. This thesis research investigated a link between 
neuroinflammation and oxidative stress, and ultimately neurodegeneration. The cytokine 
tumor necrosis factor alpha was shown to stimulate a neuronal NADPH oxidase (NOX), 
specifically by stimulating the production of ceramide and ceramide-1 -phosphate via 
Mg2+-neutral sphingomyelinase (Mg2+-nSMase) and ceramide kinase. Intriguingly, 
glucosylceramide blocked NOX activation, linking ceramide neutralization directly to a 
decline in oxidative stress. Most importantly, NOX activity interfered with actin and 
sphingosine kinase-1 via oxidation, demonstrating a positive and detrimental feedback 
mechanism that impedes neuronal survival pathways. Interestingly, crude extracts from
2_j_
wild Alaskan bog blueberries showed the ability to interfere with Mg -nSMase, 
demonstrating a specific neuroprotective property of the berry. Altogether, this thesis 
research defined a key neuronal pathway linking inflammation to oxidative stress via 
ceramide metabolism, potentially allowing for future therapeutic development to improve 
neuronal function and survival.
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1Chapter 1: Introduction 
1.1: CNS Health 
1.1.1: Neuroinflammation
The cellular make up of the central nervous system (CNS) consists of neurons, 
oligodendrocytes, astrocytes, and microglia. In particular microglia, which compose up to 
12% of cellular CNS mass, respond to extrinsic insults, similar to macrophages, by 
releasing inflammatory mediators and by phagocytosis in an innate immunological 
response known as neuroinflammation (Fetler and Amigorena 2005; Nimmerjahn et al. 
2005; Town et al. 2005; Block et al. 2007). Microglia and astrocytes play important roles 
in propagating and regulating neuroinflammation. Following activation by injury, toxins, 
excitotoxicity, or invading pathogens, microglia and to some degree astrocytes, secrete 
inflammatory mediators such as eicosanoids, cytokines, complement, and reactive 
oxygen species (ROS) (Sawada et al. 1989; Town et al. 2005; Block et al. 2007). Both 
eicosanoids and cytokines act in autocrine and paracrine fashion and exacerbate 
inflammation and stress responses.
Importantly, neuroinflammation is predominantly detrimental to CNS neurons and can 
result in loss of function, and ultimately to degeneration. Following extrinsic insults, 
microglia and astrocytes release proinflammatory cytokines such as tumor necrosis factor 
alpha (TNFa), which play a key role in the orchestration and spreading of 
neuroinflammation (Sawada et al. 1989; Lee et al. 1993; Block et al. 2007). TNFa binds 
two distinct receptors: the high affinity TNFa receptor I with molecular mass 55kD, and 
the low affinity TNFa receptor type II with molecular mass 75 kD. The type I receptor 
(TNFR I) is implicated in both global and local cellular stress responses, and apoptosis. 
TNFR I, in tight association with adaptor protein, is implicated in signaling pathways key 
in early apoptotic mechanisms as well as subsequent activation of caspases. Other stress-
Reproduced with permission o f the copyright owner. Further reproduction prohibited w ithout permission.
2induced pathways are mediated through TNFR I interactions with a different repertoire of 
adaptor proteins. More global effects of TNFa include inducing gene expression via the 
nuclear factor kappa beta pathway, ultimately mediating the transcription of both pro- 
and anti-inflammatory genes. Additionally, neuroinflammation is linked to the onset of 
oxidative stress through both releases o f reactive oxygen species (ROS) by activated 
microglia and astrocytes, as well as oxidant-generating pathways induced by TNFa in 
neurons (Colton and Gilbert 1987; Block et al. 2007).
One important aspect of neuroinflammation is guarding the CNS from toxins, cellular 
damage, and invading pathogens (Town et al. 2005). However, inflammatory responses 
accompany almost all chronic CNS diseases, acute CNS injuries, as well as several 
psychiatric disorders such as schizophrenia and autism (Town et al. 2005; Block et al. 
2007). Presently it is unclear whether neuroinflammation actually initiates CNS 
neurodegenerative disorders or represents a significant component in their progression. 
One speculation regarding adverse CNS inflammation is that microglia might 
misinterpret certain extrinsic stimuli, such as the amyloid beta fragment associated with 
Alzheimer’s disease, as “pathogens or toxins”.
1.1.2: Nutrition
Diet plays an important role in human health, including the health of the CNS. Much 
attention has been devoted to diets rich in fruits and vegetables, long known for being 
beneficial to maintaining good health, as well as for being rich sources for antioxidants 
(Galli et al. 2002). Recent studies in animal models have revealed the dietary effects of 
blueberries, showing the ability of these diets to reduce cognitive decline and to reduce 
ischemia-induced brain damage (Mattson et al. 2002; Sweeney et al. 2002; Joseph et al. 
2003). Blueberries, like many fruits, contain numerous polyphenols which can act as 
antioxidants and slow the progression of neuroinflammation (Ramassamy 2006). 
However, limited amounts o f polyphenols cross into the CNS following dietary
Reproduced with permission o f the copyright owner. Further reproduction prohibited w ithout permission.
3consumption of fruits, suggesting that the efficacy of these foods emerges from other 
compounds that may act as antagonists of pathways of neuroinflammation (Joseph et al. 
2003; Wu et al. 2004; Noyan-Ashraf et al. 2005; Ramassamy 2006). Other foods such as 
fish have shown importance to maintaining good CNS health, in particular due to the 
high content of omega-3 polyunsaturated fats (Farooqui et al. 2007). These fats can 
substitute for arachidonic acid in the synthesis of inflammatory molecules known as 
eicosanoids; producing a separate class of anti-inflammatory molecules including 
docosanoids (Eyster 2007; Farooqui et al. 2007).
1.2: NADPH oxidase
1.2.1: NADPH oxidase in phagocytes and other cells
The NADPFI oxidase was originally described as an enzyme complex responsible for the 
cellular respiratory burst in sea urchin eggs, phagocytes, and spermatocytes (Warburg 
1908; Baldridge and Gerard 1932; MacLeod 1943). In the 1960s, the phagocyte 
respiratory burst was shown to result in the generation of hydrogen peroxide through an 
NADPH oxidase activity, and in 1973 the phagocytic NADPH oxidase product was 
determined to be superoxide rather than hydrogen peroxide (Iyer et al. 1961; Rossi and 
Zatti 1964; Babior et al. 1973). Concurrent with these findings, clinical studies showed 
that a rare disorder resulting in recurrent infections accompanied by granulomatous 
reaction, defined as chronic granulomatous disease (CGD), resulted from diminished 
phagocytic antimicrobial capacity (Berendes et al. 1957; Quie et al. 1967; Babior et al. 
1975). Furthermore, it was shown in 1967 that CGD resulted from a deficiency in the 
phagocytic respiratory burst (Baehner and Nathan 1967; Holmes et al. 1967; Quie et al. 
1967). In 1978 the cytochrome b558 was identified as missing in patients with CGD, and 
later in the 1980s the gene encoding gp91phox (phox for phagocytic-oxidase like) was 
cloned (Segal and Jones 1978; Segal et al. 1978; Royer-Pokora et al. 1986; Teahan et al. 
1987). Shortly thereafter the other subunits of the NADPH oxidase complex, the
Reproduced with permission o f the copyright owner. Further reproduction prohibited w ithout permission.
4membrane-bound p22phox, cytosolic p67phox, cytosolic p47phox, and cytosolic p40phox, were 
discovered, the evaluation of the cytosolic subunits aided by the development of a cell- 
free assay system to monitor phagocytic NADPH oxidase activation (Heyneman and 
Vercauteren 1984; Bromberg and Pick 1985; Dinauer et al. 1987; Segal 1987; Nunoi et 
al. 1988; Parkos et al. 1988; Volpp et al. 1988; Wientjes et al. 1993).
Recent findings demonstrated that genetically distinct isoforms of the phagocytic 
NADPH oxidase existed in many, if  not all cell types (Meier et al. 1991; Szatrowski and 
Nathan 1991; Griendling et al. 1994; Bedard and Krause 2007). The new families of 
NADPH oxidase (NOX) enzymes are defined by gp91phox now being referred to as 
NOX2, and includes NOX1, NOX3, NOX4, and NOX5; all identified in various non- 
phagocytic cells (Suh et al. 1999; Banfi et al. 2000; Geiszt et al. 2000; Kikuchi et al.
2000; Banfi et al. 2001; Cheng et al. 2001; Shiose et al. 2001; Bedard and Krause 2007). 
Two additional large members of the NADPH oxidase family were identified as DUOX1 
and DUOX2 (dual oxidase function enzymes) (Dupuy et al. 1999; De Deken et al. 2000). 
For many NADPH oxidase isoforms the other subunits are the same in most cellular 
enzyme systems. However, in the case of NOX 1, homologues of p47phox and p67phox 
subunits were cloned and described as NOXOl and NOXA1, respectively (Banfi et al. 
2003; Geiszt et al. 2003; Takeya et al. 2003). The DUOX group was also shown to 
express maturation factors DUOXA1 and DUOXA2 (Grasberger and Refetoff 2006).
NADPH oxidase family members have been described in various cell types in addition to 
phagocytes including cardiomyocytes, skeletal muscle myocytes, hepatocytes, endothelial 
cells, hematopoietic stem cells, and neurons (Jones et al. 1996; Gorlach et al. 2000;
Cheng et al. 2001; Javesghani et al. 2002; Li and Shah 2002; Heymes et al. 2003; Serrano 
et al. 2003; Piccoli et al. 2005; Reinehr et al. 2005; Bedard and Krause 2007). Recent 
reports have demonstrated that NADPH oxidase family members and their subunits are 
also expressed in neurons, both in the central as well as peripheral nervous system 
(Cheng et al. 2001; Thiels and Klann 2002; Zimmerman et al. 2002; Kamsler and Segal
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52004; Vallet et al. 2005; Bedard and Krause 2007). Immunohistochemistry, RT-PCR, and 
in situ hybridization demonstrated the presence of NOX1, NOX2, and NOX4 in neurons 
(Tammariello et al. 2000; Tejada-Simon et al. 2005; Vallet et al. 2005; Ibi et al. 2006; 
Bedard and Krause 2007). Regulation of neuronal cell fate, synaptic activity, gene 
expression, long-term potentiation and learning, and possibly specific modulation of 
NMDA receptor signaling are potential roles o f neuronal NADPH oxidase activity 
(Tammariello et al. 2000; Thiels et al. 2000; Kim et al. 2002; Knapp and Klann 2002; 
Thiels and Klann 2002; Zimmerman et al. 2002; Kamsler and Segal 2004; Zimmerman et 
al. 2004; Kishida et al. 2005; Tejada-Simon et al. 2005; Ibi et al. 2006; Bedard and 
Krause 2007). Importantly, genetic mouse-models of CGD and human CGD patients 
have impaired learning and memory demonstrating the neurological role of the NADPH 
oxidase beyond cell culture work (Pao et al. 2004; Kishida et al. 2006). Additionally, 
reactive astrocytes have increased expression of NOX2 mRNA, suggesting a role for 
NOX2 in the oxidative stress induced during neuroinflammation (Abramov et al. 2005; 
Bedard and Krause 2007).
1.2.2: Structure and function
The NADPH oxidase complex consists of five primary subunits. The complex includes 
both membrane-bound and cytosolic subunits (Groemping and Rittinger 2005; Bedard 
and Krause 2007). The two membrane-bound subunits are NOX1-5 (gp91phox and 
homologues) and p22phox. The large subunit (gp91phox) is heavily glycosylated, composed 
of six transmembrane a-helices, contains both a NADPH and FAD binding site, contains 
the cytochrome b558, and engages in multiple interactions with cytosolic subunits (Babior 
and Kipnes 1977; Harper et al. 1985; Kleinberg et al. 1989; Rotrosen et al. 1992; 
Sumimoto et al. 1992; Doussiere et al. 1993; Koshkin and Pick 1994; Doussiere et al. 
1995; Nisimoto et al. 1995; Wallach and Segal 1997; Groemping and Rittinger 2005). 
Transmembrane helices III and V each contain two histidine residues that span 
asymmetrical iron-containing hemes (Yu et al. 1998; Biberstine-Kinkade et al. 2001;
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helices and a C-terminal proline-rich region (PRR) that interacts with the cytosolic 
subunit p47phox (Dinauer et al. 1991; Leto et al. 1994; Leusen et al. 1994; Sumimoto et al. 
1994; Huang et al. 1995; Yu et al. 1997; Yu et al. 1999; DeLeo et al. 2000; Groemping 
and Rittinger 2005).
Figure 1.1: M em brane-bound subunits o f the NADPH oxidase. Membrane-bound gp91phox and p22pllox are shown 
spanning the membrane. Transmembrane domains are depicted as dark blue cylinders. The NADPH- and FAD-binding 
domains o f  gp91phox are indicated in pink and light blue, respectively. The proline-rich m otif o f p22phox is indicated in 
gray. Cyan ovals on gp91phox depict regions that interact with cytosolic subunits. Small blue circles indicate sites o f 
glycosylation on gp91phox (Groemping and Rittinger 2005).
The three cytosolic subunits are p67phox, p47phox, and p40phox. The interactions of all five 
subunits together are required for function, and therefore regulation can occur at multiple 
points. The cytosolic subunits contain multiple domains that recognize the membrane- 
bound subunits as well as specific lipid-binding regions (Groemping and Rittinger 2005). 
The p67phox subunit is considered the activator subunit, and contains a TPR 
(tetratricopeptide repeat) motif, a PRR, two SH3 (Src homology) domains, and a PB1 
domain (Groemping and Rittinger 2005). The TPR domain is implicated in interactions 
with the small GTPase Racl (Diekmann et al. 1994; Nisimoto et al. 1997; Koga et al. 
1999). The second SH3 domain interacts with p47phox, and the PB1 domain interacts with
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7p40phox (Nakamura et al. 1998; Ito et al. 2001; Kami et al. 2002; Kuribayashi et al. 2002; 
Ponting et al. 2002; Wilson et al. 2003; Groemping and Rittinger 2005). The p67phox 
subunit also contains an activation domain that is required for superoxide production, and 
potentially interfaces with the flavocytochrome on gp91phox (Han et al. 1998; Nisimoto et 
al. 1999; Han and Lee 2000).
The p47phox subunit, or organizer subunit, contains a PX (Phox homology) domain, two 
SH3 domains, a polybasic autoinhibitory region (AIR) rich in arginine and lysine 
residues that covers the SH3 domains, and a PRR that interacts with p67phox (Ponting 
1996; Ellson et al. 2001; Kanai et al. 2001; Vignais 2002; Nauseef 2004; Quinn and 
Gauss 2004). Phosphorylation of numerous sites within the AIR results in its inactivation, 
revealing the tandem SH3 domains (El Benna et al. 1994; El Benna et al. 1996a; El 
Benna et al. 1996b; Inanami et al. 1998; Fontayne et al. 2002). The p40phox subunit 
contains a PX domain, a SH3 domain likely interacting with the PRR of p47phox, and a 
PB1 domain interacting with p67phox (Someya et al. 1993; Wientjes et al. 1993; 
Tsunawaki et al. 1994; Fuchs et al. 1995; Grizot et al. 2001). Both the p40phox and p67phox 
subunits have also been shown to have residues available for phosphorylation (Dusi and 
Rossi 1993; Benna et al. 1997; Forbes et al. 1999; Someya et al. 1999). NADPH oxidase 
complexes only produce ROS following assembly of all cytosolic subunits with the two 
membrane proteins. Phosphorylation is widely viewed as an activating event, ultimately 
promoting the translocation of the cytosolic subunits to the membrane (Groemping and 
Rittinger 2005). Interactions between the PRR of p22phox and the two SH3 domains of 
p47phox initially occur, and promote further interactions between the membrane subunits 
and both p47phox and p67phox (DeLeo et al. 1995a; DeLeo et al. 1995b; Paclet et al. 2000; 
Groemping et al. 2003).
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Figure 1.2: Cytosolic subunits o f  the NADPH oxidase. The predicted domains o f  the three cytosolic subunits, 
p40phox, p47phox, and P67pho\  are indicated in schematics o f primary structure. PX (phox homology) domains are shown 
in green, SH3 (Src homology) domains are shown in pink, P B 1 domains are shown in purple, TPR (tetratricopeptide 
repeat) motifs are shown in dark blue, the poly basic region o f p47phox is shown in yellow, PRR (proline-rich region) 
motifs are shown as thick black bars, and the activation domain o f p67phox is shown in light blue (Groemping and 
Rittinger 2005).
Other conflicting studies assign phosphorylation of p40phox an inhibitory effect 
(Sathyamoorthy et al. 1997; Cross 2000; Lopes et al. 2004). Further evaluation has 
demonstrated that phosphorylation of p47phox and p40phox induces changes in subunit 
conformation, unmasking specific lipid-binding domains (Quinn and Gauss 2004; 
Ueyama et al. 2007). The lipid-binding PX domain recognizes anionic phospholipids 
such as arachidonic acid phosphatidic acid and phosphoinositides, yet these lipid-binding 
domains in p47phox and p40phox may recognize different phosphoinositides (Sato et al. 
2001; Xu et al. 2001; Ellson et al. 2002; Wientjes and Segal 2003; Quinn and Gauss 
2004; Groemping and Rittinger 2005; Bedard and Krause 2007; Ueyama et al. 2007). 
Therefore, phosphorylation of p40phox could harbor a pivotal targeting signal for the 
NADPH oxidase complex to different membrane regions. It is important to note that 
various NADPH oxidase isoforms have been found in different cellular membranes, 
suggesting that specific membrane targeting of cytosolic subunits may be important for
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Krause 2007).
Following translocation of the cytosolic subunits to the membrane and interaction with 
the membrane-bound subunits, the active enzyme complex transfers single electrons from 
cytosolic NADPH, and to a lesser extent cytosolic NADH, via the cytochrome to oxygen, 
forming the superoxide anion (Isogai et al. 1995; Doussiere et al. 1996; Koshkin et al. 
1997; Cross et al. 1999). The production of superoxide by the NADPH oxidase is 
extremely rapid, with release of superoxide on the outside of the plasma membrane in the 
case of the NOX2 isoform. In contrast, ROS production for other NADPH oxidase 
isoforms in other cell types was shown to release ROS into the cytosol (Groemping and 
Rittinger 2005; Bedard and Krause 2007). Diphenylene iodonium, an NADPH oxidase 
inhibitor, targets the single electron transfer reaction of the cytochrome (Bedard and 
Krause 2007).
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Figure 1.3: Membrane targeting of cytosolic NADPH oxidase subunits. Phosphorylation of p47phox and p40phcx 
induce conformational changes that reveal specific membrane-binding domains. Cytosolic subunits, p47phox, p40phox, 
and p67pllox, translocate to the membrane and interact with the membrane-bound subunits gp91phox and p22phox through 
specific protein-protein interactions. Interaction of p67phox and Rac with the flavocytochrome allows full oxidase 
function (Quinn and Gauss 2004).
The small GTPases Racl and Rac2 are necessary for NADPH oxidase activation but are 
not considered true subunits since they play important roles in numerous other cellular 
processes, such as cytoskeletal dynamics (Van Aelst and D'Souza-Schorey 1997; Bishop 
and Hall 2000; Etienne-Manneville 2006; Bedard and Krause 2007). Strong evidence 
suggests that Racl regulates NOX1 and NOX2 and potentially also NOX3 and NOX4 in 
non-phagocytic cells (Gorin et al. 2003; Inoguchi et al. 2003; Groemping and Rittinger 
2005; Ueno et al. 2005; Bedard and Krause 2007; Miyano and Sumimoto 2007). Racl is 
active in its GTP-bound state, and inactive in its GDP-bound state. This molecular 
switching is regulated by GEFs (guanine nucleotide-exchange factors), which promote 
the release of GDP allowing GTP to bind, and by GAPs (GTPase-activating proteins), 
which promote GTP hydrolysis (Bourne et al. 1990, 1991). Racl is also geranylated at its
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C-terminus aiding in membrane association, and Racl can translocate to the membrane 
independent of NADPH oxidase subunits (Regazzi et al. 1992; Hoffman and Cerione 
2000; Scheffzek et al. 2000). GTP-bound Racl also interacts with the TPR domain of 
p67phox (Diekmann et al. 1994; Nisimoto et al. 1997; Koga et al. 1999). Both Racl and 
Rac2 appear to regulate NOX2, however Rac2 is inducible and is exclusively expressed 
in hematopoietic cell types (Roberts et al. 1999; Gu et al. 2001; Groemping and Rittinger 
2005; Bedard and Krause 2007).
1.3: Sphingolipids
1.3.1: Sphingolipid metabolism
Sphingolipids are important to cellular structure and function. In addition to being 
integral components of membranes, several sphingolipids are bioactive and mediate 
various cellular processes (Futerman and Riezman 2005; Eyster 2007). The nitrogen 
bound at the 2-carbon of the sphingosine-backbone is a unique characteristic to 
sphingolipids. The central lipid of sphingolipid metabolism is ceramide, a central point of 
multiple biosynthetic and catabolic pathways (Futerman and Riezman 2005; Eyster 
2007). The biosynthesis of complex sphingolipids involves the addition of various polar 
head groups to the ceramide-backbone. Various sphingolipids regulate diverse cellular 
responses, with specific alterations in the general sphingolipid-structure mediating 
dramatic differences in cellular function (Futerman and Riezman 2005; Eyster 2007). The 
synthesis of sphingolipids begins in the endoplasmic reticulum and continues in the Golgi 
apparatus and at the plasma membrane (Futerman and Riezman 2005). The breakdown of 
sphingolipids occurs at the plasma membrane and even more so in the lysosome 
(Futerman and Riezman 2005). Cellular localization of sphingolipids is reflective of their 
synthesis and function. Transport proteins like ABC (ATP-binding cassette) transporters 
and CERT (ceramide-transfer protein) regulate the localization and movement of certain 
sphingolipids.
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The de novo synthesis of ceramide begins with the condensation of serine and palmitoyl- 
CoA, a reaction catalyzed by the enzyme serine palmitoyltransferase, to give the product 
3-ketosphinganine (Futerman and Riezman 2005; Eyster 2007). In the next step, 3- 
ketoreductase reduces 3-ketosphinganine, also known as 3-ketodihydrosphingosine, to 
sphinganine or dihydrosphingosine (Futerman and Riezman 2005; Eyster 2007). 
Sphinganine is then acylated at the amide position by dihydroceramide synthase to give 
dihydroceramide and desaturation by dihydroceramide desaturase finally results in 
ceramide formation (Futerman and Riezman 2005; Eyster 2007). It is important to note 
that palmitate, a saturated fatty acid, is an essential precursor of ceramide biosynthesis, 
thus linking ceramide synthesis to saturated fat oversupply and obesity (Chavez et al. 
2003; Futerman and Riezman 2005; Eyster 2007). Another important point is that 
acylation can add a variety of fatty acid chains to the amide position, resulting in 
ceramides with different chain lengths and degrees of unsaturation. In addition to 
affecting membrane dynamics, research has indicated that different ceramides can have 
varying effects on cellular function (Hannun 1996; Hannun and Luberto 2000).
Sphingolipid metabolism continues with ceramide as a precursor to complex 
sphingolipids such as glucosylceramide (Futerman and Riezman 2005; Eyster 2007), 
lactosylceramide, various gangliosides, and sphingomyelin. Specific synthases add 
glucose or phosphocholine to form glucosylceramide or sphingomyelin respectively 
(Futerman and Riezman 2005). Lactosylceramide and the gangliosides are formed by the 
further addition of sugars, as well as sialic acid in the case of gangliosides, to 
glucosylceramide. Conversely, the degradation of sphingomyelin by sphingomyelinases, 
and glucosylceramide by cerebrosidases, liberates ceramide in mechanisms known as the 
salvage synthetic pathways (Futerman and Riezman 2005; Eyster 2007). Further 
catabolism of ceramide by ceramidases, enzymes that deacylate ceramide, results in the 
formation of sphingosine (Futerman and Riezman 2005; Eyster 2007). Importantly, 
multiple sphingomyelinases and ceramidases have been identified and characterized by 
their pH optimums. Enzymes with neutral pH optimum exist and breakdown their
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substrates at the plasma membrane, while acidic enzymes, including the cerebrosidase, 
are localized to the lysosome where significant catabolism and turnover occurs (Futerman 
and Riezman 2005; Eyster 2007). Several deficiencies in the breakdown of complex 
sphingolipids have been identified, and are characterized as lysosomal storage disorders 
because they result in specific complex sphingolipid accumulations in the lysosome.
Sphingosine can be acylated to form ceramide again by a variety of ceramide synthases, 
or it can be phosphorylated by sphingosine kinase (Futerman and Riezman 2005; Eyster 
2007). Lipid kinases are a very important feature of sphingolipid metabolism. Two 
sphingosine kinases, a sphinganine kinase, and a ceramide kinase have been identified, 
phosphorylating sphingosine, sphinganine, and ceramide respectively (Futerman and 
Riezman 2005; Eyster 2007). Phosphorylation seems to be an important event in the 
divergent roles o f sphingolipids as phosphosphingolipids are primarily implicated in 
cellular survival and growth as opposed to their non-phosphorylated counterparts.
Specific phosphatases regulate sphingosine-1-phosphate, sphinganine-1-phosphate, and 
ceramide-1-phosphate by dephosphorylation (Futerman and Riezman 2005; Eyster 2007). 
Sphingosine-1-phosphate is also a target of irreversible degradation by a specific lyase 
(Futerman and Riezman 2005; Eyster 2007). The regulation of these kinases, 
phosphatases, the lyase, and the enzymes described in ceramide metabolism are tightly 
regulated. Alterations in the regulation of these enzymes can lead to a variety of disorders 
ranging from degenerative pathologies to cancer.
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Figure 1.4: Sphingolipid metabolism . De novo ceramide synthesis begins with the condensation o f palmitoyl-CoA 
and serine, followed by reduction o f 3-ketosphinganine, acylation o f sphinganine, and finally introduction o f the trans 
double bond into dihydroceramide. Alternatively, ceramide can be formed from the hydrolysis o f complex 
sphingolipids, like sphingomyelin, through salvage pathways (Summers and Nelson 2005).
1.3.2: Neutral Sphingomyelinase
Sphingomyelinases are enzymes that catalyze the hydrolysis of sphingomyelin, liberating 
ceramide and phosphocholine (Marchesini and Hannun 2004; Clarke et al. 2006). 
Sphingomyelinases are identified by their pH optimum and ion dependence (Marchesini 
and Hannun 2004). Neutral sphingomyelinases, which predominantly localize to the 
plasma membrane, and acidic sphingomyelinases residing in the lysosome are the most 
widely studied. Neutral sphingomyelinases were identified as the primary 
sphingomyelinase induced by cellular stress, including serum deprivation, and growth 
confluency (Clarke et al. 2006). Mammalian neutral sphingomyelinases share some 
homology to bacterial sphingomyelinases particularly in the catalytic regions (Clarke et 
al. 2006). The brain-specific magnesium-dependent neutral sphingomyelinase, neutral 
sphingomyelinase-2, is specifically inhibited by the pharmacological agent GW4869
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(Luberto et al. 2002; Clarke et al. 2006). The activity of this isoform has since been 
identified in other tissues. In contrast to bacterial sphingomyelinases, mammalian neutral 
sphingomyelinases are membrane bound proteins and this has made their characterization 
more difficult (Clarke et al. 2006).
Structures of the catalytic regions of mammalian neutral sphingomyelinases were 
determined by homology modeling using crystal structures from bacterial 
sphingomyelinases. Specifically, the acidic residues such as aspartates and histidines 
were discovered to be important to catalysis (Tomita et al. 1993; Tamura et al. 1995; 
Matsuo et al. 1996; Hofmann et al. 2000), while other aspartate residues were shown to 
be important for substrate recognition (Tamura et al. 1995). Some neutral 
sphingomyelinases have catalytic activity that is dependent on the presence of ions such 
as magnesium. Two magnesium-binding sites were found, including one requiring a 
conserved glutamate residue (Fujii et al. 1998; Obama et al. 2003).
Aside from analysis of catalytic sites, additional structural information is more limited. It 
is known that mammalian neutral sphingomyelinases contain two hydrophobic 
transmembrane regions (Hofmann et al. 2000; Tani and Hannun 2007), as well as a 
binding site for anionic phospholipids such as phosphatidylserine (Okamoto et al. 2002; 
Marchesini et al. 2003; Clarke et al. 2006). The neutral sphingomyelinase also interacts 
with an adapter protein known as the factor associated with neutral sphingomyelinase 
(FAN). The TNFa type I receptor couples to FAN, and this interaction mediates TNFa- 
induced neutral sphingomyelinase activation (Adam-Klages et al. 1996; Segui et al. 2001; 
Marchesini and Hannun 2004). The enzyme is also redox-sensitive, as the addition of 
hydrogen peroxide induced its activity (Levy et al. 2006). A recent study evaluated 
specific S-palmitoylation o f cysteine residues o f the neutral sphingomyelinase (Tani and 
Hannun 2007). Two clusters, termed the Cys3 and Cys5 positions, were shown to be S- 
palmitoylated. The Cys3 modification occurs in the hydrophobic region of the enzyme, 
suggesting importance in membrane targeting and stability of the enzyme (Tani and
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Hannun 2007). The Cys5 modification is localized in the catalytic region, however no 
specific role was identified (Tani and Hannun 2007). Enzyme activity was determined to 
be independent of palmitoylation.
1.3.3: Sphingosine Kinase
Sphingosine kinases are novel lipid kinases that phosphorylate sphingosine, producing 
sphingosine-1-phosphate (Maceyka et al. 2002; Spiegel and Milstien 2003; Hait et al. 
2006; Taha et al. 2006b; Wattenberg et al. 2006; Alemany et al. 2007). There are two 
main homologues of sphingosine kinase. Both sphingosine kinase-1 and -2 phosphorylate 
D-erythro-sphmgosine, but sphingosine kinase-2 has the ability to phosphorylate 
additional isomers of sphingosine that would otherwise inhibit sphingosine kinase-1 
(Olivera et al. 1998; Liu et al. 2000; Melendez et al. 2000; Nava et al. 2000; Pitson et al. 
2000b; Billich et al. 2003; Alemany et al. 2007). Sphingosine kinase-1 is a cytosolic 
protein, while sphingosine kinase-2 is a membrane protein and interestingly is involved 
in the regulation of apoptosis. Sphingosine kinase-1 responds to various stimuli such as 
growth factors, hormones, and cytokines, and has been shown to translocate to different 
membranes including the plasma membrane and phagosomal membranes (Olivera and 
Spiegel 1993; Maceyka et al. 2002; Spiegel and Milstien 2003; Taha et al. 2006b; 
Wattenberg et al. 2006; Alemany et al. 2007). Recently, research has identified important 
structural features of sphingosine kinase-1.
The catalytic domain of sphingosine kinase is a DAG kinase catalytic domain (Pitson et 
al. 2002; Alemany et al. 2007). In sphingosine kinase-1, the nucleotide-binding site has a 
consensus sequence of SGDGX17-21K, where X is any residue (Pitson et al. 2002). The 
specific glycine-82 was determined to be absolutely essential for catalytic activity, and its 
mutation to aspartate resulted in a dominant negative kinase (Pitson et al. 2000a). 
Similarly, glycine-212 in sphingosine kinase-2 was found to be essential for catalytic 
activity (Yoshimoto et al. 2003; Maceyka et al. 2005). Glycine-133 is also critical to the
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function of sphingosine kinase-1 (Pitson et al. 2001). Mutation to aspartate decreased 
function while mutation to alanine enhanced catalytic function (Pitson et al. 2001). 
Sphingosine binding was also evaluated and found to localize to a C4 domain in 
sphingosine kinase-1, with an essential aspartate residue identified in a mouse isoform of 
sphingosine kinase-1 (Yokota et al. 2004).
Additional features o f sphingosine kinase-1 were identified as its function was evaluated. 
Research had demonstrated that phosphorylation of sphingosine kinase-1 at serine-225 
occurred in response to agonist stimulation (Pitson et al. 2003; Alemany et al. 2007). 
Mutation analysis later demonstrated that phosphorylation was not required for basal 
function, but that it was necessary for kinase translocation to the plasma membrane in 
response to growth factor and cytokine stimuli (Pitson et al. 2005; Alemany et al. 2007). 
Research has identified TNFa as a stimulating factor for sphingosine kinase-1. 
Specifically, it was shown that the kinase interacts with TNF receptor associated factor-2 
through a consensus PPEE binding site (Xia et al. 2002). Additionally, it was noted that 
sphingosine kinase-1 bound acid phospholipids via a specific phosphatidylserine-binding 
site including essential residues threonine-54 and asparagine-89 (Olivera et al. 1996; 
Stahelin et al. 2005; Alemany et al. 2007). Inhibition of phosphorylation decreased 
binding to phosphatidylserine, and a model was proposed where phosphorylation causes a 
conformation change revealing the phosphatidylserine-binding site (Pitson et al. 2003; 
Stahelin et al. 2005). Sphingosine kinase-1 also interacts with the acidic phospholipid 
phosphatic acid through a binding site located somewhere in the C-terminal half of the 
enzyme (Delon et al. 2004). This interaction may be important for targeting to endosomal 
or phagosomal compartments.
Sphingosine kinase-1 interacts with calcium-dependent calmodulin, an interaction used to 
measure proper folding of the enzyme (Kohama et al. 1998; Alemany et al. 2007). Some 
studies suggest that calcium is necessary for kinase activity, but no specific interaction 
has been noted (Alemany et al. 2007). Other studies imply that the kinase regulates
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mobilization of intracellular calcium (Alemany et al. 2007). The calmodulin-binding site 
has been mapped to residues 191-206 (Sutherland et al. 2006). Without a functional 
binding site, catalytic activity and phosphorylation remain intact, however phorbol ester- 
stimulated membrane translocation was impeded (Sutherland et al. 2006). Interestingly in 
PC 12 cells, calcium influx through voltage-gated calcium channels elevated sphingosine- 
1-phosphate levels, and ultimately enhanced noradrenaline release (Alemany et al. 2001). 
A more recent study has also implicated sphingosine kinase as a modulator of glutamate 
release from hippocampal neurons (Kajimoto et al. 2007).
New contradicting studies have suggested that TNFa impedes sphingosine kinase-1- 
mediated signaling. In one study, MCF-7 breast cancer cells treated with TNFa for a 
prolonged period entered apoptosis involving lysosomal disruption and release of 
cathepsin B (Taha et al. 2005; Taha et al. 2006a). Cathepsin B, a cysteine protease, 
cleaved sphingosine kinase-1 at multiple sites. Another study in SH-SY5Y 
neuroblastoma cells revealed that the soluble, toxic amyloid beta fragment resulted in a 
loss of sphingosine kinase-1 activity (Gomez-Brouchet et al. 2007). The researchers were 
able to overcome loss in kinase activity by using the antioxidant N-acetyl-L-cysteine. 
These reports suggest that prolonged or excessive exposure to TNFa or amyloid beta 
actually result in downregulation of sphingosine kinase in certain cell types.
1.3.4: Gangliosides and neuronal membranes
The membranes of neurons contain phospholipids, sphingolipids, cholesterol, and 
protein. Sphingomyelin and glycosphingolipids, including gangliosides, are particularly 
prevalent in neuronal membranes (Prioni et al. 2004; Farooqui et al. 2007). These lipids, 
in addition to cholesterol, play important roles in the organization of lipid microdomains 
associated with growth factor and cytokine-mediated signaling. Gangliosides regulate cell 
adhesion, differentiation, neuritogenesis, as well as signaling processes such as those 
leading to oxidative stress (Prioni et al. 2004; Sonnino et al. 2006). Gangliosides exert
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their effects through direct interactions with proteins and enzymes, such as growth factor 
receptors and protein kinases, found on the outer leaflet of the plasma membrane (Prioni 
et al. 2004; Sonnino et al. 2006).
An important feature of gangliosides is their strict localization to the outer leaflet of the 
plasma membrane. Glycosphingolipid synthesis begins with the glycosylation of 
ceramide by glucosylceramide synthase, an enzyme with activity on the cytosolic-side of 
the Golgi membrane (Futerman and Riezman 2005; Sonnino et al. 2006). 
Glucosylceramide is subsequently transported across the membrane, where further 
glycosylation and sialic acid additions occur on membranes destined to become the outer 
leaflet of the plasma membrane. The transport of glucosylceramide across the Golgi 
membrane has been attributed to P-glycoprotein, an ATP-binding cassette (ABC) 
transporter (Liu et al. 2001; Gouaze-Andersson and Cabot 2006). The position of 
gangliosides in the outer leaflet of the plasma membrane not only allows for specific 
interactions with proteins, but also for the space required by the large polar head groups 
(Futerman and Riezman 2005; Sonnino et al. 2006). Enrichment of gangliosides within 
microdomains induces positive membrane curvature due to the space required by the 
head groups with significant consequences for membrane invaginations (Fig. 1.5) 
(Sonnino et al. 2006).
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Figure 1.5: G anglioside-induced m em brane alterations. Gangliosides reside on the outer leaflet o f the plasma 
membrane. The large polar head group o f gangliosides, when packed together, induces positive membrane curvature 
due to space constraints. Positive membrane curvature is important to the formation of membrane invaginations 
(Sonnino et al. 2006).
1.3.5: Interconversion of ceramide and sphingosine-l-phosphate: a potential biostat
Ceramide and sphingosine-l-phosphate are both important bioactive sphingolipids with 
distinctly opposing functions. Ceramide is implicated in the regulation of cellular stress, 
oxidative stress regulated by oxidoreductases, ceramide-mediated mitochondrial 
dysfunction, and apoptosis (Hannun 1996; Hannun and Luberto 2000). Ceramide induces 
apoptosis through activation of caspases as well as by mediating mitochondrial 
alterations and release of cytochrome c (Hannun 1996; Hannun and Luberto 2000). 
Additionally, ceramide can activate various kinases and phosphatases essential for the 
regulation of cellular stress and apoptosis (Hannun 1996; Hannun and Luberto 2000). A 
classic example of ceramide-mediated cellular signaling is the case of insulin resistance 
in which the activity of Akt/PKB is negatively regulated by ceramide (Summers et al. 
1998; Chavez et al. 2003; Stratford et al. 2004). Furthermore, ceramide was shown to 
accumulate in a variety degenerative disorders ranging from diabetes to Alzheimer’s 
disease (Chavez et al. 2003; Grimm et al. 2005; Zheng et al. 2006).
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Recent studies suggested that ceramide forms large pores in membranes. Molecular 
models and experimental data suggest that ceramides pack together, and that the double 
bond of ceramide was critical to the ability to pack together (Anishkin et al. 2006). In 
these studies, dihydroceramide was unable to form stable pores. Hydrogen bonding was 
also proposed as an important structural feature, both between ceramide molecules and 
between ceramide molecules and with water molecules that fill the pore. Ceramide as a 
sphingolipid, has several hydrogen bond donors and acceptors within its hydroxyl groups, 
the carboxyl group, and the amide linkage (Anishkin et al. 2006). The addition of more 
ceramide molecules was suggested to increase pore size, allowing molecules as large as 
small proteins to pass through the membrane. '
Figure 1.6: C eram ide channel. C16-ceramide channel formed by molecules in 6 layers and 14 columns. Neighboring 
columns are in antiparallel orientation. Hydrogen bonding stabilizes the channel, and the double bond o f ceramide 
stabilizes the stacking o f ceramide molecules (Anishkin et al. 2006).
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In contrast to ceramide, sphingosine-l-phosphate regulates cell growth and survival, 
cytoskeletal dynamics and motility, inflammation, thermotolerance, angiogenesis, 
tumorgenesis, development, and antagonizes the effects of ceramide (Cuvillier et al.
1996; Pyne and Pyne 2000; Spiegel and Milstien 2002). Sphingosine-l-phosphate 
regulates these processes by binding to specific G-protein coupled receptors known as 
sphingosine-l-phosphate receptors (Cuvillier et al. 1996; Pyne and Pyne 2000; Spiegel 
and Milstien 2002). Additional evidence suggests that intracellular targets may also exist 
for sphingosine-l-phosphate. However, these targets are currently not defined (Van 
Brooklyn et al. 1998; Xia et al. 1998; Morita et al. 2000; Rosenfeldt et al. 2001). In 
summary, these findings suggest that a ceramide-sphingosine-1-phosphate ‘biostat’ exists 
where the ratio of ceramide to sphingosine-l-phosphate regulates cellular fate (Pyne and 
Pyne 2000). In this model, significant accumulation o f ceramide would result in 
degenerative processes while clearance of ceramide and/or accumulation of sphingosine- 
l-phosphate would promote cell survival and growth. It is noteworthy that certain cancers 
were identified where the ratio of sphingosine-l-phosphate to ceramide was increased 
(Ogretmen and Hannun 2004).
1.3.6: Regulation of eicosanoid biosynthesis
Eicosanoids are lipid-derived bioactive molecules with important pro- and anti­
inflammatory functions (Needleman et al. 1986; Piomelli 1993; Goetzl et al. 1995; Eyster 
2007). Two well-known categories of eicosanoids, prostaglandins and leukotrienes, are 
products of cyclooxygenases (COX) and lipoxygenases (LOX), respectively (Murakami 
and Kudo 2006). While eicosanoids are the primary products of these enzymes, ROS 
represent additional byproducts. COXs include two isoforms that are targeted by several 
well-known pain medications (Eyster 2007). COX-2 is inducible and its dysregulation 
has been implicated in a variety of pathological conditions. There are three LOX 
isoforms, 5-LOX, 12-LOX, and 15-LOX, corresponding to the carbon positions that they 
oxygenate (Eyster 2007).
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COXs and LOXs both utilize arachidonic acid as their primary substrates (Eyster 2007; 
Farooqui et al. 2007). Arachidonic acid is an omega-6 polyunsaturated fatty acid liberated 
by phospholipase A2 activity (Eyster 2007). Arachidonic acid also acts as an important 
mediator of NADPH oxidase isoforms acting as a membrane anchor (Quinn and Gauss 
2004; Groemping and Rittinger 2005; Bedard and Krause 2007). Interestingly, omega-3 
polyunsaturated fatty acids such as docosahexaenoic acid reduce the activity of both 
COXs and LOXs, therefore having an anti-inflammatory effect (Eyster 2007; Farooqui et 
al. 2007). Additionally, a lipoxygenase-like enzyme utilizes docosahexaenoic acid as a 
substrate to produce docosatrienes and resolvins (Eyster 2007; Farooqui et al. 2007). 
These bioactive molecules are known collectively as docosanoids, and act to antagonize 
eicosanoid effects, as well as down-regulate cytokine production in glial cells (Eyster 
2007; Farooqui et al. 2007). Polyunsaturated fatty acids are acquired from dietary sources 
with omega-6 polyunsaturated fatty acids arising from Western diets, and omega-3 
polyunsaturated fatty acids arising from diets rich in certain fish such as salmon and tuna. 
The importance of arachidonic acid as a substrate for eicosanoid biosynthesis and in the 
regulation of several other enzymes, suggests that phospholipase A2 activity is essential 
for inducible-inflammatory responses. Research has demonstrated that the cytosolic 
phospholipase A2 (cPLA2) is a target of ceramide-mediated signaling (Huwiler et al. 
2001). In addition to activation through phosphorylation (Kudo and Murakami 2002; 
Ghosh et al. 2006), which has been proposed to unveil specific lipid-binding domains, it 
was shown that ceramide could directly interact with cPLA2 (Huwiler et al. 2001). More 
recent research has shown that cPLA2 interacts with, and is activated by, ceramide-1- 
phosphate (Pettus et al. 2004; Subramanian et al. 2005; Subramanian et al. 2007). 
Subsequently, ceramide-1-phosphate has gained considerable attention lately as an 
important bioactive sphingolipid regulating inflammatory responses. The role of 
ceramide-1-phosphate appears to be involved in enhancing the association of cPLA2 with 
target membranes (Pettus et al. 2004; Subramanian et al. 2005; Subramanian et al. 2007). 
Target membranes of cPLA2 include the nuclear envelope, the endoplasmic reticulum, 
the Golgi apparatus, and the plasma membrane (Channon and Leslie 1990; Nalefski et al.
Reproduced with permission o f the copyright owner. Further reproduction prohibited w ithout permission.
24
1994; Clark et al. 1995; Leslie 1997). Moreover, ceramide kinase, the enzyme 
responsible for the phosphorylation of ceramide, is regulated in a calcium-dependent 
manner. Ceramide kinase is localized to the Golgi apparatus as well as the plasma 
membrane, thus putting the production of ceramide-1-phosphate near the cPLA2 (Lamour 
et al. 2007). Ceramide-1-phosphate acts as an allosteric activator of cPLA2 enhancing the 
association of the C2 domain of the enzyme with the target membrane (Pettus et al. 2004; 
Subramanian et al. 2005; Subramanian et al. 2007). Importantly, several basic amino 
acids in the C2 domain of cPLA2 were shown to be important to the interaction with and 
regulation by ceramide-1-phosphate (Pettus et al. 2004; Subramanian et al. 2005; 
Subramanian et al. 2007).
1.3.7: Regulation of m ulti-drug resistant and invasive cancer
Chemotherapy and radiation are mainstays of cancer treatment worldwide and resistance 
to these treatments is often observed in cancers. Advanced cancers also invade secondary 
tissues and organs (metastasis). Recent research has focused on the role of sphingolipids 
in cancer drug resistance and invasiveness. Several studies have focused on the proposed 
ceramide-sphingosine-1-phosphate biostat, and the role these bioactive lipids play in 
cellular survival (Senchenkov et al. 2001; Ogretmen and Hannun 2004).
Importantly, most chemotherapeutics and radiation treatments induce significant 
accumulations of ceramide (Senchenkov et al. 2001; Ogretmen and Hannun 2004), which 
was not the original design of most of these treatments. However, ceramide is an 
important cellular signal that leads to apoptosis (Hannun 1996; Zheng et al. 2006). 
Therefore, newer chemotherapeutics aim to increase ceramide levels or deliver ceramide 
into cancer cells (Senchenkov et al. 2001; Fox et al. 2006; Gouaze-Andersson and Cabot
2006). A recently described feature of drug-resistant cancers is the ability to clear 
ceramide from the system. Specifically, enzymes that neutralize ceramide or degrade 
ceramide have been shown to be upregulated in certain drug-resistant cancers
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(Senchenkov et al. 2001; Ogretmen and Hannun 2004; Gouaze-Anders son and Cabot
2006). Another important feature of drug resistance is the ability to eliminate 
chemotherapeutic agents. Positive regulation of drug transporters, including the ABC 
transporters that also move lipids, was demonstrated in multi-drug resistant cancers (Liu 
et al. 2001; Gouaze-Andersson and Cabot 2006). Interestingly, glucosylceramide, a 
sphingolipid generated by neutralizing ceramide through glycosylation, interacts with and 
positively regulates multi-drug transporters (Liu et al. 2001; Gouaze-Andersson and 
Cabot 2006).
Additional studies have focused on the roles of acid ceramidase and sphingosine kinase 
in cancer. Acid ceramidase is upregulated in certain cancers, and this may be important 
not only in clearing ceramide, but also in allowing sphingosine to accumulate as a 
substrate for sphingosine kinase (Senchenkov et al. 2001; Ogretmen and Hannun 2004). 
Sphingosine-l-phosphate, the product of sphingosine kinase, was evaluated due to its role 
as a pro-survival, pro-growth, and anti-ceramide regulator. Not surprisingly, sphingosine 
kinase is upregulated in several highly invasive cancers since it also regulates motility 
(Senchenkov et al. 2001; Ogretmen and Hannun 2004). Additionally, sphingosine-l- 
phosphate, as a regulator of angiogenesis, allows tumors to form extensive blood vessel 
networks that maintain high levels of nutrients. In fact, inhibitors of sphingosine kinase 
or glucosylceramide synthase concurrently with common chemotherapeutics can restore 
sensitivity of resistant cancers to these treatments (Senchenkov et al. 2001; Ogretmen and 
Hannun 2004; Gouaze-Andersson and Cabot 2006).
1.4: Rationale and significance of thesis research
Neuroinflammation is a key component in the progression of acute and chronic 
pathologies of the CNS (Fetler and Amigorena 2005; Block et al. 2007; Farooqui et al.
2007). Induction of oxidative stress during neuroinflammation directly contributes to 
irreversible damage that affects neuronal function and survival. The primary hypothesis
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of this thesis research is that ceramide metabolism plays a crucial role in the regulation of 
NADPH oxidase-driven oxidative stress in the CNS. This research set forth to elucidate a 
molecular pathway in neurons linking inflammatory stimuli to the onset of oxidative 
stress and to neurodegeneration, and evaluated the role of ceramide metabolism and the 
NADPH oxidase in this process.
In particular, the regulation of the NADPH oxidase by sphingolipids and subsequent 
oxidative modulation of macromolecules important to neuronal function and survival 
were evaluated. The sphingolipids ceramide, ceramide-1-phosphate, and sphingosine-l- 
phosphate, as bioactive molecules regulate a diversity of cellular functions including 
inflammatory responses, growth, survival, and oxidative stress (Eyster 2007). Therefore, 
these lipids and their metabolism provided an intriguing potential mechanism for the 
regulation of the NADPH oxidase, as well as important targets of NADPH oxidase- 
dependent oxidation. Importantly, ceramide and ceramide-1-phosphate are well 
established as regulators of Rac GTPase (Yi et al. 2007), protein kinase (Fox et al. 2007), 
and CPLA2 activity (Huwiler et al. 2001; Subramanian et al. 2005), which are all 
important regulators o f NADPH oxidase (Bedard and Krause 2007).
This research further evaluated NADPH oxidase-dependent oxidation of macromolecules 
key to neuronal survival and function such as sphingosine kinase-1, a survival kinase, and 
actin, a component of the neuronal cytoskeleton. Actin plays a prominent role in growth 
cone motility, axon regeneration, dendritic arborization, and plasticity of synapses 
(Gungabissoon and Bamburg 2003; Calabrese et al. 2006; Tada and Sheng 2006). 
Furthermore, disruption of the neuronal actin cytoskeleton is prevalent in both acute CNS 
injury and chronic CNS pathologies (Fiala et al. 2002; Maloney and Bamburg 2007).
This research also investigated whether a specific ceramide metabolite, 
glucosylceramide, regulates NADPH oxidase. Since ceramide clearance is linked to cell 
survival, and generally opposes ceramide exposure, we tested the hypothesis that
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glucosylceramide could antagonize the NADPH oxidase. Intriguingly, reports have 
shown that accumulations of glucosylceramide during type I Gaucher’s disease, a 
lysosomal deficiency in cerebrosidase, are associated with dramatic reductions in 
superoxide production, similar to that observed in chronic granulomatous disease, which 
is characterized by a deficiency in NADPH oxidase activity (Liel et al. 1994; Won and 
Singh 2006).
Detailed knowledge o f the pathway between neuroinflammatory mediators and oxidative 
stress would potentially lead to the development of improved therapeutics to manage 
acute CNS insults, chronic CNS diseases, and psychiatric disorders. As such, the final 
portion of this thesis research addressed the possibility that wild Alaskan blueberries 
contain components that could antagonize pathways of neuroinflammation, particularly 
sphingolipid-mediated pathways. This study showed the value of blueberries beyond their 
role as antioxidants and suggested that therapeutics targeting neuroinflammation may 
already exist in nature.
1.5: Aims, hypotheses, and methods of individual chapters
Chapter 2 - TNFoc-Induced Neuronal NADPH Oxidase Activity Mediates Oxidative 
Damage to the Neuronal Actin Cytoskeleton.
Aim 1: To determine if a neuronal NOX activity is responsive to the pro-inflammatory 
cytokine TNFa.
Aim 2: To determine the impact of NOX-derived ROS on the neuronal actin 
cytoskeleton.
Hypothesis: TNFa stimulates a neuronal NOX activity leading to the oxidation of the 
actin cytoskeleton.
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M ethods: Immunochemistry was used to detect the presence of NOX subunits in 
neuronal cells. NOX activity was characterized by analysis of cytosolic subunit 
phosphorylation, the ability of individual subunits to translocate from the cytosol to the 
plasma membrane, NADPH-reducing ability, and ROS production. Confocal imaging 
was used to detect alterations in the actin cytoskeleton in response to TNFa, while actin 
oxidation in response to TNFa was quantified by immunoprecipitation of actin followed 
by derivatization of protein carbonyls, and western blotting.
Chapter 3 - TNFa- and AJ3-Induced Neutral Sphingomyelinase Activity Regulates 
the Neuronal NADPH Oxidase and Subsequent Oxidative Damage to Sphingosine
Kinase-1.
Aim 1: To define a role for ceramide, produced by Mg2+-nSMase activation, in the 
stimulation of neuronal NOX activity in response to either TNFa or A(3'"42, the soluble 
fragment of the amyloid precursor protein associated with Alzheimer’s disease.
Aim 2: To determine the impact of NOX-derived ROS on SphKl, an enzyme responsible 
for the production of the pro-survival bioactive lipid sphingosine-l-phosphate.
Hypothesis: TNFa and A p1'42 stimulate Mg2+-nSMase activity, leading to an increase in 
neuronal NOX activity and the subsequent oxidation o f actin and SphKl.
M ethods: The activity of Mg2+-nSMase was measured to determine its activation in 
response to treatment with TNFa or A p1'42. The serum-stimulated activity of SphKl was 
measured to determine if treatment with TNFa or A[31-42 caused loss of activity. Analysis 
of cytosolic subunit phosphorylation, cytosol-to-membrane translocation, and ROS 
production were used to evaluate activity of the neuronal NOX in response to TNFa, 
A p1'42, ceramide analogs, or palmitate, the precursor of de novo synthesized ceramide. 
Oxidation of actin and SphKl, in response to treatment with TNFa or A p1-42, was
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evaluated by derivatization of the protein carbonyls from respective immunoprecipitates, 
followed by western blotting. Lastly, neurite outgrowth was used to evaluate neuronal 
integrity and functionality in response to treatments.
C hapter 4 - Ceram ide Kinase Regulates TN Fa-Induced NADPH Oxidase Activity 
and Eicosanoid Biosynthesis in Neurons.
Aim 1: To explore the role of CerK in TNFa-stimulated neuronal NOX activity.
Aim 2: To evaluate the role of CerK in TNFa-stimulated neuronal eicosanoid 
biosynthesis.
Hypothesis: CerK mediates TNFa-stimulated neuronal NOX activity and eicosanoid 
biosynthesis.
M ethods: The activity of CerK was evaluated in response to TNFa. Analysis of 
cytosolic subunit phosphorylation and cytosol-to-membrane translocation, and ROS 
production were used to evaluate activity of the neuronal NOX in response to TNFa. 
Pharmacological agents were further used to determine the contribution of 5-LOX and 
COX-2 to ROS production in response to TNFa exposure. As an enzyme key to 
prostaglandin biosynthesis, a class of eicosanoids, COX-2 activity was measured in 
response to TNFa treatment. Phosphorylation o f 5-LOX and CPLA2 was used to evaluate 
activation in response to treatment with TNFa, while 3H-labeled arachidonic acid release 
was used to evaluate eicosanoid synthesis and release in response to TNFa. Cellular 
viability assays were also used to evaluate survival in response to TNFa exposure. To 
evaluate CerK, siRNA was employed using a cationic nanoliposome transfection scheme 
that was validated by confocal microscopy.
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C hapter 5 -  Inhibition of NADPH Oxidase by Glucosylceramide Synthase Confers 
Chemoresistance.
Aim 1: To evaluate the inhibition of NOX by glucosylceramide synthase, either by its 
depletion of ceramide or via its production of glucosylceramide.
Aim 2: To compare the anti oxidant capacity, including glucosylceramide synthase 
activity, of neuroblastoma and glioblastoma cell lines, and correlate this with differential 
responses to chemotherapy.
Aim 3: To evaluate the efficacy of interfering with glucosylceramide synthase, or 
catalase, in combination with chemotherapy.
Hypothesis: Increased glucosylceramide synthase activity, associated with aggressive 
cancer, impedes TNFa- and chemotherapy-stimulated NOX activity.
M ethods: Enzyme activity assays were used to study basal activities of glucosylceramide 
synthase, superoxide dismutase, and catalase in SH-SY5Y neuroblastoma cells, U-87 MG 
glioblastoma cells, and LN-18 glioblastoma cells. Analysis of cytosol-to-membrane 
translocation, and ROS production were used to evaluate NOX activity in response to 
treatment with TNFa, chemotherapeutics, or nanoliposomes. Viability assays were 
employed to evaluate cell death in response to treatments with TNFa, chemotherapeutics, 
or nanoliposomes. Pharmacological agents were evaluated to impede glucosylceramide 
synthase and catalase activity, while molecular targeting of glucosylceramide synthase 
was achieved using specific siRNA delivered using a cationic nanoliposome delivery 
system. Additionally, glucosylceramide synthase was overexpressed in SH-SY5Y 
neuroblastoma cells to further demonstrate its role in conferring drug-resistance.
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C hapter 6 -  W ild Alaskan B lueberry Extracts Inhibit a M agnesium-Dependent 
N eutral Sphingomyelinase Activity in Neurons Exposed to TNFa.
Aim: To determine if  wild Alaskan blueberries protect against neuroinflammation, and
2_j_ .
more specifically block Mg -nSMase activity.
2 |
Hypothesis: Components of wild Alaskan blueberries block TNFa-stimulated Mg - 
nSMase activity.
M ethods: Wild Alaskan blueberries were collected by hand at various locations in the 
Alaskan interior and aqueous or organic extracts were prepared. Enzyme activity assays 
were utilized to evaluate impediment of TNFa-stimulated Mg2+-nSMase activity by 
blueberry extracts. Antioxidant capacity assays were used to justify dosage o f extracts as 
non-antioxidant in the traditional sense, while cellular viability assays were used to 
evaluate the toxicology of the extracts.
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Chapter 2: TNFa-induced neuronal NADPH oxidase activity mediates oxidative 
damage to the neuronal actin cytoskeleton1
2.1: Abstract
Inflammation accompanied by oxidative stress substantially contributes to the 
progression and possibly the initiation of neurodegeneration prevalent in many chronic 
central nervous system (CNS) disorders and acute CNS injuries. The proinflammatory 
cytokine tumor necrosis factor alpha (TNFa) plays a key role in the orchestration and 
progression of CNS inflammatory processes. In several non-neuronal cell types, TNFa 
stimulates the formation of reactive oxygen species (ROS) and reorganizes actin 
filaments. Our studies demonstrated that TNFa activates a neuronal NADPH oxidase 
(NOX) isoform in human neuroblastoma cells and primary chick cortical neurons, which 
increases the formation of ROS leading to a redox-dependent reorganization of actin 
filaments into stress fibers. TNFa exposure caused a significant increase in the 
carbonylation of actin, a marker of irreversible oxidative damage, which was abolished 
by pharmacological inhibition of NOX activity. Taken together, our findings suggest that 
TNFa neurotoxicity could be attributed in part to NOX-mediated damage to the neuronal 
actin cytoskeleton, thus compromising essential cellular processes. Neuronal NOX 
isoforms might play a key role in inflammation-dependent CNS neurodegeneration.
1 Brian M. Barth, Shelli Stewart-Smeets, Mark V. Wright, Sally J. Gustafson, Danielle L. 
LaVictorie, and Thomas B. Kuhn. Portions of this chapter are published in Molecular and 
Cellular Neuroscience (2009), Volume 41, Issue 2, pages 274-285.
I, Brian Barth, affirm my contributions to the work outlined in this chapter. I contributed 
to the conceptualization and experimental design of the study, worked directly on ROS 
detection, NOX subunit detection, NOX function studies, and actin oxidation studies, and 
helped in the draft preparation of a manuscript containing most data presented in this 
chapter all under the supervision, mentorship, and advisement of Dr. Thomas Kuhn. 
Please see section 2.7 on page 92 for the contributions of the other authors.
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2=2: Introduction
Most CNS pathologies, whether associated with acute injuries or chronic disorders, 
activate microglia and astrocytes and lead to an increase in inflammatory mediators and 
reactive oxygen species (ROS) (Fetler and Amigorena 2005; Nimmerjahn et al. 2005; 
Block et al. 2007). The proinflammatory cytokine tumor necrosis factor alpha (TNFa) 
stimulates apoptosis and elicits the formation ROS in neuronal cells, which cause 
oxidative stress and irreversibly damage proteins, carbohydrates, membrane lipids, and 
nucleic acids (Colton and Gilbert 1987; Sawada et al. 1989; Babior 2000; Town et al. 
2005; Block et al. 2007).
The classic NADPH oxidase in phagocytic cells represents the prototypic NADPH 
oxidoreductase activity of the NOX/DUOX family and the large membrane subunit 
gp91phox (new nomenclature NOX2) defines the NOX/DUOX family (NOX1-5 and 
DUOX1-2) (Lambeth 2002; Quinn and Gauss 2004; Bedard and Krause 2007). NOX 
isoforms are multi-subunit protein complexes composed of two membrane-bound 
subunits (gp91phox and p22phox), and at least three cytosolic subunits (p67phox, p47phox, and 
p40phox) (Quinn and Gauss 2004; Groemping and Rittinger 2005; Bedard and Krause 
2007). Recently, NOX isoforms and their components have been identified in various 
non-phagocytic cell types including hematopoietic stem cells, endothelial cells, epithelial 
cells, myocardial cells, muscle cells, hepatocytes, and neurons (Tammariello et al. 2000; 
Li and Shah 2002; Bedard and Krause 2007). In neuronal cells, functional NADPH 
oxidase complexes predominately consist either of Noxl, Nox2, or Nox4 (Tejada-Simon 
et al. 2005; Vallet et al. 2005; Bedard and Krause 2007). NOX activation requires the 
activation and translocation of all cytosolic subunits to the membrane as well as a series 
of intricate interactions with the membrane-bound subunits and among cytosolic subunits 
(Quinn and Gauss 2004; Groemping and Rittinger 2005; Bedard and Krause 2007). 
Activation of the cytosolic subunits encompasses phosphorylation of specific residues on 
p40phox and p47phox, enabling protein-lipid interactions, and recruitment of p67phox by the
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small GTPase Racl or Rac2 (Quinn and Gauss 2004; Groemping and Rittinger 2005; 
Ueyama et al. 2007).
ROS generated by NOX isoforms are implicated in physiological redox signaling (growth 
factors, cytokines, hormones) in addition to pathogen defense (Incerpi et al. 2007). Many 
cellular processes aside from motility are intimately linked to actin filament dynamics 
including gene expression, mitochondrial homeostasis, and vesicle traffic (Gourlay and 
Ayscough 2005b; Moldovan et al. 2006; Formigli et al. 2007; Lanzetti 2007).
Importantly, disruption of the neuronal actin cytoskeleton is prevalent in both acute CNS 
injury and chronic CNS pathologies and might represent a major step in 
neurodegenerative events (Fiala et al. 2002; Maloney and Bamburg 2007). Munch and 
co-workers recently demonstrated that proinflammatory mediators released from 
microglia attenuated neurite outgrowth and caused neurite retraction (Munch et al. 2003). 
Hippocampal neurons responded to TNFa with a reduction in outgrowth and branching 
of neurites (Neumann et al. 2002). TNFa also induces rearrangements of actin filament 
organization in non-neuronal cells (Hanna et al. 2001). Actin filament dynamics are 
highly sensitive to oxidative modification (Lassing et al. 2007). For instance, hydrogen 
peroxide and nitric oxide reduce the assembly rate of actin filaments and also weaken 
filament stability, whereas superoxide causes actin oligomerization through 
conformational changes in monomeric actin (DalleDonne et al. 1995; Milzani et al. 1997; 
DalleDonne et al. 1998; Milzani et al. 2000). Studies in endothelial cells demonstrated 
that ROS are involved both in physiological as well as pathological actin filament 
reorganization (Moldovan et al. 1999; Moldovan et al. 2000; Karnoub et al. 2001).
The primary aim of this study was to determine if  a neuronal NOX activity was 
responsive to TNFa. Secondly, this study sought to evaluate the impact of neuronal 
NOX-derived ROS on the neuronal actin cytoskeleton. It was hypothesized that TNFa- 
stimulated neuronal NOX activity would oxidatively damage actin. In this study, we 
demonstrated that TNFa stimulated NOX activity and the subsequent formation of ROS
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in both human SH-SY5Y neuroblastoma cells and primary cortical neurons. Increases in 
intracellular ROS caused a rapid reorganization of the neuronal actin cytoskeleton 
concomitant with an increase in actin carbonylation, an irreversible and damaging 
oxidative modification. Therefore, inflammation-mediated disruption of the neuronal 
actin cytoskeleton could represent a key step in CNS neurodegeneration.
2.3: Experimental Procedures
Reagents - Recombinant human tumor necrosis factor alpha (TNFa) was purchased from 
Millipore (Temecula, CA). DMEM and Penicillin/Streptomycin were obtained from 
Mediatech (Herndon, VA). GlutaMAX-1. Hank’s Balanced Salt Solution (HBSS), and 
trypsin/EDTA solution were from Invitrogen (Carlsbad, CA). Fetal bovine serum was 
received from Atlanta Biologicals (Atlanta, GA). Streptavidin-agarose beads, protease 
inhibitor cocktail (PIC), Pico Super Signal chemiluminescent kit, and a BCA protein 
assay kit were obtained from Pierce (Rockland, IL). Polyclonal rabbit anti-DNP 
(dinitrophenyl) primary antibodies were from Invitrogen. A polyclonal rabbit anti-human 
p67phox antibody, and a monoclonal mouse anti-human p40phox antibody were from 
Millipore. Polyclonal goat antibodies against human gp91phox, human p22phox, and human 
phospho-p40phox were from Santa Cruz (Santa Cruz, CA) as well as monoclonal mouse 
antibodies against human p47phox and, human (3-actin, normal mouse serum, and 
horseradish peroxidase-conjugated secondary antibodies. Rhodamine phalloidin was from 
Cytoskeleton Inc. (Denver, CO), and all other reagents were from Sigma (St. Louis, MO).
Cell Culture - Human SH-SY5Y neuroblastoma cells were grown in 100 mm dishes 
(Falcon) in medium composed of DMEM, 10% Fetal Bovine Serum (FBS), 1%
Glutamax, 100 U/rnl Penicillin and 100 U/ml Streptomycin -humidified atmosphere, 5% 
C02,37°C-. For amplification, SH-SY5Y cells were incubated for 5 min with trypsin (0.5 
mg/ml)/EDTA (0.2 mg/ml), washed, and immediately re-suspended in medium. Primary 
cortical neurons were obtained from forebrains of 7 day-old chick embryos (E7), as
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detailed by Wright and Kuhn (Wright and Kuhn 2002). Cortical neurons were plated in 6- 
well plates (5x106 cells per well) coated with poly-D-lysine and grown (humidified 
atmosphere, 5% CO2 ,37°C) in DMEM, 1% Glutamax, 10% FBS, and 1% N3 supplement 
according to Bottenstein and Sato (Bottenstein and Sato 1979).
Growth Cone Particle Preparation - Highly enriched preparations of sealed growth cone 
particles (GCPs) were obtained as described by Pfenninger and co-workers (Pfenninger et 
al. 1983), and as modified by Kuhn and co-workers (Kuhn et al. 1999). After 
homogenizing fresh brains (El 1) in 5 mM HEPES, pH 7.3, 1 mM MgCl2 , 0.32 M 
sucrose, nuclei and intact cells were removed by a low spin centrifugation (1,500 x gmax, 
15 min, 4°C). The supernatant was overlaid onto 5 mM HEPES, pH 7.3, 1 mM MgCb, 
0.75 M sucrose, centrifuged (150,000 x gmax, 60 min, 4°C), and the interface material was 
collected. Following dilution with 5 mM HEPES, pH 7.3, 1 mM MgCl2 , 0.32 M sucrose, 
the solution was overlaid onto Maxidense (Sigma), centrifuged (40,000 x graax, 60 min, 
4°C), and sealed GCPs were collected at the interface. GCPs were re-suspended in Kreb’s 
buffer and used immediately.
Confocal Microscopy - Human SH-SY5Y neuroblastoma cells were grown on collagen- 
coated glass cover slips (0.13 mm thick german glass) in serum-free medium for 24 h. 
Cultures were supplied with 10 pM DPI or 40 pM MnTBAP (60 min) prior to acute 
addition of 200 ng/ml TNFa in serum-free medium. Cultures were fixed 15 min or 30 
min after TNFa exposure for 30 min (room temperature) in 4% paraformaldehyde, 10 
mM MES, pH 6.1, 138 mM KC1, 3 mM MgC^, 2 mM EGTA, 0.5% Triton X-100. After 
rinsing with 0.1% Triton X-100 in Tris-buffered saline (TBS-TX), cultures were 
incubated with rhodamine phalloidin (1:10 dilution, TBS-TX, 20 min, room temperature), 
followed by several rinses (TBS-TX), and transferred into 60% glycerol/40% PBS.
Images were acquired (40X) with a LSM 510 Zeiss confocal microscope equipped with a 
He/Ne laser and an Argon laser using TRITC fluorescence filter combination.
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Quantification o f  Reactive Oxygen Species Production - Increases in reactive oxygen 
species (ROS) were detected with the oxidation-sensitive fluorescence indicator 2’,7’- 
dihydrodichlorofluorescein diacetate (H2 DCFDA), or dihydroethidium (DHE).
H2DCFDA is retained in the cytosol after deacetylation to dihydrodichlorofluorescein and 
increases in fluorescence upon oxidation by H 2 O2 to dichlorofluorescein (DCF). In 
contrast, DHE is oxidized to ethidium (Eth) preferentially by superoxide. SH-SY5Y cells 
or E7 cortical neurons were grown (48 h) in 96-well tissue culture dishes (Falcon, 105 
cells per well) in their respective medium. Cultures were incubated for 1 h either with 50 
pM H2DCFDA, or a combination of both DHE and H2DCFDA (160 pM DHE and 10 
pM H2DCFDA), in the presence or absence of pharmacological inhibitors or ROS 
scavenging enzymes. Following a medium exchange, neuronal cells were exposed to 100 
ng/ml TNFa (increasing time periods, or 15 min), washed with PBS, and lysed (2 M 
Tris-Cl pH 8.0, 2% SDS, 10 mM Na3V 0 4 ). Maximum Eth- or DCF-fluorescence was 
quantified (100 pi cell lysate) using a Beckman Coulter Multimode DTX 880 microplate 
reader (Eth: 485 nm excitation filter, 610 emission filter; DCF: 495 nm excitation filter, 
525 emission filter). All Eth- or DCF-fluorescence intensity data were normalized to the 
average maximum Eth- or DCF-fluorescence under control conditions (relative Eth- or 
DCF-fluorescence values).
Cellular Fractionation - Cells were washed with, and scraped into Buffer A (20 mM 
HEPES pH 7.4, 250 mM sucrose, 2 mM EDTA, 5 mM MgCl2, 1 mM dithiothreitol, 1 
mM AEBSF, and 1% PIC). Following centrifugation (200 x gmax, 2 min), the cell pellet 
was re-suspended in ice cold Buffer A and sonicated. Following centrifugation (1,200 x 
gmax, 5 min), the supernatant was collected (total cellular suspension). Following 
centrifugation of the total cellular suspension (100,000 x gmax, 30 min, 4°C), the 
supernatant was collected (cytosolic fraction). The pellet was re-suspended in Buffer B 
(Buffer A containing 1% Triton X-100 and 0.01% saponin), incubated on ice for 15 min, 
and centrifuged (100,000 x gmax, 30 min, 4°C). The supernatant was collected (membrane 
fraction), and the pellet was re-suspended in Buffer B (cytoskeleton fraction).
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Plasma Membrane Translocation o f  p67phox -  An enriched plasma membrane protein 
fraction was obtained by biotinylation and streptavidin-affinity chromatography as 
described by Li and Shah with minor modifications (Li and Shah 2002). SH-SY5Y 
neuroblastoma cells or E7 cortical neurons were grown in 6-well plates (5xl06 cells per 
well) for 48 h prior to incubation with arachidonyl trifluoromethylketone (ATK, 10 iiM, 
60 min) or buffer. Next, cultures were exposed to 100 ng/ml TNFa for 15 min, washed 
with HBSS-CM (HBSS, 0.1 g/1 CaCl2, 0.1 g/1 MgCl2, pH 7.5), and incubated with 0.5 
mg/ml Sulfo-NHS-Biotin (prepared in 20 mM HEPES, HBSS-CM, pH 8.0) for 40 min on 
ice. Excess Sulfo-NHS-Biotin was neutralized (on ice, 15 min) with 50 mM glycine 
(prepared in HBSS-CM), and cells were scraped into HBSS-CM. After centrifugation 
(200 x gmax, 2 min), cells were resuspended in 500 pL loading buffer (20 mM HEPES pH 
7.5, HBSS, 1% Triton X-100, 0.2 mg/ml saponin, 1% PIC), and sonicated. Cell lysates 
were incubated with streptavidin-agarose beads (25 pi, 2 h, 4°C), beads collected (2,500 
x gmax, 2 min), and resuspended in 150 pL of loading buffer. After heating beads (5 min, 
boiling water bath), and centrifugation (2,500 x gmax, 2 min), membrane proteins were 
enriched in the supernatant and total protein content was determined using a BCA protein 
assay.
Derivatization o f  Carbonylated Actin - SH-SY5Y cells were treated with 10 pM DPI or 
10 pM ATK for 60 min, prior to acute addition of TNFa (100 ng/ml) for 60 min. Cells 
were lysed in 2 M Tris-Cl pH 8.0, 2% SDS, 1 mM Na3VC>4 and centrifuged (3,000 x gmax, 
4°C, 20 min), supernatants (100 pi) incubated with 1 pg normal mouse serum (45 min, 
25°C, agitated), and normal IgG removed with protein A/G agarose beads (20 pi).
Cleared lysates (100 pi) were mixed with 1 pg monoclonal mouse anti-human |3-actin 
primary antibody (agitation 2 h, 4°C) followed by overnight incubation with protein A/G 
agarose beads (20 pi, 4°C, agitation). Protein A/G beads were collected by centrifugation 
(200 x gmax, 2 min), washed three times in lysis buffer, and bound proteins were released 
by boiling for 5 min. Actin carbonyl residues were derivatized with 2,4- 
dinitrophenylhydrazine (DNPH) according to Levine and co-workers (Levine et al.
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1994). Briefly, immunoprecipitated actin samples in lysis buffer were mixed with an 
equal volume of 12% SDS, and further incubated with two sample volumes of 20 mM 
DNPH in 2M HC1 (45 minutes, 25°C). Actin was recovered by chloroform/methanol 
precipitation according to Wessel and Flugge (Wessel and Flugge 1984), and protein 
concentration was determined (BCA protein assay).
Polyacrylamide Gel Electrophoresis and Western blotting - Equal amounts of total 
protein (30-50 pg total cellular protein, or 5 pg immunoprecipitated protein) were 
separated by SDS-polyacrylamide (15%) gel electrophoresis (125 volts, 50 watts, 75 
mA). For native gel electrophoresis, stacking gel (3% acrylamide) and separation gel (3% 
to 12% acrylamide-gradient) were prepared in 200 mM Tris, 162.5 mM glycine, and 
0.2% Triton X-100 and chilled (4°C). Protein samples (20 pg per well in 1.25% Triton X- 
100, 20 mM Tris-Cl pFI 7.5, 1 mM EDTA, 15% glycerol, 0.01% bromphenol blue) were 
subjected to gel electrophoresis (10 mA, 4°C, 90 min). For in-gel NADPH 
oxidoreductase activity staining, gels were incubated in 100 mM potassium phosphate pH 
7.0, 1 mg/ml NBT, 0.3 mg/ml NADPH at room temperature. The staining reaction was 
stopped with 5% acetic acid. For western blotting, proteins were transferred from SDS or 
native polyacrylamide gels onto PVDF membranes (2.5 hours, 50 volts, 50 watts, 250 
mA) according to Towbin and co-workers (Towbin et al. 1992). Following transfer, 
membranes were blocked with TBST-BSA (50 mM Tris-Cl pH 7.4, 150 mM NaCl, 0.1% 
Tween-20 mg/ml, bovine serum albumin), and probed overnight with the respective 
primary antibody (1 pg/pl in TBST). After several washes in TBST, membranes were 
incubated with the corresponding secondary antibody (0.2 pg/pl in TBST, 45 min). 
Immunoreactivity was detected by chemiluminescence and quantified using a GE 
Healthcare Typhoon Imager with ImageQuant software (United Kingdom).
Statistical Analysis - Analysis of variance (ANOVA) was used to determine statistically 
significant differences between treatments (p<0.05). At least three independent 
experiments were performed for each condition. Post hoc comparisons of specific
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treatments were performed using Scheffe’s test to determine statistical significance based 
on the calculated ANOVA data. A Dunette’s test was used for multiple comparisons 
between treatments and a single control. All error bars represent standard deviations.
2.4: Results
TNFa stimulates ROS production in SH-SY5Y neuroblastoma cells and primary cortical 
neurons. Studies in endothelial cells, hepatocytes, cardiomyocytes, and other non­
neuronal cells revealed that TNFa stimulates the formation of ROS (Vilcek and Lee 
1991; Babior 2000). We expanded these findings into neuronal cells, since many 
neuronal cell types contain TNFa receptors and are vulnerable to TNFa exposure both in 
vitro and in vivo (Sawada et al. 1989; Fetler and Amigorena 2005; Block et al. 2007).
Human SH-SY5Y neuroblastoma cells or cortical neurons obtained from 
forebrain of 7-day old chick embryos (E7) were loaded with the oxidation-sensitive 
fluorescence indicator H2DCFDA. Upon exposure to 100 ng/ml TNFa, ROS formation 
was quantified in cell lysates every 7.5 min time over a 60 min time period (Fig. 2.1). 
Indicative of ROS formation, TNFa elicited a rapid increase in relative DCF- 
fluorescence intensity (1.34 ±0.17, *p<0.05, n=5) in lysates of SH-SY5Y cells within 7.5 
minutes after addition compared to control (0.95 ±  0.08, n=3), which persisted for up to 
60 min (Fig. 2.1 A). A presence of 5 mM N-acetyl-L-cysteine (NAC; 0.86 ±  0.04, n=3), 
or 5000 U/ml exogenous catalase (CAT; 1.14 ±  0.10, n=3) negated TNFa-induced ROS 
formation (Fig. 2.1 A). In sharp contrast, ROS formation was not compromised by the 
presence of 200 U/ml exogenous superoxide dismutase (SOD; 1.20 ±  0.08, n=3) (Fig.
2 .1A). TNFa-mediated ROS formation was further inhibited by the 1 e‘ transport inhibitor 
diphenylene iodonium (10 pM DPI; 0.97 ± 0.06, n=4) as well as the cPLA2 inhibitor 
arachidonyl trifluoromethylketone (10 pM ATK; 0.92 ± 0.03, n=3), (Fig. 2. IB). In 
lysates of E7 cortical neurons, TNFa (15 min) stimulated a significant ROS formation 
(2.22 ±0.18, *p<0.05, n=13) as opposed to control (0.99 ± 0.10, n=25), which was 
sensitive to 5 mM NAC (0.79 ± 0.13, n=7), 5000 U/ml CAT (1.54 ±  0.27, n=7), 10 pM
Reproduced with permission o f the copyright owner. Further reproduction prohibited w ithout permission.
77
DPI (1.16 ± 0.32, n=7), and 10 pM ATK (1.31 ± 0.20, n=7), but not 200 U/ml SOD (2.98 
+ 0.40, **p<0.05, n=7) (Fig. 2.1C). To more closely evaluate superoxide, SH-SY5Y cells 
were pre-incubated simultaneously with both H2 DCFDA (10 pM) and DHE (160 pM). 
The ROS species preference of DCF is mostly for peroxide, while Eth is for superoxide. 
In the presence of both indicators, TNFa (15 min) only stimulated a significant increase 
in relative Eth-fluorescence (Eth-control: 1.00 ±0.13, n=6; Eth-TNFa: 1.47 + 0.07, 
*p<0.01, n=3) (DCF-control: 1.00 + 0.09, n=6; DCF-TNFa: 1.06 + 0.21, n=3), indicative 
of superoxide formation (Fig. 2. ID). TNFa-stimulated superoxide formation was still 
abrogated by 5 mM NAC (Eth: 1.00 + 0.08, n=3; DCF: 0.63 + 0.09, n=3), 10 pM DPI 
(Eth: 0.92 ±  0.03, n=3; DCF: 0.95 ±  0.27, n=3), and 10 pM ATK (Eth: 1.03 ± 0.20, n=3; 
DCF: 0.95 ± 0.07, n=3). Taken together, these findings demonstrate that TNFa 
stimulates the formation of ROS in human SH-SY5Y neuroblastoma cells and E7 cortical 
neurons. The apparent ineffectiveness o f SOD to quench DCF-detected ROS, combined 
with the ability of Eth to detect ROS and quench DCF-detected ROS, together with the 
sensitivity of ROS formation to DPI (NOX inhibitor) and ATK (CPLA2 inhibitor) implied 
a superoxide-generating mechanism; presumably a neuronal NADPH oxidase activity.
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Figure 2.1. T N F a  stim ulates ROS production  in neuronal cells via a NOX activity. Human SH-SY5Y 
neuroblastoma cells and E7 cortical neurons were pre-loaded (1 h) with 50 pM 2 ’,7’-dihydrodichlorofluorescein 
diacetate (H2DCFDA), or a combination o f dihydroethidium (DHE, 160 uM) and H2DCFDA (10 pM), in the presence 
or absence o f pharmacological inhibitors or antioxidant enzymes. H2DCFDA is oxidized preferentially by peroxide, 
while DHE is oxidized primarily by superoxide. Cultures were exposed to 100 ng/ml TN Fa, and maximum ethidium 
(Eth)- or DCF-fluorescence was quantified in whole cell lysates. Eth- or DCF measurements were normalized to the 
average maximum Eth- or DCF-fluorescence under control conditions (relative fluorescence values). (A) In SH-SY5Y 
cells, T N Fa stimulated ROS formation within 7.5 min upon exposure and lasting up to 60 min (TNF, filled squares) 
indicated by significant increases in relative DCF-fluorescence (*p<0.05) compared to control (CON, filled circles). 
TNFa-stimulated ROS formation was blocked by 5 mM NAC (TNF+NAC, open triangles) or 5,000 U/ml catalase 
(TNF+CAT, filled diamonds), but not 200 U/ml superoxide dismutase (TNF+SOD, filled triangles), which was 
ineffective. (B) Pre-treatment o f SH-SY5Y cells with 10 pM DPI (TNF+DPI, filled diamonds), a NOX inhibitor, or 10 
pM ATK (TNF+ATK, filled triangles), a cPLA2 inhibitor, also abolished TNFa-stimulated ROS formation. (C) E7 
cortical neurons also responded with a significant formation of ROS (TNF, black bar) within 15 min o f TN Fa exposure 
compared to controls (CON, white bar) (*p<0.05). ROS formation was suppressed by a presence o f 5 mM NAC 
(TNF+NAC, grey bar), 5,000 U/ml catalase (TNF+CAT, grey bar), 10 pM DPI (TNF+DPI, grey bar), or 10 pM ATK 
(TNF+ATK, grey bar), but not by 200 U/ml superoxide dismutase (TNF+SOD, black bar, **p<0.05 compared to 
TNFa-alone). (D) SH-SY5Y cells exposed to 15 min of T N Fa exhibited a significant increase in relative Eth- 
fluorescence (red bars) (sensitive to 5 mM NAC, 10 pM DPI, or 10 pM ATK) (*p<0.01), even in the presence o f 
H2DCFDA, indicative of a superoxide-generating mechanism (DCF-fluorescence: green bars). All data represent the 
mean of at least three independent experiments + standard deviations.
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SH-SY5Y neuroblastoma cells and E7 cortical neurons express a functional NO X activity. 
The classic NADPH oxidase (NOX) in phagocytes is a multi-subunit complex composed 
of two membrane-bound subunits (gp91phox or NOX2, and p22phox), and at least three 
cytosolic subunits (p67phox, p47phox, and p40phox). Only recently, NOX2 homologues were 
identified in many different cell types including sensory and cortical neurons (Bedard and 
Krause 2007).
Using human subunit-specific antibodies, we found immunoreactivity against all 
subunits of the NOX2 complex in whole cell lysates of human SH-SY5Y neuroblastoma 
cells with apparent molecular weights of 65 kDa for NOX2, 20 kDa for p22phox, 65 kDa 
for p67phox, 45 kDa for p47phox, and 40 kDa for p40phox (Fig. 2.2A). In phagocytes, 
phorbol 12-myristate 10-acetate (PMA) and arachidonic acid potently stimulate NOX2 
activity reflected by a translocation of cytosolic subunits such as p67phox to the plasma 
membrane. Treatment of SH-SY5Y cells with 200 nM PMA and 50 pM arachidonic acid 
caused a time-dependent translocation of the cytosolic subunit p67phox to the plasma 
membrane (Fig. 2.2B). More importantly, TNFa (100 ng/ml, 15 min) induced a 
significant translocation of p67phox to the plasma membrane (1.48 + 0.09, *p<0.05, n=3) 
in SH-SY5Y cells compared to control (1.01 + 0.02, n=3), which was completely negated 
by the CPLA2 inhibitor ATK (10 pM; 1.13 + 0.03, n=3) (Fig. 2.2C). Similarly, 
phosphorylation of the cytosolic subunit p40phox (1.65 + 0.21, *p<0.05, n=3) significantly 
increased compared to control (1.02 + 0.08, n=3) upon TNFa stimulation (100 ng/ml, 15 
min) (Fig. 2.2D).
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Figure 2.2. SH-SY5Y neuroblastom a cells express a functional NOX2. (A) Whole cell lysates o f human SH-SY5Y 
neuroblastoma cells revealed immunoreactivity against both membrane-bound subunits (gp91phox, p22phox) and the 
cytosolic subunits (p67phox, p47phox, and p40phox) o f the NOX2 complex using anti-human subunit specific antibodies 
(loading-control: actin). (B) Treatment o f SH-SY5Y cells over a 60 min time course with 200 nM phorbol 12-myristate 
10-acetate (PMA) and 50 pM arachidonic acid stimulated a time-dependent translocation o f p67phox into plasma 
membrane. Equal amounts o f total plasma membrane protein were separated by SDS-gel electrophoresis followed by 
western blotting against p67phox and quantification o f p67phox immunoreactivity. (C) SH-SY5Y cells were incubated 
with 100 ng/ml T N Fa for 15 min and plasma membrane proteins biotinylated with Sulfo-NHS-biotin. Membrane 
proteins were affinity-purified on streptavidin-agarose, and equal amounts o f membrane protein were separated by 
SDS-gel electrophoresis, followed by western blotting. Immunoreactivity against p67phox was quantified 
(chemiluminescence). T N Fa elicited a significant translocation o f p67phox to plasma membranes (1.48 + 0.09, *p<0.05, 
n=3, black bar), which was blocked by the cPLA2 inhibitor ATK, (10 pM, TNF+ATK, grey bar). (D) SH-SY5Y cells 
were incubated with T N Fa (100 ng/ml, 15 min) and whole cell lysates subjected to gel electrophoresis followed by 
western blotting. Phospho-p40phox immunoreactivity (chemiluminescence) was quantified using a Typhoon Imager 
with ImageQuant software. Clearly, TN Fa increased levels o f  phospho-p40phox (1.65 + 0.21, *p<0.05, n=3, black bar) 
in SH-SY5Y cells compared to control (CON, white bars). All data represent the mean of three independent 
experiments + standard deviations.
Cortical neurons also expressed a TNFa-sensitive NOX2-like activity. We found 
immunoreactivity against all NOX subunits in E7, E9, and E l 1 whole brain homogenates 
using human NOX subunit-specific antibodies (Fig. 2.3A). The apparent molecular
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weight of the subunits were nearly identical to those detected in SH-SY5 Y cells. Utilizing 
native polyacrylamide gel electrophoresis followed by NBT staining, NADPH 
oxidoreductase activities were detected in E7 whole brain homogenates (Fig. 2.3B, lane 
1), in growth cone particles freshly prepared from E l 1 whole brains (Fig. 2.3B, lane 2), 
as well as in a plasma membrane preparations obtained from E7 cortical neurons (Fig. 
2.3B, lane 3) with one activity corresponding to NOX2 (Fig. 2.3B, lane 4). Quantitative 
analysis revealed a significant translocation of p67phox to plasma membranes of E7 
cortical neurons stimulated with 100 ng/ml TN Fa (1.36 ± 0.03, *p<0.05, n=3) compared 
to control (1.04 + 0.04, n=3). As in the case of human SH-SY5Y neuroblastoma cells, 
p67phox membrane translocation was abolished by 10 pM ATK (1.13 + 0.01, n=3) (Fig. 
2.3C). Taken together, these findings provided evidence that human SH-SY5Y 
neuroblastoma cells and E7 cortical neurons both express a functional NOX2 complex.
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Figure 2.3. P rim ary  cortical neurons express a functional NOX2. (A) Membrane-bound subunits (gp91phox, 
p22phox) and cytosolic subunits (p67phox, p47phox, and p40phox) o f the NOX2 complex were detected in chick E7, E9, and 
El 1 whole brain homogenates using anti-human subunit specific antibodies (loading-control: actin). (B) NADPH 
oxidoreductase activities were detected in E7 whole brain homogenates (lane 1) and growth cone particles freshly 
prepared from chick E l 1 brains (lane 2) by native-gel electrophoresis and subsequent in-gel NBT staining. Similar 
activities were found in plasma membranes o f E7 cortical neurons (lane 3), with one activity corresponding to Nox2 
(lane 4, western blot against gp91phox). (C) T N Fa stimulated a significant translocation o f p67phox to plasma 
membranes (1.36 + 0.03, *p<0.05, n=3, black bar) o f E7 cortical neurons, which was blocked by 10 pM ATK 
(TNF+ATK, grey bar). Following stimulation of E7 cortical neurons with 100 ng/ml T N Fa (15 min), plasma 
membrane proteins were biotinylated (Sulfo-NHS-biotin), affinity-purified on streptavidin-agarose, analyzed by SDS- 
gel electrophoresis followed by western blotting, and p67phox immunoreactivity was quantified (Typhoon Imager). All 
values were normalized to control (CON, white bar). All data represent the mean of three independent experiments + 
standard deviations.
TNFa stimulates a redox-dependent reorganization o f  the neuronal actin cytoskeleton. 
The proinflammatory cytokine TNFa induces a rearrangement of the cellular actin 
cytoskeleton in many cell types reflecting changes in actin filament dynamics (Hanna et 
al. 2001). Moldovan and coworkers recently demonstrated in endothelial cells a causal
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link between intracellular formation of ROS and reorganization of actin filaments 
(Moldovan et al. 2006). Thus, we explored in human SH-SY5Y neuroblastoma cells 
whether TNFa mediated a ROS-dependent rearrangement o f the neuronal actin 
cytoskeleton.
Serum-starved SH-SY5Y neuroblastoma cells grown on collagen displayed a 
highly condensed morphology with little or no lamellipodia but responded with a 
dramatic, yet transient increase in lamellipodial formation within 15 min upon exposure 
to 200 ng/ml TNFa (Fig. 2.4, upper panel). In sharp contrast, incubation o f serum-starved 
SH-SY5Y neuroblastoma cells with 10 pM DPI negated lamellipodial activity in 
response to TNFa, and cells retained their condensed morphology (Fig. 2.4, middle 
panel). Similarly, scavenging ROS with the catalytic antioxidant Manganese (III) tetrakis 
(4-benzoic acid) porphyrin chloride (MnTBAP, 40 pM), a superoxide dismutase mimetic, 
largely suppressed a rearrangement of the neuronal actin cytoskeleton in the presence of 
TNFa. The sensitivity of actin filament dynamics to DPI and the catalytic antioxidant 
MnTBAP suggested a direct role of ROS in TNFa-mediated reorganization of the 
neuronal actin cytoskeleton.
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Figure 2.4. TNFa stimulates a redox-dependent, transient rearrangement of actin filaments in neuronal cells.
Human SH-SY5Y neuroblastoma cells were grown on collagen in serum-free medium and incubated either with 10 uM 
DPI, 40 pM MnTBAP, or buffer for 1 h. Next, cultures were exposed to 200 ng/ml T N Fa and then processed for 
rhodamine phalloidin staining. Serum-starved SH-SY5Y cells exhibited a condensed morphology with little or no 
lamellipodia (control). In contrast, acute exposure o f serum-starved SH-SY5Y cells to T N Fa elicited the formation of 
lamellipodia -arrow heads- within 15 min. However, lamellipodia formation ceased and 30 min after TNFa-exposure, 
SH-SY5Y cells reverted to their condensed morphology. The NOX inhibitor DPI blocked lamellipodia formation upon 
addition o f  TN Fa (200 ng/ml, 15 min), and SH-SY5Y cells retained a condensed morphology typical o f serum-starved 
cells. Preincubation of SH-SY5Y cells with MnTBAP also interfered with a transient formation of lamellipodia in the 
presence o f T N Fa (200 ng/ml, 15 min).
TNFa elicits oxidative damage to the neuronal actin cytoskeleton. Actin is highly 
susceptible to oxidative modification, which compromises polymerization, 
depolymerization, and the stability of actin filaments (Lassing et al. 2007). Thus 
oxidative damage of actin adversely affects many critical cellular processes that depend
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on proper actin dynamics such as cellular motility (Moldovan et al. 2006), gene 
expression (Formigli et al. 2007), mitochondrial viability (Gourlay and Ayscough 2005a), 
vesicle trafficking (Lanzetti 2007), and synaptic plasticity (Gungabissoon and Bamburg 
2003; Calabrese et al. 2006; Tada and Sheng 2006). In fact, actin oxidation is prevalent in 
many neurodegenerative disorders (Fiala et al. 2002; Maloney and Bamburg 2007). 
Therefore, we examined whether the neurotoxicity of TNFa, at least partially, could be 
attributed to oxidative damage to the neuronal actin cytoskeleton using carbonylation as a 
marker of oxidative stress.
As shown in Figure 2.5, SH-SY5Y neuroblastoma cells exhibited significant actin 
carbonylation upon treatment with TNFa (100 ng/ml, 60 min) (1.24 + 0.02, *p<0.05, 
n=3) compared to control (0.99 + 0.02, n=3). As expected, preincubation of SH-SY5Y 
neuroblastoma cells with 10 pM DPI completely negated actin carbonylation in the 
presence of TNFa to levels comparable to control conditions (1.09 + 0.01, n=3). 
Inhibition of CPLA2 using 10 pM ATK also reduced actin carbonylation (0.98 ±0.01, 
n=3). Neither pharmacological treatment altered actin carbonylation in the absence of 
TNFa and residual carbonylation was indistinguishable from control conditions -data not 
shown-. These findings provide evidence that TNFa exposure results in irreversible 
oxidative damage (carbonylation) to the neuronal actin cytoskeleton by stimulating a 
NOX2-like activity.
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Figure 2.5. T N Fa mediates carbonylation of actin in neuronal cells via NOX2 activation. Total actin was 
immunoprecipitated from whole cell lysates o f SH-SY5Y neuroblastoma cells treated with T N Fa (100 ng/ml, 60 min) 
following a lh  pretreatment with the NOX inhibitor DPI (10 pM), or the cPLA2 inhibitor ATK (10 pM). Protein 
carbonyls o f the precipitated actin were derivatized with 2,4-dinitrophenylhydrazine (DNP). Following SDS-gel 
electrophoresis and western blotting, DNP immunoreactivity (chemiluminescence) was quantified using a Typhoon 
Imager with ImageQuant software. T N Fa induced a significant increase in carbonylation of total actin (1.24 + 0.02, 
*p<0.05, n=3, black bar) compared to control (CON, white bar). Note, either DPI or ATK diminished carbonylation o f 
actin (grey bars) to control levels despite a presence of TNFa. All values were normalized to controls and represent the 
mean of three independent experiments + standard deviations.
2.5: Discussion
Our studies in human SH-SY5Y neuroblastoma cells and E7 chick cortical 
neurons demonstrated that TNFa stimulated the formation of ROS via a neuronal NOX2 
activity resulting in increased carbonylation concomitant with a dramatic rearrangement 
o f actin filaments into stress fibers. Carbonylation o f actin, an irreversible and likely 
debilitating oxidative modification, could severely compromise fundamental cellular 
processes such as motility, gene expression, vesicle traffic, and mitochondrial 
homeostasis, which all require proper actin filament dynamics. These findings imply a 
key role for neuronal NOX activities in CNS inflammation ultimately contributing to 
neuronal cell death.
The pro-inflammatory cytokine TNFa exerts pleiotropic effects in the developing, 
adult, and injured CNS. Yet persistent, high expression levels o f TNFa are neurotoxic
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due to the generation of ROS and production of adverse lipid second messengers. We 
measured a significant increase in maximum DCF-fluorescence intensity, indicative of 
ROS formation, in both human SH-SY5Y neuroblastoma cells and E7 cortical neurons 
exposed to TNFa (Fig. 2.1). Passive ROS scavenging with the antioxidant NAC or 
enzymatic ROS scavenging by exogenous catalase both completely abolished TNFa- 
mediated ROS formation whereas exogenous superoxide dismutase (SOD) was 
ineffective. Since addition of exogenous SOD did not quench ROS formation, it could be 
implied that the TNFa-stimulated ROS source may either produce peroxide directly, or 
generate superoxide, which would rapidly be converted by the additional SOD to 
peroxide (detected preferentially by DCF). To further evaluate this discrepancy, we 
utilized two ROS indicators simultaneously (Eth and DCF) (Figure 2. ID). The preference 
o f Eth is almost entirely for superoxide; therefore its use in excess would deplete 
superoxide and only allow remaining peroxide to react with DCF. Indeed, Eth detected a 
significant increase in ROS in response to TNFa, however the excess of Eth negated any 
DCF-detectable ROS. This demonstrated that TNFa-stimulated intracellular ROS 
production was from a superoxide-generating source. The fact that both the le'transport 
inhibitor DPI and the CPLA2 inhibitor ATK, respectively, abolished ROS formation in 
response to TNFa provided indirect evidence for a superoxide-generating source such as 
neuronal NOX isoform. Also, activity of many NOX isoforms depends on the transfer of 
electrons from NADPH onto oxygen and the lipid second messenger arachidonic acid, 
the product of CPLA2 activity (Bedard and Krause 2007). Indeed, recent studies describe 
the expression of the multi subunit proteins N oxl, Nox2, and Nox4 in neuronal cells 
(Tejada-Simon et al. 2005; Vallet et al. 2005; Bedard and Krause 2007). Using human- 
specific antibodies, we found immunoreactivity against all subunits of Nox2 in human 
SH-SY5Y neuroblastoma cells (Fig. 2.2). Our finding was in agreement with Nikolova 
and co-workers who recently found mRNA for all subunits of Nox2 in SH-SY5Y cells 
(Nikolova et al. 2005). We further corroborated this finding in homogenates prepared 
from whole brains of 7 day-, 9 day-, and 11 day-old chick embryos (Fig. 2.3).
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In addition to increases in ROS formation, stimulus-dependent translocation of 
the cytosolic subunit p67phox to plasma membranes or phosphorylation o f p40phox are 
strong indicators of a functional NOX assembly. PMA and arachidonic acid are well- 
documented activators o f NOX enzymes due to PMA stimulating kinase activities and 
arachidonic acid serving as a membrane-anchor upon interaction with Phox homology 
domains present in the p40phox and p47phox subunits (Groemping and Rittinger 2005; 
Bedard and Krause 2007; Ueyama et al. 2007). SH-SY5Y cells exposed to PMA and 
arachidonic acid revealed qualitative increases in p67phox in a plasma membrane protein 
fraction suggesting the translocation of p67phox from the cytosol to the plasma membrane. 
Native gel electrophoresis in conjunction with NBT staining demonstrated a presence of 
NADPH oxidoreductase activities in whole E7 chick brain homogenates, growth cone 
particles freshly prepared from E l l  chick brains, as well as in plasma membrane 
preparations of E7 chick cortical neurons (Fig. 2.3). Relevant to our studies, TNFa 
stimulated both phosphorylation of p40phox (SH-SY5Y neuroblastoma cells) and plasma 
membrane translocation of p67phox (SH-SY5Y cells and E7 cortical neurons). Together 
these findings provide evidence that human SH-SY5Y neuroblastoma cells and primary 
cortical neurons express a NOX2 isoform generating ROS upon stimulation by TNFa. 
Whether other NOX isoforms are expressed in neuronal cells, and contribute to ROS 
formation, remains to be determined. If TNFa neurotoxicity could be attributed to 
increased ROS formation, oxidation-sensitive cellular targets should be detectable. We 
focused our investigations on the neuronal actin cytoskeleton due to 1) a strong 
vulnerability to oxidative damage, 2) the presence of oxidized actin in many chronic CNS 
disorders, 3) the ability of TNFa to alter actin filament organization, and 4) the essential 
role of actin in fundamental cellular processes.
Due to the complex morphology of primary neurons, we focused our studies on 
SH-SY5Y neuroblastoma cells and their actin cytoskeleton response to TNFa exposure. 
Serum-starved SH-SY5Y neuroblastoma cells grown on a collagen substrate exhibited an 
atrophic, condensed morphology with some actin stress fibers but virtually no 
lamellipodia or filopodia (Fig. 2.4). Upon bath application of TNFa, SH-SY5Y
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neuroblastoma cells displayed a transient phase of cell spreading associated with the 
formation of lamellipodia and filopodia followed by stress fiber formation. Notably, this 
rearrangement of actin filaments was not reversible by washing out TNFa and exhibited 
a prolonged recovery phase, suggesting an irreversible process (data not shown). 
Conversely, preincubation o f SH-SY5Y neuroblastoma cells with DPI or the catalytic 
SOD mimetic MnTBAP, preserved a predominant atrophic condensed morphology of 
SH-SY5Y neuroblastoma cells despite TNFa exposure. These findings implied that 
TNFa elicited a permanent reorganization o f the neuronal actin cytoskeleton via NOX- 
derived ROS. Carbonylation of amino acid residues (lysines, prolines, and arginines) and 
the protein backbone reflect an irreversible oxidative modification known to cause 
dramatic conformational changes, oligomerization, as well as loss of protein function 
(Nystrom 2005). Indeed, we found a profound increase in carbonyl residues in total actin 
of SH-SY5Y neuroblastoma cells exposed to TNFa, which was completely abolished by 
inhibiting NOX activity via a preincubation of cells with either DPI or ATK (Fig. 2.5).
In conclusion, our studies revealed that SH-SY5Y neuroblastoma cells and chick 
E7 cortical neurons, and likely other neuronal cell types, express a functional NOX 2 
activity responding to the proinflammatory cytokine TNFa. Furthermore, TNFa-induced 
neuronal NOX activity resulted in an irreversible oxidation of actin concomitant with a 
severe rearrangement of actin filaments into stress fibers. Organization and dynamics of 
actin filaments are essential for fundamental neuronal processes ranging from changes in 
the motility and morphology of subcellular structures (spines, synapses, axons, 
dendrites), to gene expression, mitochondrial homeostasis, and vesicle trafficking. 
Therefore irreversible oxidative modification of actin could dramatically compromise the 
functionality and survivability of CNS neurons.
There is a substantial presence o f activated microglia and astrocytes in the CNS 
associated with acute injuries, chronic neurodegenerative diseases, and psychiatric 
disorders. Activated microglia and astrocytes play a key role in the orchestration and 
progression o f CNS inflammation by releasing numerous inflammatory mediators such as 
cytokines and eicosanoids as well as ROS (Fetler and Amigorena 2005; Nimmerjahn et
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al. 2005; Block et al. 2007). Therefore, persistent inflammation accompanied by 
oxidative stress contributes, to a large extent, to neuronal death. Our findings provided 
evidence that inflammatory mediators (TNFa) prevalent in many CNS pathologies could 
compromise neurons through a direct and irreversible oxidative modification of actin, 
thus disrupting key cellular processes. The fact that neuronal NOX isoforms play a vital 
role in this neurotoxicity-mechanism could potentially open new therapeutic strategies to 
alleviate neurodegeneration and improve neuronal survival and connectivity.
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Chapter 3: TNFa- and Af3-induced neutral sphingomyelinase activity regulates the 
neuronal NADPH oxidase and subsequent oxidative damage to sphingosine 
kinase-l
3.1: Abstract
Inflammation and its mediators are implicated in the orchestration and 
progression of chronic degenerative CNS pathologies commonly accompanied by signs 
of severe oxidative stress. The bioactive sphingolipid ceramide is generated by the 
hydrolysis o f sphingomyelin through the action of neutral sphingomyelinase (nSMase), 
which is found associated with type I receptors of the pro-inflammatory cytokine tumor 
necrosis factor alpha (TNFa). Ceramide and its metabolites play a key role in mediating 
oxidative stress and stimulating apoptosis in neurons and non-neuronal cells. In human 
SH-SY5Y neuroblastoma cells or primary cortical neurons, both TNFa and the amyloid 
beta fragment (A|3M2) stimulated nSMase activity, subsequent ceramide generation, and 
the formation of ROS via a neuronal NADPH oxidase (NOX) activity. Neuronal 
degeneration was further provoked by NOX-dependent oxidative damage to sphingosine 
kinase-1, an enzyme responsible for the generation of the pro-survival messenger 
sphingosine-1-phosphate. Our studies suggest that ceramide-mediated activation of a 
neuronal NOX activity in combination with a loss o f sphingosine-1-phosphate formation 
greatly contributes to CNS neurodegeneration.
2 Brian M. Barth, Sally J. Gustafson, Danielle L. LaVictorie, and Thomas B. Kuhn. 
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I, Brian Barth, affirm my contributions to the work outlined in this chapter. I contributed 
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and advisement o f Dr. Thomas Kuhn. Please see section 3.7 on page 128 for the 
contributions of the other authors.
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3.2: Introduction
Central nervous system (CNS) neurodegeneration associated with acute injuries, 
chronic diseases, or psychiatric disorders, exhibits widespread inflammation [1]. 
Microglia and astrocytes respond to injury, toxins, and invading pathogens by secreting 
inflammatory mediators such as cytokines, eicosanoids, and reactive oxygen species 
(ROS) [1-4]. The pro-inflammatory cytokine tumor necrosis factor alpha (TNFa) elicits 
ceramide accumulation and formation of ROS upon binding to a high affinity (type I) 
receptor expressed on the surface of many neuronal cell types [1, 5-7]. The TNFa type I 
receptor is coupled to Mg2+-dependent neutral sphingomyelinase (Mg2+-nSMase) through 
the adaptor protein FAN (factor associated with nSMase) [8-10], SMases are enzymes 
identified by their pH optimum and ion dependence that catalyze the hydrolysis of 
sphingomyelin, liberating ceramide and phosphocholine [9, 11]. Mg2+-nSMase is 
localized at the plasma membrane, and was identified as the primary SMase induced by 
cellular stress signaling [11]. The brain-specific SMase, Mg2+-nSMase2, is specifically 
inhibited by the pharmacological agent GW4869 [11, 12],
Ceramide, the product of SMase activity, is implicated in stress kinase activation, 
oxidative stress, and apoptosis [9, 10, 13-15]. Oxidative stress results from aberrant 
stimulation of a variety of oxidoreductases, as well as through ceramide-mediated 
mitochondrial dysfunction that results in the uncoupling of electron transport [1, 14, 16, 
17]. One particular family of oxidoreductases, the NADPH oxidase (NOX) family, was 
originally discovered in phagocytic cells, yet has recently been identified in various non- 
phagocytic cell types, including neurons [18-21], NOX enzymes are highly regulated 
multi-subunit complexes. Assembly of NOX requires phosphorylation of cytosolic 
subunits followed by interactions between lipid-binding PX (Phox-homology) domains 
and anionic phospholipids [19, 22-24],
Activation of NOX results in the rapid production of superoxide anion, a highly 
reactive oxygen radical [18]. Numerous cellular processes are sensitive to oxidative 
modification, including those associated with cellular function and survival. Sphingosine 
kinases (SphK) are novel lipid kinases that phosphorylate the ceramide metabolite
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sphingosine to produce sphingosine-1-phosphate (SIP), a pro-growth and pro-survival 
mediator [25-28], Importantly, SIP opposes the detrimental effects o f ceramide. In 
addition to regulating survival, recent studies have also implicated SIP as a modulator of 
neurodevelopment. Toman and co-workers demonstrated that SIP induced neurite 
outgrowth in both PC 12 cells and dorsal root ganglia (DRG) neurons [29], while another 
study by Mizugishi and co-workers showed that mice with both isoforms o f SphK 
knocked out did not develop to term due to neurodevelopment complications [30], 
Additionally, a more recent study by Strochlic and co-workers suggested that SIP was 
involved in axon guidance of the developing Xenopus visual system by acting as a 
repulsive factor, directing retinal growth cones toward the optic tectum and away from 
other regions of the brain [31].
The aim of our study was to determine the pathway by which TNFa and the 
amyloid beta fragment (Ap1-42) stimulated NOX in neurons. We demonstrated that both 
TNFa and Aj31-42 stimulated Mg2+-nSMase activity, and that the subsequent generation of 
ceramide stimulated a neuronal NOX activity. We further showed that SphKl was a 
novel target for NOX-derived ROS; identifying a mechanism where ceramide-signaling 
interfered directly with SIP formation and neuron survival.
3.3: Materials and Methods
Reagents
Recombinant human TNFa was purchased from Millipore (Temecula, CA). A p1' 
42 was from AnaSpec (San Jose, CA). Sphingolipids were from Avanti Polar Lipids 
(Alabaster, AL). GW4869 and naphthalene dicarboxylaldehyde (NDA) were purchased 
from EMD Biosciences (San Diego, CA). Polyclonal rabbit anti-DNP (dinitrophenyl) 
primary antibodies were from Invitrogen (Carlsbad, CA). Polyclonal rabbit anti-human 
p67phox primary antibodies were from Millipore. Polyclonal goat anti-mouse SphKl 
primary antibodies, polyclonal goat anti-human phospho-p40phox primary antibodies, 
monoclonal mouse anti-human P-actin primary antibodies, normal goat serum, and
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horseradish peroxidase-conjugated secondary antibodies were from Santa Cruz (Santa 
Cruz, CA). DMEM and Penicillin/Streptomycin were obtained from Mediatech 
(Herndon, VA). GlutaMAX-1, Hank’s Balanced Salt Solution (HBSS), trypsin/EDTA 
solution, and an Amplex Red Sphingomyelinase assay kit were purchased from 
Invitrogen. Fetal bovine serum was received from Atlanta Biologicals (Atlanta, GA). 
Streptavidin-agarose beads, protease inhibitor cocktail (PIC), Pico Super Signal 
chemoluminescent kit, and a BCA protein assay kit were obtained from Pierce 
(Rockland, IL). All other reagents were purchased from Sigma (St. Louis, MO).
Cel! Culture
Human SH-SY5Y neuroblastoma cells were grown in 100 mm dishes (Falcon) in 
medium composed of DMEM, 10% fetal bovine serum (FBS), 1% Glutamax, 100 U/ml 
Penicillin and 100 U/ml Streptomycin (humidified atmosphere, 5% C02,37°C). For 
amplification, SH-SY5Y cells were incubated for 5 min with trypsin (0.5 mg/ml)/EDTA 
(0.2mg/ml), washed, and immediately re-suspended in medium. Primary cortical neurons 
were obtained from forebrains of 7 day-old chicken embryos (E7), as detailed by Wright 
and Kuhn [32], Cortical neurons were plated and grown on poly-D-lysine-coated 6-well 
plates (5 million cells per well) in DMEM, 1% Glutamax, 10% FBS, and 1% N3 
supplement (humidified atmosphere, 5% CO2 ,37°C) according to Bottenstein and Sato
[33].
Dorsal Root Ganglia Neurite Outgrowth Assay
Dorsal root ganglia (DRG) were harvested from 9 day-old chick embryos and 
plated in 24-well falcon dishes pre-coated with poly-D-lysine (50 pg per cm2) and 
laminin (2 pg per cm2). Ganglia were maintained for 36 hours in DMEM, 1% Glutamax, 
10% FBS, and 1% N3 supplement (humidified atmosphere, 5% C02,37°C) according to 
Bottenstein and Sato [33], After a pre-incubation of ganglia for 60 min with 10 pM 
GW4869, 10 pM diphenylene iodonium (DPI), 10 pM dimethylsphingosine (DMS), or 5 
mM N-acetyl-L-cysteine (NAC), 100 ng/ml TNFa was acutely added to the medium for
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15 min, and ganglia were fixed in 10% glutaraldehyde solution. Six neurites, from four 
separately treated ganglia, were counted for each condition using Metamorph imaging 
software.
Sphingomyelinase Assay
Subconfluent cultures of SH-SY5Y cells or cortical neurons (5 million cells per 
well) were treated, harvested in cold PBS, and sonicated. Quantitative measurement of 
Mg2+-neutral sphingomyelinase (nSMase) activity was performed in cell lysates 
containing equal amounts of total protein (BCA assay) and using an enzyme coupled 
Amplex Red fluorescence assay kit. Briefly, Mg2+-nSMase activity in samples generates 
ceramide and phosphocholine. Next, choline is liberated by alkaline phosphatase and then 
converted to betaine and peroxide by choline oxidase. In the last step, horseradish 
peroxidase reacts with Amplex Red and peroxide to form the highly fluorescent product 
resorufm measured at 590 nm using a Beckman Coulter Multimode DTX 880 microplate 
reader.
Sphingosine Kinase-1 Assay
Cortical neurons (5 million cells per well) were pre-incubated for 60 min with 10 
pM DMS, 100 ng/ml TNFa, or vehicle, and 20% serum was acutely added to the 
medium for 60 min, and cortical neurons were scraped into PBS and sonicated. Samples 
containing equal amounts of total protein (BCA assay) were incubated for 60 min with 50 
pM D-eryt/zro-sphingosine, 1 mM CaCf, 4 mg/ml BSA, 2% Triton X-100, 1% PIC, and 
1 mM Na3V 0 4  (150 pL total reaction volume). Reactions were terminated with an equal 
volume of chloroform, and sphingosine-1-phosphate was extracted by basic-pH 
chloroform:methanol extraction. Sphingosine-1-phosphate was derivatized with NDA 
(one volume sample, one volume 1 mM NDA in methanol, one volume 1 mM NaCN in 
sodium tetraborate buffer pH 10.3), and separated by silica thin layer chromatography 
(chloroform/acetone/methanol/acetic acid/water) (10/4/3/2/1). NDA-labeled sphingosine-
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1-phosphate was observed and quantified using a GE Healthcare Typhoon Imager with 
ImageQuant software (United Kingdom).
Quantification of Reactive Oxygen Species Production
Increases in ROS were detected with dihydro-dichlorofluorescein diacetate 
(H2DCFDA), an oxidation-sensitive fluorescence indicator. Upon uptake by cells, 
H2DCFDA is de-acetylated to dihydro-dichlorofluorescein and increases in fluorescence 
upon oxidation by H20 2 to dichlorofluorescein (DCF). SH-SY5Y cells or E7 cortical 
neurons were grown in 96-well tissue culture dishes (Falcon, poly-D-lysine coated for 
cortical neurons, 100,000 cells per well, 48 h) in their respective medium. Cultures were 
incubated for 1 h with 50 pM H2DCFDA in the presence or absence of pharmacological 
inhibitors or oxygen radical scavenging enzymes. Following a medium exchange, 
neuronal cells were exposed to TNFa (100 ng/ml, 15 min),.C2-ceramide (10 pM, 30 
min), N-oleoylethanolamine (NOE, 10 pM, 2 h), or palmitic acid (250 pM, 4 h), washed 
with IX PBS, and lysed in 2 M Tris-HCl pH 8.0, 2% SDS, 10 mM Na3VQ4. DCF- 
fluorescence was quantified (100 pi cell lysate) using a Beckman Coulter Multimode 
DTX 880 microplate reader (495 nm excitation filter, 525 emission filter). All DCF- 
fluorescence data were normalized to the average DCF-fluorescence under control 
conditions (relative DCF-fluorescence values).
Plasma Membrane Translocation of p67phox
Plasma membrane proteins were prepared by biotinylation and streptavidin- 
affmity chromatography as described by Li and Shah with minor modifications [34], SH- 
SY5Y neuroblastoma cells were grown in 6-well plates (5 million cells per well) for 48 h. 
Following incubation with GW4869 (10 pM, 60 min), L-cycloserine (5 mM, 60 min), or 
vehicle, cultures were treated with TNFa (100 ng/ml, 15 min), or palmitic acid (250 pM, 
4 h). After washing with HBSS-CM (IX  HBSS, 0.1 g/1 CaCl2, 0.1 g/1 MgCl2, pH 7.5), 
cultures were incubated with 0.5 mg/ml Sulfo-NHS-Biotin (prepared in 20 mM HEPES, 
HBSS-CM, pH 8.0) for 40 min on ice, and excess Sulfo-NHS-Biotin was neutralized with
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50 mM glycine (prepared in HBSS-CM) on ice for 15 min. Cells were scraped into 
HBSS-CM, centrifuged (200 x graax, 2 min), re-suspended in 500 pL loading buffer (20 
mM HEPES pH 7.5, HBSS, 1% Triton X-100, 0.2 mg/ml saponin, 1% PIC), and 
sonicated. Streptavidin-agarose beads (25 pL) were added to the cell lysates (2 h, 4°C). 
Beads were collected (2,500 x gmax, 2 min), re-suspended in 150 pL of loading buffer, 
and heated (5 min, boiling water bath). Supernatants were obtained by centrifugation 
(2,500 x gmax, 2 min), and total cellular protein content was determined (BCA protein 
assay).
Derivatization of Carbonylated Sphingosine Kinase-1
SH-SY5Y cells were treated for 60 min with TNFa (100 ng/ml) or A (31-42 (5 pM) 
+ 60 min pre-treatment with GW4869 (10 pM), DPI (10 pM), or NAC (5 mM), and lysed 
(2 M Tris-Cl pH 8.0, 2% SDS, 1 mM Na3V 0 4), and centrifuged (3,000 x gmax, 4°C, 20 
min). Lysate supernatants (100 pi) were incubated with 1 pg normal goat serum (45 min, 
25°C, agitated). After removing normal IgG with protein A/G agarose beads (20 pi), 
cleared lysates (100 pi) were first incubated with polyclonal goat anti-mouse SphKl 
primary antibodies (1 pg, 4°C, agitated) for 2 h and then overnight with protein A/G 
agarose beads (20 pi, 4°C, agitated). Protein A/G beads were collected by centrifugation 
(200 x graax, 2 min), washed three times in lysis buffer, and bound proteins were released 
by boiling for 5 min. SphKl carbonylation was revealed by 2,4-dinitrophenylhydrazine 
(DNPH) modification according to Levine and co-workers [35], Briefly, 
immunoprecipitated SphKl samples in lysis buffer were mixed with an equal volume of 
12% SDS, and further incubated with two sample volumes of 20 mM DNPH in 2M HC1 
(45 minutes, 25°C). SphKl was recovered by chloroform/methanol precipitation 
according to Wessel and Flugge [36], and protein concentration was determined (BCA 
protein assay).
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Western Blotting
Equal amounts of total protein (30 pg total cellular protein, or 5 pg 
immunoprecipitated protein, BCA protein assay) were separated by SDS-polyacrylamide 
(15%) gel electrophoresis (125 volts, 50 watts, 75 mA). Proteins were transferred from 
SDS-polyacrylamide gels onto PVDF membranes (2.5 hours, 50 volts, 50 watts, 250 mA) 
according to Towbin and co-workers [37]. Following transfer, membranes were blocked 
with IX TBST-BSA (5 mg/ml bovine serum albumin, 50 mM Tris-HCl pH 7.4, 150 mM 
NaCl, 0.1% Tween-20), and probed overnight with polyclonal rabbit anti-human p67phox 
primary antibodies (1 pg/pl in IX TBST), polyclonal goat anti-human phospho-p40phox 
primary antibodies (1 pg/pl in IX TBST), polyclonal goat anti-mouse SphKl primary 
antibodies (1 pg/pl in IX TBST), monoclonal mouse anti-human (3-actin primary 
antibodies (1 pg/pl in IX TBST), or polyclonal rabbit anti-DNP primary antibodies (1 
pg/pl in IX TBST. Following incubation with horseradish peroxidase-conjugated 
secondary antibodies (0.2 pg/pl in IX TBST, 45 min), immunoreactivity was detected by 
chemoluminescence and quantified using a GE Healthcare Typhoon Imager with 
ImagcQuant software (United Kingdom).
Statistical Analysis
Analysis o f variance (ANOVA) was used to determine statistically significant 
differences between treatments (p<0.05). At least three independent experiments were 
performed for each condition. Post hoc comparisons of specific treatments were 
performed using a Bonferroni test or a Dunette’s test. All error bars represent standard 
error of the mean (SEM).
3.4: Results
TNFa stimulated Mg2+-nSMase activity in neurons.
Recent studies in non-neuronal cells have demonstrated that the inflammatory 
stimulus TNFa mediates nSMase-dependent accumulation of the bioactive lipid ceramide
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[15]. In our study, TNFa elicited significant Mg2+-nSMase activity in human SH-SY5Y 
neuroblastoma cells (Fig. 3.1A). Compared to controls (1.00 + 0.10, n=4), addition of 
TNFa stimulated significant Mg2+-nSMase activity within 15 min (100 ng/ml TNFa, 
1.71 ±0.15, *p<0.05, n=4, and 200 ng/ml TNFa, 1.52 + 0.04, *p<0.05, n=4, 
respectively), a response completely blocked by 60 min pretreatment with 10 pM of the 
Mg2+-nSMase-specific inhibitor GW4869 (100 ng/ml TNFa, 0.48 + 0.03, n=4, and 200 
ng/ml TNFa, 0.45 + 0.03, n=4, respectively). Notably, the presence of GW4869 also 
significantly reduced basal Mg2+-nSMase activity in SFI-SY5Y cells (0.45 ±  0.02, 
**p<0.05, n=4) compared to control (1.00 + 0.10, n=4), suggesting a role for Mg2+- 
nSMase in neuronal homeostasis.
TNFa-stimulated Mg2+-nSMase activity was corroborated in primary cortical 
neurons isolated from 7 day-old (E7) chick embryos (Fig. 3 .IB). 100 ng/ml TNFa 
significantly increased Mg2+-nSMase activity (1.26 + 0.05, *p<0.05, n=3) measured 15 
min after exposure compared to control (1.00 + 0.06, n=3). Pre-treatment of E7 cortical 
neurons with 10 pM GW4869 (60 min) completely blocked Mg2+-nSMase activity (0.91 
+ 0.03, n=3). These findings demonstrated that Mg2+-nSMase activity increased in both 
human SFI-SY5Y neuroblastoma cells as well as primary E7 cortical neurons in response 
to the pro-inflammatory cytokine TNFa.
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Fig. 3.1. T N F a stim ulates M g2+'n eu tra l sphingom yelinase activity in neuronal cells. Cultures o f  SH-SY5Y 
neuroblastoma cells or E7 cortical neurons were exposed to TN Fa in the presence or absence o f 10 u.Vf GW4869. 
Mg2+'neutral sphingomyelinase (Mg2+"nSMase) activity was quantified in whole cell lysates using an enzyme-coupled 
Amplex Red fluorescence assay. (A) Incubation o f SH-SY5Y neuroblastoma cells with 100 or 200 ng/ml T N Fa for 15 
min resulted in an increase in Mg2+'nSMase activity (*p<0.05) compared to untreated cells, which was significantly 
abolished by pre-treated with the Mg2+"nSMase inhibitor GW4869 (**p<0.05). (B) In E7 cortical neurons, 100 ng/ml 
T N Fa stimulated Mg2+'nSMase activity (*p<0.05) compared to control or cultures treated with GW4869. Data 
represent SEM of at least three independent experiments.
AP1-42 stimulated Mg2+-nSMase activity in neurons.
Reports have indicated a pathological role for SMases in the progression of 
Alzheimer’s disease, and a recent study by Grimm and co-workers demonstrated that 
A p1'42 could interact directly with a recombinant nSMase in a cell-free system [38], In 
line with these data, we found that exposure of human SH-SY5Y neuroblastoma cells for
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10 min to 5 pM A (31-42 dramatically stimulated Mg2+-nSMase activity (1.81 + 0.25, 
*p<0.05, n=3) compared to control (1.00 + 0.03, n=3), which was suppressed by 60 min 
pre-treatment with 10 pM GW4869 (0.51 + 0.03, n=3) (Fig. 3.2). Taken together, both 
TNFa and A|3!"42 are able stimulate Mg2+-nSMase activity in neuronal cells.
-D-COM
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Time (min)
Fig. 3.2. AfJ1"42 stim ulates M g2+_neu tra l sphingom yelinase activity in SH-SY5Y cells. SH-SY5Y neuroblastoma 
cells were exposed to 5 pM A|3M2 and Mg2+"nSMase activity was quantified as a function o f time using an enzyme- 
coupled Amplex Red fluorescence assay. A p1-42 elicited a significant increase in Mg2+'nSMase activity within 10 min 
after acute addition (*p<0.05) compared to control that was blocked by 10 pM GW4869 (Mg2+'nSMase inhibitor). Data 
represent SEM of at least three independent experiments.
Neuronal NOX activity mediates TNFa-stimulated ROS accumulation.
Activation of NOX results in the generation of superoxide anions, which are 
rapidly dismutated to hydrogen peroxide by superoxide dismutase (SOD), or converted to 
other reactants such as hydroxyl radicals, or peroxynitrite. We measured intracellular 
ROS accumulation utilizing the redox-sensitive indicator DCF. In cultures of human SH- 
SY5Y neuroblastoma cells (Fig. 3.3A) or primary E7 cortical neurons (Fig. 3.3B), 100 
ng/ml TNFa elicited, within 15 min, a significant increase in maximum DCF- 
fluorescence intensity (SH-SY5Y cells: 1.24 + 0.05, *p<0.05, n=5; cortical neurons: 2.23 
± 0.05, *p<0.05, n=14) compared to control (SH-SY5Y cells: 1.00 + 0.03, n=12, cortical 
neurons: 0.99 + 0.02, n=21) indicative of an accumulation of intracellular ROS. Addition
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of 200 units/ml of SOD to SH-SY5Y neuroblastoma cells or E7 cortical neurons 
concurrent with TNFcc-exposure augmented ROS production measured as maximum 
DCF-fluorescence (SH-SY5Y cells: 1.39 + 0.07, *p<0.05, n=3; cortical neurons: 2.98 + 
0.15, **p<0.05, n=7). This effect suggested that a superoxide-generating mechanism was 
stimulated by TNFa because the indicator DCF primarily measures H2 O2 , and SOD 
converts superoxide to H2 O2 . In stark contrast, incubation of neuronal cultures with 5000 
units/ml of catalase concurrently with TNFa-exposure, negated increases in DCF- 
fluorescence intensity (SH-SY5Y cells: 1.02 ± 0.04, n=3; cortical neurons: 1.54 + 0.10, 
n=7). TNFa-dependent ROS formation was also completely blocked by a presence o f 5 
mM of the antioxidant NAC (SH-SY5Y cells: 0.92 ±0.01, n=3; cortical neurons: 0.79 ± 
0.05, n=7). Lastly, 60 min pre-treatment of neuronal cultures with 10 uM of the NOX 
inhibitor diphenylene iodonium negated TNFa-stimulated intracellular ROS formation 
(SH-SY5Y cells: 1.02 ± 0.04, n=8; cortical neurons: 1.16 ± 0.12, n=7), indicating the 
involvement of a neuronal NOX activity.
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Fig. 3.3. T N F a  stim ulates a neuronal NOX activity increasing in tracellu lar ROS form ation. ROS formation in 
neuronal cells was quantified employing the H20 2-sensitive fluorescence indicator dihydrodichlorofluorescein.
Cultures o f SH-SY5Y neuroblastoma cells (A) or E7 cortical neurons (B) were exposed to 100 ng/ml T N Fa for 15 min, 
maximum DCF fluorescence was quantified in whole cell lysates and normalized to control. T N Fa stimulated a robust 
formation o f ROS (*p<0.05) compared to control SH-SY5Y cultures or E7 cortical cultures. ROS formation in 
response to TNF a  was negated by a pre-incubation of cultures with 10 pM diphenylene iodonium (DPI, a NOX 
inhibitor), 5 mM N-acetyl-L-cysteine (NAC, an antioxidant), or 5000 U/ml exogenous catalase (CAT). Addition of 
exogenous superoxide dismutase (SOD, 200 U/ml) was ineffective, or even significantly augmented TNFa-stim ulated 
ROS formation (**p<0.05). This effect suggested a superoxide-generating mechanism as DCF responds primarily to 
H2 O2 . Data represent SEM o f at least three independent experiments.
Ceram ide mediates TN Fa-stim ulated neuronal ROS accumulation.
Since TNFa stimulated ceramide accumulation via Mg2+-nSMase activity (Fig. 
3.1), as well as ROS accumulation (Fig. 3.3), we tested whether ceramide is directly 
involved in the generation of ROS. In cultures of human SFI-SY5Y neuroblastoma cells 
(Fig. 3.4A) or primary E7 cortical neurons (Fig. 3.4B), 100 ng/ml TNFa elicited, within 
15 min, significant increases in DCF-fluorescence intensity (SH-SY5Y cells: 1.24 + 0.05,
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*p<0.05, n=5; cortical neurons: 2.23 ± 0.05, *p<0.05, n=14) compared to control cells 
(SH-SY5Y cells: 1.00 ± 0.03, n=12; cortical neurons: 0.99 ±  0.02, n=21), which was
2_j_
negated by 60 min pre-treatment of neuronal cultures with 10 pM of the Mg -nSMase 
inhibitor GW4869 (SH-SY5Y cells: 1.07 ±0.01, n=4; cortical neurons: 1.21 ± 0.07, n=7). 
This finding suggested that Mg2+-nSMase-generated ceramide is involved in the 
formation of ROS.
Incubation of neuronal cells for 30 min with 10 pM C2-ceramide, a short-chain 
ceramide analog, resulted in significant increases in DCF-fluorescence intensity (SH- 
SY5Y cells: 1.23 ± 0.03, *p<0.05, n=4; cortical neurons: 1.54 ± 0.04, *p<0.05, n=7). 
Additionally, stimulation of de novo ceramide synthesis in human SH-SY5Y 
neuroblastoma cells (250 pM palmitate, 4 h) indeed caused a significant increase in DCF- 
fluorescence intensity suggesting an increase in ROS (1.26 ± 0.06, *p<0.05, n=6) as 
opposed to control (1.00 ± 0.03, n=12). Inhibition of de novo ceramide synthesis in SH- 
SY5Y cells by a pre-treatment (60 min) with 5 mM L-cycloserine (a serine 
palmitoyltransferase inhibitor), or 10 pM fumonisin Bi, (a dihydroceramide synthase 
inhibitor) both completely blocked palmitate-stimulated increases in DCF-fluorescence 
(1.03 ± 0.03, n=6, or 0.98 ± 0.03, n=6, respectively).
In E7 cortical neurons, ceramide metabolism was further evaluated by treating 
neurons for 2 h with 10 pM of A-oleoylethanolamine (NOE), an acid ceramidase 
inhibitor, thus blocking ceramide-degradation. Monitoring de novo ceramide synthesis 
was impractical in E7 cortical neurons due to their extremely high sensitivity. A presence 
of NOE significantly increased DCF-fluorescence intensity in cortical neurons indicative 
of an increase in intracellular ROS production (1.64 ± 0.04, *p<0.05, n=7). Taken 
together, these results provided evidence that ceramide is actively involved in the 
regulation of intracellular ROS production. Combined, these results further demonstrated 
that TNFa-stimulated ROS production was due in part to TNF a - stimulation of a 
neuronal NOX activity.
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Fig. 3.4. C eram ide stim ulates in tracellu lar ROS form ation. ROS formation in neuronal cells was quantified 
employing the H202-sensitive fluorescence indicator dihydrodichlorofluorescein. Maximum DCF fluorescence was 
quantified in whole cell lysates and normalized to controls. (A) In SH-SY5Y cells, TN Fa (100 ng/ml, 15 min) 
stimulated a robust formation o f ROS (*p<0.05) compared to control cultures. Inhibiting ceramide production through 
sphingomyelin hydrolysis with 10 pM  GW4869 (Mg2+"nSMase inhibitor) negated TNFa-mediated ROS formation. In 
contrast, 30 min treatment with 10 pM  C2-ceramide (CER) significantly increased ROS formation (*p<0.05) in the 
absence of TN Fa. Alternatively, stimulation of de novo ceramide synthesis with palmitate (250 pM, 4 h) also 
significantly increased ROS formation (*p<0.05). Palmitate effects were mitigated with 5 mM L-cycloserine (CS; 
serine palmitoyltransferase inhibitor), or 10 pM fumonisin Bj (FBI; dihydroceramide synthase inhibitor). (B) In E7 
cortical neurons, T N F a (100 ng/ml, 15 min) stimulated a robust formation ofRO S (*p<0.05) compared to controls. 
Inhibiting ceramide production through sphingomyelin hydrolysis with 10 pM GW4869 significantly negated T N Fa- 
mediated ROS formation (**p<0.05). In the absence o f TNFa, 10 pM CER (30 min) exposure to E7 cortical cultures 
significantly increased ROS formation (*p<0.05). Additionally, inducing ceramide accumulation by inhibition of acid 
ceramidase with 10 pM  yV-oIeoylethanolamine (NOE) resulted in significantly increased ROS formation (*p<0.05). 
Data represent SEM o f at least three independent experiments.
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Ceramide mediates TNFa-stimulated neuronal NOX assembly.
NOX is a multi-subunit NADPH oxidoreductase responsible for the rapid 
production o f superoxide, requiring proper assembly of both membrane and cytosolic 
subunits [18, 19]. Release of auto-inhibitory conformations o f cytosolic subunits such as 
p40phox by phosphorylation is key for NOX activation [18, 19]. In this study, we 
evaluated membrane assembly of the neuronal NOX subunits p40phox and p67phox in 
response to either TNFa or ceramide. Treatment of SH-SY5Y cells with 100 ng/ml 
TNF a  for 15 min significantly increased phosphorylation of p40phox (1.65 + 0.12, 
*p<0.05, n=3) compared to control (1.02 + 0.05, n=3) (Fig. 3.5 A). TNFa-stimulated 
p40phox phosphorylation was completely blocked by incubating SH-SY5Y cultures with 
10 pM of the Mg2+-nSMase inhibitor GW4869 (1.19 + 0.04, n=3) prior to TNFa 
exposure. Likewise, we quantified the translocation of the p67phox subunit to plasma 
membranes o f SH-SY5Y neuroblastoma cells (Fig. 3.5B). We measured a significant 
translocation o f p67phox to plasma membranes (1.48 + 0.05, *p<0.05, n=3) within 15 min 
after application of 100 ng/ml TNFa compared to control (1.01 + 0.01, n=3). Similarly, 
p67phox membrane translocation was significantly negated following a 60 min pre­
treatment of SH-SY5Y neuroblastoma cells with 10 pM of GW4869 (1.20 + 0.02, 
**p<0.05, n=3). These findings demonstrated that both p40phox phosphorylation and 
p67phox membrane translocation critically depended on the generation of ceramide 
through Mg2+-nSMase activity.
To further corroborate that ceramide is implicated in the proper assembly of 
NOX, we stimulated de novo ceramide synthesis by treating SH-SY5Y cells with 
palmitate (250 pM, 4 h), a precursor of endogenous ceramide synthesis. As opposed to 
controls (1.01+0.01, n=3), palmitate did elicit a significant translocation of p67phox to 
plasma membranes (1.34 + 0.02, *p<0.05, n=3) that was significantly prevented by a 60 
min pre-treatment with 5 mM L-cycloserine (1.07 + 0.01, ***p<0.05, n=3), a serine 
palmitoyltransferase inhibitor. Taken together, these data strongly suggested that 
ceramide acts as a pivotal lipid-activator of NOX in response to the pro-inflammatory 
cytokines TNFa.
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Fig. 3.5. Ceramide mediates TNFa-dependent neuronal NOX assembly. SH-SY5Y neuroblastoma cells were 
exposed to 100 ng/ml T N Fa for 15 min following a one-hour pre-incubation with either 10 pM GW4869, which blocks 
ceramide generation through Mg2+‘nSMase activity, or buffer only (control). Increases in the phosphorylation o f p40phox 
and translocation o f p67phox to plasma membranes were evaluated as an indication o f NOX activation. (A) TNFa 
substantially increased phosphorylation o f p40phox (*p<0.05) compared to control or a presence o f  GW4869. (B) TN Fa 
stimulated the translocation ofp67phox to plasma membranes (*p<0.05) as opposed to control (CON), or a presence o f 
GW4869 (**p<0.05). Stimulation o f de novo ceramide synthesis palmitate (250 pM, 4 hours) also increased p67phox 
levels in SH-SY5Y plasma membranes (*p<0.05), which was completely negated with 5 mM L-cycloserine 
(***p<0.05), a serine palmitoyltransferase inhibitor. Data represent SEM of at least three independent experiments.
SphKl activity is impeded by TNFa-stimulated ROS.
SphKs are responsible for the formation of sphingosine-l-phosphate, a pro­
survival and pro-growth lipid messenger [25], Since several studies have suggested that 
SphKl is activated by TNFa in non-neuronal cells, we tested the responses of neuronal 
cells [25], Important to our study, it was shown that SphKl is stimulated by a variety of
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mitogens as well as serum [25, 39], In human SH-SY5Y neuroblastoma cells we found 
that addition of 20% FBS for 30 min stimulated a significant increase in SphKl activity 
(1.81 + 0.17, *p<0.05, n=3) compared to basal activity (1.00 + 0.06, n=3) (Fig. 3.6A). 
Likewise, in E7 cortical neuron cultures, we found a significant increase in SphKl 
activity in response to 30 min of 20% FBS (1.89 + 0.19, *p<0.05, n=3) compared to basal 
activity (1.00 + 0.03, n=3) (Fig. 3.6B). Expectedly, FBS-stimulated SphKl activity was 
blocked by 60 min pre-treatment with 10 pM of the SphKl inhibitor N ’,N’- 
dimethylsphingosine (DMS) (SH-SY5Y cells: 1.07 + 0.06, n=3; cortical neurons: 0.80 + 
0.06, n=3). In contrast to other studies done in non-neuronal cells, 60 min exposure to 
100 ng/ml TNFa alone had no measurable effects on basal SphKl activity (SH-SY5Y 
cells: 1.07 + 0.08, n=3; cortical neurons: 0.81 + 0.01, n=3), showing that TNFa alone did 
not stimulate SphKl activity in neuronal cells. However, 60 min pre-treatment with 100 
ng/ml TNFa prior to 20% FBS stimulation (30 min) completely blunted increases in 
SphKl activity (SH-SY5Y cells: 1.08 + 0.02, n=3; cortical neurons: 0.95 ± 0.07, n=3) 
above basal levels. FBS-stimulated SphKl activity impeded by TNFa was restored by 60 
min pre-treatment with 10 pM of the Mg2+'nSMase inhibitor GW4869 (SH-SY5Y cells: 
1.60 + 0.07, *p<0.05, n=3; cortical neurons: 1.44 + 0.02, *p<0.05, n=3), 10 pM of the 
NOX inhibitor DPI (SH-SY5Y cells: 1.93 + 0.13, *p<0.05, n=3; cortical neurons: 1.45 + 
0.03, *p<0.05, n=3), or 5 mM of the antioxidant NAC (SH-SY5Y cells: 1.72 ± 0.10, 
*p<0.05, n=3; cortical neurons: 1.48 + 0.04, *p<0.05, n=3). These data showed that 
TNFa-mediated loss of serum-stimulated SphKl activity was due to Mg2+'nSMase- and 
NOX-regulated mechanisms in neuronal cells.
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Fig. 3.6. T N Fa-stim ula ted  ROS inh ib it neuronal sphingosine kinase-1 activity. Sphingosine kinase-1 (SphK l) 
activity was greatly stimulated in SH-SY5Y cells (A) or E7 cortical neuron cultures (B) by an addition o f 20% fetal 
bovine serum for 60 min (*p<0.05), but not by T N Fa alone (100 ng/ml). In both SH-SY5Y cells and E7 cortical 
neurons, serum-stimulated SphKl activity was blocked with a 60 min pre-treatment with 10 pM o f the SphKl inhibitor 
N ’,N’-dimethylsphingosine (DMS), as well as by TN Fa exposure (100 ng/ml). TNFa-abolished serum-stimulated 
SphKl activity was restored by 60 min pre-treatment with 10 pM GW4869 (Mg2+'nSMase inhibitor), 10 pM DPI 
(NOX inhibitor), or 5 mM NAC (antioxidant). Data represent SEM o f at least three independent experiments.
Inhibition of SphKl by oxidation in neurons exposed to TNFa or A p1'42.
A recent study in human SH-SY5Y neuroblastoma cells revealed that A|31-42 also 
inhibited SphKl activity, and that this inhibition was negated by a presence of the 
antioxidant NAC [40]. Thus, we assayed SphKl for TNFa-dependent and A(3142-
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dependent carbonylation, an irreversible oxidative modification detrimental to protein 
stability and function (Fig. 3.7). Treatment of human SH-SY5Y neuroblastoma cells with 
100 ng/ml TNFa (60 min) resulted in a substantial increase in carbonylation of SphKl 
(27.91 + 1.79, *p<0.05, n=5) compared to control (1.00 ± 0.13, n=5). Likewise, treatment 
of SH-SY5Y cells with 5 pM A (31-42 (60 min) resulted in a dramatic increase in 
carbonylation of SphKl (75.49 + 13.23, *p<0.05, n=5) compared to control. TNFa- and 
A(3 ^ -s tim u la ted  SphKl carbonylation was completely abolished by 60 min pre­
treatment with 10 uM of the Mg2+'nSMase inhibitor GW4869 (TNFa+GW4869: 0.83 ± 
0.22, n=5; A(31'42+GW4869: 3.06 ±  0.99, n=5), 10 pM of the NOX inhibitor DPI 
(TNFa+DPI: 1.00 ± 0.25, n=5; A|3M2+DPI: 10.91 ± 5.70, n=5), or 5 mM of the 
antioxidant NAC (TNFa+NAC: 2.00 + 1.06, n=5; A ^'^+ N A C : 3.75 + 1.57, n=5). Taken 
together, TNFa- and A |3^-m ediated loss of SphKl activity, and therefore loss of a 
critical survival signal in neuronal cells, was due to irreversible Mg2+"nSMase- and NOX- 
dependent oxidative modification of SphKl.
Fig. 3.7. T N F a- and  A p '^ -s tim u la te d  ROS oxidize neuronal sphingosine kinase-1. (A) Sphingosine kinase-1 
(SphK l) was immunoprecipitated from lysates o f SH-SY5Y cultures treated with T N Fa (100 ng/ml, 1 h) or A(51-42 (5 
pM) with or without a pre-incubation with 10 pM GW4869 (Mg2+"nSMase inhibitor), 10 pM DPI (NOX inhibitor), or 5 
mM NAC (antioxidant). SphKl carbonyls were derivatized with 2,4-dinitrophenylhydrazine (DNPH), subjected to SDS 
gel electrophoresis followed by western blotting, and DNP immunoreactivity quantified. T N Fa or Afl1"42 exposure 
caused a significant increase in SphKl carbonylation (*p<0.05). In contrast, inhibiting Mg24‘nSMase , NOX, or simply 
using an antioxidant substantially blocked oxidative damage to S phK l. Data represent SEM o f at least three 
independent experiments.
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TNFa inhibited nenrite outgrowth.
Neurite outgrowth is a functional process important to development of the CNS, 
and to neuronal connectivity. Neurite outgrowth is dependent on pro-growth signaling 
and a dynamic actin cytoskeleton [41, 42], Importantly, a recent study in phagocytic cells 
revealed that actin co-localized with functional SphKl suggesting a causal link between 
the production of SIP and the actin cytoskeleton [43]. In this study we evaluated the 
impact of TNFa-induced oxidative stress, inhibitory to SphKl, on neurite outgrowth 
(Fig. 3.8). DRG from 9 day-old chick embryos were plated on laminin and maintained for 
36 hours to allow vigorous neurite outgrowth in a radial fashion away from the ganglia 
body. DRG cultures were incubated with inhibitors for 1 h prior to acute addition of 100 
ng/ml TNFa for 15 min. TNFa caused a rapid retraction of outgrown neurites (67% +
3%, *p<0.05, n=24) compared to neurites of control DRG (100% + 4%, n=24).
Preventing ceramide accumulation by inhibition of Mg2+-nSMase (10 pM GW4869) 
prior to TNFa-exposure protected neurite outgrowth (95% ± 3%, n=24). Likewise, 
inhibition of NOX activity (10 uM DPI) or scavenging of ROS with 5 mM NAC rescued 
neurite outgrowth in the presence of TNFa (DPI: 107% + 3%, n=24; NAC: 109% + 2%, 
n=24). In contrast inhibition of SphKl activity (10 pM DMS) had no effect on TNFa- 
stimulated neurite retraction, yielding neurites of significantly reduced neurite length 
(64% + 3%, *p<0.05, n=24) as compared to control. This nearly identical response to 
what was measured in the presence of TNFa-alone indicates again that in neurons SphKl 
is not a downstream effector of TNFa. Altogether these findings suggest that SphKl 
plays an important role in neurite outgrowth, a process important to neurodevelopment 
and synaptic plasticity, and that TNFa impedes this process via oxidation of SphKl.
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Fig. 3.8. T N F a-dependen t inhibition o f neurite  outgrow th is m ediated by ceram ide and  ROS. E9 dorsal root 
ganglia (DRG) were plated on laminin (2 pg/cm2) and maintained for 36 hours to allow radial neurite outgrowth. After 
pre-incubation with pharmacological inhibitors, DRG cultures were treated with T N Fa (100 ng/ml, 15 min), fixed with 
10% glutaraldehyde, and neurite length measured using Metamorph Imaging software. T N Fa significantly impeded 
neurite outgrowth (*p<0.05) compared to control. Neurite outgrowth in the presence o f  T N Fa was protected when 
blocking ceramide generation by sphingomyelin hydrolysis through Mg2+‘nSMase (10 pM GW4869), preventing NOX 
activity (10 pM DPI), or by scavenging ROS formation (10 pM NAC). Inhibiting SphKl activity with 10 pM DMS did 
not protect neurite outgrowth from TN Fa. Data represent SEM of at least three independent experiments.
3.5: Discussion
The pro-inflammatory cytokine TNFa, and soluble amyloid fragment A [31-42, are 
severely detrimental to the viability of neuronal cells, due in part to their roles as a 
mediators of the production of damaging ROS. Prolonged inflammation, and therefore 
prolonged oxidative stress, is strongly linked to neurodegeneration associated with acute 
CNS injuries, chronic CNS disorders, and psychiatric conditions [1]. In particular, the 
oxidation of cellular targets including lipids, DNA, and protein ultimately drives these 
pathologies to a point where survival and regeneration of the CNS becomes impossible.
In our study we demonstrated that TNFa or A p1'42 stimulated Mg2+'nSMase activity in
2_|_
neuronal cells. We further demonstrated that ceramide, the product of Mg 'nSMase
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activity, induced production of ROS via a neuronal NOX activity. It is very intriguing 
that ceramide and SIP, metabolically linked sphingolipids, are diametrically opposed 
regulators of cell survival [15, 17, 25]. On this notion we investigated and determined 
that in neurons, SphKl was a target of ceramide-mediated NOX-dependent oxidation; an 
event shifting sphingolipid metabolism towards ceramide production, and subsequently 
impeding neuron survival and regeneration.
In response to injury, pathogens, and a variety of toxins including chemical 
compounds, heavy metals, prions, and others peptides, the microglia of the CNS elicit a 
dramatic response characterized by the release of ROS and a variety inflammatory 
mediators including TNFa [1, 2, 7], While TNFa exerts pleiotropic effects in the CNS, 
persistent high levels are highly neurotoxic. TNFa, as an inflammatory cytokine, elicits 
numerous cellular stress responses itself, including oxidative stress [1,2, 7]. TNFa type I 
receptors are bound to the adaptor protein FAN, allowing rapid activation of Mg2+' 
nSMase in response to stimuli. In our study, we evaluated the effects of TNFa on human 
SH-SY5Y neuroblastoma cells and primary chick (E7) cortical neurons. We determined 
that the Mg2+"nSMase was significantly stimulated in SH-SY5Y cells and cortical 
neurons in response to treatment with TNFa (Fig. 3.1). Mg2+'nSMase activity generates 
the bioactive lipid ceramide; a mediator of cellular stress, and in our study, a second 
messenger transducing TNFa-signaling to more detrimental responses in neuronal cells.
In Alzheimer’s disease, A p1'42 is generated by improper proteolytic cleavage of 
the amyloid precursor protein [38]. A p1'42 is highly neurotoxic and acts in much the same 
way as a cytokine, by eliciting cellular stress responses associated with 
neuroinflammation such as oxidative stress. Additionally A p1'42 has been shown to 
induce the expression, production, and release of pro-inflammatory cytokines from 
microglia and astrocytes, which previously was thought to be the primary mechanism that 
A p1'42 induces neuroinflammatory responses [1, 2, 4, 7], In our study, we determined that 
the Mg2+"nSMase was significantly stimulated in SH-SY5Y cells in response to treatment 
with A p1"42 (Fig. 3.2). The rapid activation of the Mg2+"nSMase by A p1'42 may indicate 
that a direct interaction between A p1'42 and the Mg2+'nSMase occurs as suggested by cell-
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free studies done by Grimm and coworkers [38]. Furthermore, these results demonstrated 
that A(3M2 alone can stimulate a neuroinflammatory pathway in neuronal cells.
Neuroinflammation is characterized by responses of microglia and astrocytes in 
the CNS during acute injuries, chronic disorders, and psychiatric conditions [1, 2, 7]. A 
key part of the inflammatory response is the release of damaging ROS, however the 
characterization of ROS release by neurons is not well established. In our study we 
utilized the FFOa-sensitive dye DCF to study intracellular ROS in neuronal cells. We 
found that human SH-SY5Y neuroblastoma cells and primary chick (E7) cortical neurons 
responded to TNFa with significant increases in DCF-fluorescence indicative of ROS 
production (Fig. 3.3). We further characterized this ROS production utilizing SOD, 
which dismutates superoxide to H2 O2 , and catalase, which neutralizes H2 O2 to water. By 
adding exogenous SOD to accelerate the conversion of superoxide to the DCF-detectable 
H2 O2 , we demonstrated that TNFa-stimulated ROS were derived from a superoxide- 
generating source. Further investigation with the NOX inhibitor DPI allowed us to 
attribute this TNFa-stimulated superoxide generation to a neuronal NOX activity.
Previous work by other labs has linked ceramide to the onset o f oxidative stress in 
non-neuronal cells [14, 15]. Since we linked TNFa responses in neuronal cells to the 
stimulation of the Mg2+"nSMase, it became important to evaluate the role of ceramide in 
the regulation of ROS generation in neurons (Fig. 3.4). In both SH-SY5Y cells and 
cortical neurons, we employed the Mg2+'nSMase-specific inhibitor GW4869 to block 
TNFa-stimulated ROS production indicating a role for ceramide as a mediator of ROS 
generation in neuronal cells. To further evaluate ceramide, we manipulated its levels in a 
variety o f ways. In both SH-SY5Y cells and cortical neurons, exogenous addition of the 
short-chain C2 analog of ceramide stimulated ROS production. Alternatively we induced 
de novo ceramide synthesis in SH-SY5Y cells with the saturated fat palmitate, and noted 
a dramatic increase in ROS production. Palmitate-stimulated ROS production was 
completely blocked by inhibitors of serine palmitoyltransferase and (dihydro)ceramide 
synthase, two enzymes critical to de novo ceramide synthesis. In primary cortical 
neurons, palmitate-based studies were impractical due to the high sensitivity of the
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primary cultures. Consequentially we evaluated ceramide in primary cortical neurons by 
preventing acid ceramidase activity, which degrades ceramide to sphingosine. Prevention 
o f ceramide degradation also resulted in dramatic ROS production. Altogether these 
results clearly showed that ceramide is a mediator of ROS production in neuronal cells.
Since we demonstrated that TNFa and A(31-42 stimulated ceramide-generating 
Mg2+~nSMase activity, and that TNFa-stimulated ROS were derived from a neuronal 
NOX, we speculated that the oxidase itself may be regulated by ceramide. NOX is a 
highly regulated multi-subunit complex that generates superoxide anion [18]. NOX2 (the 
phagocytic oxidase-like isoform) requires at least two membrane-bound subunits, 
gp91phox and p22phox (phox for phagocytic-oxidase-like), and at least three cytosolic 
subunits p67phox, p47phox, and p40phox [18, 22], NOX2 activity relies on phosphorylation 
of cytosolic subunits followed by their translocation to and assembly with the membrane- 
bound subunits. The role of ceramide or ceramide metabolites may be to stimulate NOX2 
directly, stimulate known regulators of NOX2 (protein kinases; Rac GTPase), or to 
stimulate the production of the lipid arachidonic acid. The ceramide/ceramide-1- 
phosphate-binding protein CPLA2 produces arachidonic acid [44, 45], while ceramide has 
been shown to interact with and activate PK Ct [46]: a kinase capable of regulating the 
multiple targets including the stress activated protein kinase JNK (c-jun N-terminal 
kinase) [47]. In our study we evaluated the role of ceramide in the assembly of NOX2 in 
human SFI-SY5Y neuroblastoma cells (Fig. 3.5). We demonstrated that the Mg2+'nSMase 
inhibitor GW4869 blocked TNFa-stimulated phosphorylation of p40phox. Further 
evaluation of membrane translocation of p67phox revealed a similar Mg2+'nSMase- 
dependent response to TNFa. We expanded our study of ceramide-mediated NOX2 
assembly by showing that palmitate-stimulated p67phox membrane translocation was 
blocked by preventing de novo ceramide synthesis. Combined these results showed that 
TNFa stimulated ROS generation through activation of Mg2+'nSMase-dependent 
ceramide production, and that ceramide mediated the activation o f a neuronal NOX2. 
Likewise other mechanisms that stimulate ceramide accumulation, through SMase 
activity or de novo synthesis, potentially could stimulate NOX2 activity.
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Lastly, our research investigated a recent report that SphKl was inhibited through 
a redox-mechanism. Gomez-Brouchet and co-workers reported that A|3M2 inhibited 
SphKl activity in SH-SY5Y neuroblastoma cells, and that inhibition could be prevented 
by the antioxidant NAC [40], Likewise, we were able to show that TNFa prevented 
serum-stimulated SphKl activity in both SH-SY5Y neuroblastoma cells and primary E7 
cortical neurons (Fig. 3.6). We showed that this inhibition o f SphKl activity was directly 
attributed to Mg2+'nSMase and NOX activity. We further demonstrated for the first time, 
by monitoring protein carbonylation, that SphKl is a target o f oxidative modification 
(Fig. 3.7). Carbonylation is a specific, prevalent, and irreversible oxidative modification 
that can result in dramatic protein conformational changes, protein oligomerization, as 
well as protein loss of function [48]. We showed that both TNFa and A(31-42 caused 
specific oxidation of SphKl. By utilizing pharmacological inhibitors, we further showed 
that Mg2+"nSMase and NOX activity in SH-SY5Y neuroblastoma cells was responsible 
for TNFa- and A|3M2-induced oxidation of SphKl. Lastly, we showed that TNFa caused 
retraction of outgrown neurites from DRGs (Fig. 3.8). Neurite outgrowth is an important 
neurodevelopment mechanism, as well as a mechanism important to dendritic spine 
formation and synaptic plasticity. Therefore neurite outgrowth from DRGs can be used as 
a measure of neuronal development and function. We found that TNFa-stimulated 
neurite retraction was prevented by an antioxidant, inhibition of NOX, or inhibition of the 
Mg2+'nSMase. This demonstrated the role of TNFa-mediated, Mg2+'nSMase-dependent 
stimulation of a neuronal NOX2 that subsequently caused oxidative damage to critical 
neuronal components, including SphKl.
SphKl is an important component of neurons not only due to its role in regulating 
survival, but also in roles important to synaptic plasticity, development, and potentially to 
regeneration. SIP has been shown to stimulate neurite outgrowth, a process important to 
both the developing and adult CNS [29], Actin, another important effector of neurite 
outgrowth, has been recently reported to interact with functional SphKl, suggesting a 
link between actin cytoskeletal dynamics and SIP production [43]. Interestingly we have 
also found that actin is a target of NOX2-mediated oxidation in neurons (data to be
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published elsewhere). Additionally, other recent studies have implicated SIP as a 
modulator of neuronal function. Alemany and co-workers showed that calcium influx 
through voltage-gated calcium channels elevated SIP levels, and ultimately enhanced 
noradrenaline release from PC 12 cells [49], Additionally, Kajimoto and co-workers 
provided evidence that SphK is a modulator of glutamate release from hippocampal 
neurons [50]. Combined these studies suggest that SphKs may play a more profound role 
in the functionality o f neurons, further demonstrating that disruption of SIP-signaling 
could have profound and highly detrimental effects on the CNS.
Altogether, our research identified Mg2+‘nSMase-dependent NOX2 activity as a 
specific neuroinflammatory pathway that resulted in oxidation of SphKl, an important 
neuronal survival, developmental, and functional component. We showed that both 
TNFa and A p1'42 stimulated Mg2+"nSMase activity, indicating a diversity of molecules 
that stimulated this particular neuroinflammatory pathway. The ceramide-driven NOX2- 
dependent oxidative down-regulation of SphKl revealed by our study further showed 
how ceramide-signaling directly promoted neurodegeneration (Fig. 3.9). NOX enzymes 
are important players in normal redox-signaling; hence their expression and abundance in 
non-phagocytic cells. However chronic activation of NOXs can contribute to a massive 
and excessive oxidative response. Oxidative regulation of specific neuronal survival
mechanisms, as well as functional and regenerative mechanisms allows for CNS
• 2+pathologies to become degenerative in nature. Specific therapeutic targeting of the Mg ' 
nSMase or the neuronal NOX2 could offer improved treatments for acute injuries of the 
CNS, chronic neurodegenerative disorders of the CNS, and psychiatric disorders, and 
ultimately strategies to improve neuronal survival, connectivity and functionality, and 
perhaps promote regeneration.
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Fig. 3.9. C eram ide elicits oxidative dam age via N OX-derived ROS to S p h K l. Ceramide and sphingosine-1- 
phosphate (SIP) are metabolically linked through the intennediate sphingosine. These two lipid messengers regulate 
fundamental yet opposing cellular processes. Whereas ceramide is implicated in apoptosis and other mechanisms 
detrimental for cellular homeostasis, SIP  plays a key role in cell survival pathways. Our study defined a specific 
neuroinflammatory pathway that directly influences ceramide/SIP metabolism, therefore influencing neuronal fate. 
Specifically we showed that Mg2+'nSMase-generated ceramide stimulated a neuronal NOX, which subsequently 
inhibited SphKl via irreversible oxidation.
3.6: Acknowledgements
This study was supported by National Institutes of Health U54 grant NS41069 (SNRP: 
NINDS, NIMH, NCRR, NCMHD), and United States Department of Agriculture grant 2005­
34495-16519 (TBK). We thank our colleagues in the Alaskan Basic Neuroscience Program and 
the Department of Chemistry and Biochemistry, Dr. Larry Duffy, Dr. Marvin Schulte, Dr. 
Thomas Clausen, Dr. Thomas Green, Colin McGill, and Daniel Kirschner, for their review of the 
manuscript, and many helpful insights during the progress of this study.
3.7: Contributions
Two students contributed directly to this research study. Danielle LaVictorie 
spent a semester helping to optimize the p67phox translocation studies. Later, Sally 
Gustafson joined the lab and assisted in Mg2+‘nSMase assays, as well as ROS detection 
and neurite outgrowth studies.
3.8: References
[1] Block, M. L.; Zecca, L.; Hong, J. S. Microglia-mediated neurotoxicity: Uncovering 
the molecular mechanisms. Nat. Rev. Neurosci.8:57-69; 2007.
R e p ro d u ce d  with perm ission  o f the copyright ow ner. Further reproduction  prohibited w ithout perm ission .
126
[2] Fetler, L.; Amigorena, S. Neuroscience, brain under surveillance: The microglia
patrol. Science309:392-393; 2005.
[3] Nimmerjahn, A.; Kirchhoff, F.; Helmchen, F. Resting microglial cells are highly
dynamic surveillants o f brain parenchyma in vivo. Science2>§%\ 1314-1318; 2005.
[4] Polazzi, E.; Contestabile, A. Reciprocal interactions between microglia and neurons:
From survival to neuropathology. Rev. Neurosci. 13:221-242; 2002.
[5] Colton, C. A.; Gilbert, D. L. Production of superoxide anions by a CNS macrophage,
the microglia. FEBSLett.223:284-288; 1987.
[6] Sawada, M.; Kondo, N.; Suzumura, A.; Marunouchi, T. Production of tumor necrosis
factor-alpha by microglia and astrocytes in culture. Brain Res.491:394-397; 1989.
[7] Town, T.; Nikolic, V.; Tan, J. The microglial "activation" continuum: From innate to
adaptive responses. J. Neuroinflammation2i24; 2005.
[8] Adam-Klages, S.; Adam, D.; Wiegmann, K.; Struve, S.; Kolanus, W.; Schneider-
Mergener, J.; Kronke, M. FAN, a novel WD-repeat protein, couples the p55 TNF- 
receptor to neutral sphingomyelinase. Ce//86:937-947; 1996.
[9] Marchesini, N.; Hannun, Y. A. Acid and neutral sphingomyelinases: Roles and
mechanisms of regulation. Biochem. Cell Biol. 82:27-44; 2004.
[10] Segui, B.; Cuvillier, O.; Adam-Klages, S.; Garcia, V.; Malagarie-Cazenave, S.; 
Leveque, S.; Caspar-Bauguil, S.; Coudert, J.; Salvayre, R.; Kronke, M.; Levade, T. 
Involvement of FAN in TNF-induced apoptosis. J. Clin. Invest. 108:143-151; 2001.
[11] Clarke, C. J.; Snook, C. F.; Tani, M.; Matmati, N.; Marchesini, N.; Hannun, Y. A. 
The extended family of neutral sphingomyelinases. BiochemistryiS: 11247-11256;
2006.
R e p ro d u ce d  with perm ission  o f the copyright ow ner. Further reproduction  prohibited w ithout perm ission .
127
[12] Luberto, C ; Hassler, D. F.; Signorelli, P.; Okamoto, Y.; Sawai, H.; Boros, E.; 
Hazen-Martin, D. J.; Obeid, L. M ; Hannun, Y. A.; Smith, G. K. Inhibition of tumor 
necrosis factor-induced cell death in MCF7 by a novel inhibitor of neutral 
sphingomyelinase. J. Biol. Chem.211 :A\ 128-41139; 2002.
[13] Andrieu-Abadie, N.; Gouaze, V.; Salvayre, R.; Levade, T. Ceramide in apoptosis 
signaling: Relationship with oxidative stress. Free Radio. Biol. Med.31:7l 7-728;
2001.
[14] Hannun, Y. A. Functions of ceramide in coordinating cellular responses to stress. 
Science274:1855-1859; 1996.
[15] Hannun, Y. A.; Luberto, C. Ceramide in the eukaryotic stress response. Trends Cell 
Biol. 10:73-80; 2000.
[16] Babior, B. M. Phagocytes and oxidative stress. Am. J. Med. 109:33-44; 2000.
[17] Eyster, K. M. The membrane and lipids as integral participants in signal 
transduction: Lipid signal transduction for the non-lipid biochemist. Adv. Physiol. 
Educ.31:5-16; 2007.
[18] Bedard, K.; Krause, K. H. The NOX family of ROS-generating NADPH oxidases: 
Physiology and pathophysiology. Physiol. Rev.87:245-313; 2007.
[19] Quinn, M. T.; Gauss, K. A. Structure and regulation of the neutrophil respiratory 
burst oxidase: Comparison with nonphagocyte oxidases. J. Leukoc. Biol.76:760-781; 
2004.
[20] Cheng, G.; Cao, Z.; Xu, X.; van Meir, E. G.; Lambeth, J. D. Homologs of gp91phox: 
Cloning and tissue expression ofNox3, Nox4, andNox5. Gene269:131-140; 2001.
R e p ro d u ce d  with perm ission  o f the copyright ow ner. Further reproduction  prohibited w ithout perm ission .
128
[21] Serrano, F.; Kolluri, N. S.; Wientjes, F. B.; Card, J. P.; Klann, E. NADPH oxidase 
immunoreactivity in the mouse brain. Brain Res.988:193-198; 2003.
[22] Groemping, Y.; Rittinger, K. Activation and assembly of the NADPH oxidase: A 
structural perspective. Biochem. .7.386:401-416; 2005.
[23] Cross, A. R.; Erickson, R. W.; Cumutte, J. T. Simultaneous presence of p47(phox) 
and flavocytochrome b-245 are required for the activation of NADPH oxidase by 
anionic amphiphiles. evidence for an intermediate state o f oxidase activation. J. Biol. 
C/zenz. 274:15519-15525; 1999.
[24] Ueyama, T.; Tatsuno, T.; Kawasaki, T.; Tsujibe, S.; Shirai, Y.; Sumimoto, H.; Leto, 
T. L.; Saito, N. A regulated adaptor function of p40phox: Distinct p67phox 
membrane targeting by p40phox and by p47phox. Mol. Biol. Ce//18:441-454; 2007.
[25] Alemany, R.; van Koppen, C. J.; Danneberg, K.; Ter Braak, M.; Meyer Zu 
Heringdorf, D. Regulation and functional roles of sphingosine kinases. Naunyn 
Schmiedebergs Arch. Pharmacol.314:4\3-428; 2007.
[26] Maceyka, M.; Payne, S. G.; Milstien, S.; Spiegel, S. Sphingosine kinase, 
sphingosine-1-phosphate, and apoptosis. Biochim. Biophys. H ctal585:193-201;
2002 .
[27] Taha, T. A.; Hannun, Y. A.; Obeid, L. M. Sphingosine kinase: Biochemical and 
cellular regulation and role in disease. J. Biochem. Mol. Biol.39:113-131; 2006.
[28] Wattenberg, B. W.; Pitson, S. M.; Raben, D. M. The sphingosine and diacylglycerol 
kinase superfamily of signaling kinases: Localization as a key to signaling function. 
J. Lipid Res Al-A  128-1139; 2006.
R e p ro d u ce d  with perm ission  o f the copyright ow ner. Further reproduction  prohibited w ithout perm ission .
129
[29] Toman, R. E.; Payne, S. G.; Watterson, K. R.; Maceyka, M.; Lee, N. H.; Milstien,
S.; Bigbee, J. W.; Spiegel, S. Differential transactivation of sphingosine-l-phosphate 
receptors modulates NGF-induced neurite extension. J. Cell Biol. 166:381-392; 2004.
[30] Mizugishi, K.; Yamashita, T.; Olivera, A.; Miller, G. F.; Spiegel, S.; Proia, R. L. 
Essential role for sphingosine kinases in neural and vascular development. Mol. Cell. 
Biol.IS'A  1113-11121; 2005.
[31] Strochlic, L.; Dwivedy, A.; van Horck, F. P.; Falk, J.; Holt, C. E. A role for SIP 
signalling in axon guidance in the xenopus visual system. Development!35:333-342; 
2008.
[32] Wright, M. V.; Kuhn, T. B. CNS neurons express two distinct plasma membrane 
electron transport systems implicated in neuronal viability. J. Neurochem.83:655- 
664; 2002.
[33] Bottenstein, J. E.; Sato, G. H. Growth of a rat neuroblastoma cell line in serum-free 
supplemented medium. Proc. Natl. Acad. Sci. U. S. ^4.76:514-517; 1979.
[34] Li, J. M.; Shah, A. M. Intracellular localization and preassembly of the NADPH 
oxidase complex in cultured endothelial cells. J. Biol. Chem. 277:19952-19960;
2002.
[35] Levine, R. L.; Williams, J. A.; Stadtman, E. R.; Shacter, E. Carbonyl assays for 
determination of oxidatively modified proteins. Methods Enzymol.233:346-351;
1994.
[36] Wessel, D.; Flugge, U. I. A method for the quantitative recovery of protein in dilute 
solution in the presence of detergents and lipids. Anal. Biochem. 138:141-143; 1984.
R e p ro d u ce d  with perm ission  o f the copyright ow ner. Further reproduction  prohibited w ithout perm ission .
130
[37] Towbin, H.; Staehelin, T.; Gordon, J. Electrophoretic transfer of proteins from 
polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. 1979. 
Biotechnology24:\45-l49', 1992.
[38] Grimm, M. O.; Grimm, H. S.; Patzold, A. J.; Zinser, E. G.; Halonen, R.; Duering,
M.; Tschape, J. A.; De Strooper, B.; Muller, U.; Shen, J.; Hartmann, T. Regulation 
of cholesterol and sphingomyelin metabolism by amyloid-beta and presenilin. Nat. 
CellBiol.l'A  US-1123; 2005.
[39] Olivera, A.; Spiegel, S. Sphingosine-1-phosphate as second messenger in cell 
proliferation induced by PDGF and FCS mitogens. Nature365:551-560; 1993.
[40] Gomez-Brouchet, A.; Pchejetski, D.; Brizuela, L.; Garcia, V.; Altie, M. F.; 
Maddelein, M. L.; Delisle, M. B.; Cuvillier, O. Critical role for sphingosine kinase-1 
in regulating survival of neuroblastoma cells exposed to amyloid-beta peptide. Mol. 
Pharmacol. 72:341-349; 2007.
[41] Gourlay, C. W.; Ayscough, K. R. The actin cytoskeleton: A key regulator of 
apoptosis and ageing? Nat. Rev. Mol. Cell Biol.6:583-589; 2005.
[42] Gungabissoon, R. A.; Bamburg, J. R. Regulation of growth cone actin dynamics by 
ADF/cofilin. J. Histochem. Cytochem.51:411-420; 2003.
[43] Kusner, D. J.; Thompson, C. R.; Melrose, N. A.; Pitson, S. M.; Obeid, L. M.; Iyer, S. 
S. The localization and activity of sphingosine kinase 1 are coordinately regulated 
with actin cytoskeletal dynamics in macrophages. J. Biol. Chem.2H2:23147-23162;
2007.
[44] Huwiler, A.; Johansen, B.; Skarstad, A.; Pfeilschifter, J. Ceramide binds to the CaLB 
domain of cytosolic phospholipase A2 and facilitates its membrane docking and 
arachidonic acid release. FASEB J. 15:7-9; 2001.
R e p ro d u ce d  with perm ission  o f the copyright ow ner. Further reproduction  prohibited w ithout perm ission .
131
[45] Pettus, B. J.; Bielawska, A.; Subramanian, P.; Wijesinghe, D. S.; Maceyka, M.; 
Leslie, C. C.; Evans, J. H.; Freiberg, J.; Roddy, P.; Hannun, Y. A.; Chalfant, C. E. 
Ceramide 1-phosphate is a direct activator of cytosolic phospholipase A2. J. Biol. 
Chem.219:11320-11326; 2004.
[46] Fox, T. E.; Houck, K. L.; O'Neill, S. M.; Nagarajan, M.; Stover, T. C.;
Pomianowski, P. T.; Unal, O.; Yun, J. K.; Naides, S. J.; Kester, M. Ceramide recruits 
and activates protein kinase C zeta (PKC zeta) within structured membrane 
microdomains. J. Biol. C/zew. 282:12450-12457; 2007.
[47] Bourbon, N. A.; Yun, J.; Kester, M. Ceramide directly activates protein kinase C 
zeta to regulate a stress-activated protein kinase signaling complex. J. Biol.
C/ze/zz. 275:35617-35623; 2000.
[48] Nystrom, T. Role of oxidative carbonylation in protein quality control and 
senescence. EM BO 7.24:1311-1317; 2005.
[49] Alemany, R.; Kleuser, B.; Ruwisch, L.; Danneberg, K.; Lass, H.; Hashemi, R.; 
Spiegel, S.; Jakobs, K. H.; Meyer zu Heringdorf, D. Depolarisation induces rapid 
and transient formation of intracellular sphingosine-l-phosphate. FEBS
Lett.509:239-244; 2001.
[50] Kajimoto, T.; Okada, T.; Yu, H.; Goparaju, S. K.; Jahangeer, S.; Nakamura, S. 
Involvement of sphingosine-l-phosphate in glutamate secretion in hippocampal 
neurons. Mol. Cell. Biol.27:3429-3440; 2007.
R e p ro d u ce d  with perm ission  o f the copyright ow ner. Further reproduction  prohibited w ithout perm ission .
132
Chapter 4: Ceramide kinase regulates TNFa-induced NADPH oxidase activity and 
eicosanoid biosynthesis in neuronal cells3
4.1: Abstract
Inflammation plays a key role in the exacerbation of neurodegeneration in acute, chronic, 
and psychiatric pathologies of the central nervous system (CNS). Activated microglia and 
astrocytes secrete inflammatory mediators, such as tumor necrosis factor alpha (TNFa), 
which stimulate ceramide metabolism. Bioactive lipids are implicated in oxidative stress 
and eicosanoid biosynthesis, respectively affecting cellular survival. In our study, we 
demonstrated that TNFa-stimulated oxidative stress was due in part to the stimulation of 
NADPH oxidase (NOX) activity, as well as oxidoreductases responsible for eicosanoid 
production. We further demonstrated that TNFa increases ceramide kinase activity in 
human SH-SY5Y neuroblastoma cells, and that this activity stimulated neuronal NOX, as 
well as neuronal eicosanoid biosynthesis. We further found that blockade of TNFa- 
stimulated ceramide kinase activity, and therefore neuronal NOX activity, prevented loss 
of neuronal viability. Therefore, ceramide kinase could represent a promising therapeutic 
target for intervention of CNS degeneration.
3 Brian M. Barth, Sally J. Gustafson, Jody L. Hankins, James M. Kaiser, Mark Kester, 
and Thomas B. Kuhn Prepared for submission to the Journal of Neurochemistry.
I, Brian Barth, affirm my contributions to the work outlined in this chapter. I contributed 
to the conceptualization and experimental design of the study, worked directly on all 
aspects of the study, coordinated collaborations, and prepared the manuscript, all under 
the supervision, mentorship, and advisement of Dr. Thomas Kuhn. Please see section 4.7 
on page 160 for the contributions of the other authors.
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4.2: Introduction
Many pathologies of the central nervous system (CNS) exhibit a strong inflammatory 
component that substantially contributes to neurodegeneration (Block et al. 2007). 
Microglia and astrocytes respond to acute injury, toxins, or invading pathogens by 
secreting inflammatory mediators such as eicosanoids, cytokines, and reactive oxygen 
species (ROS) (Block et al. 2007; Fetler and Amigorena 2005; Nimmerjahn et al. 2005; 
Polazzi and Contestabile 2002). Tumor necrosis factor alpha (TNFa), a pro-inflammatory 
cytokine, binds to two receptors. The type I receptor is coupled to the Mg2+-dependent 
neutral sphingomyelinase (Mg2+-nSMase) through an adaptor protein known as the factor 
associated with nSMase (FAN) (Adam-Klages et al. 1996; Marchesini and Hannun 2004; 
Segui et al. 2001). SMases hydrolyze sphingomyelin to produce the bioactive lipid 
ceramide, which is implicated in mediating oxidative stress and apoptosis (Andrieu- 
Abadie et al. 2001; Chalfant and Spiegel 2005; Hannun 1996; Hannun and Luberto 2000; 
Marchesini and Hannun 2004).
Ceramide, and its metabolites, have been shown to regulate numerous enzymes key to 
inflammatory pathways. Cytosolic phospholipase A2 (CPLA2 ), which liberates 
arachidonic acid, is targeted to specific lipid microdomains by ceramide and its 
metabolites (Huwiler et al. 2001). In response to distinct extrinsic stimuli, CPLA2 
translocates to target membranes such as the endoplasmic reticulum, the Golgi apparatus, 
and the plasma membrane (Channon and Leslie 1990; Clark et al. 1995; Leslie 1997; 
Nalefski et al. 1994). Ceramide kinase (CerK), the enzyme responsible for the 
phosphorylation of ceramide, is localized in the Golgi apparatus as well as at the plasma 
membrane, thus establishing a connection between the production of ceramide-1- 
phosphate and CPLA2 (Lamour et al. 2007). More recently, it was shown that CPLA2 
interacts with and is activated by ceramide-1-phosphate (Balsinde et al. 2000; Pettus et al. 
2004; Subramanian et al. 2005; Subramanian et al. 2007).
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The principal product of CPLA2 activity, arachidonic acid, is a pivotal precursor of 
eicosanoid biosynthesis. Eicosanoids are lipid-derived bioactive molecules with 
pleiotropic effects regulating pro- and anti-inflammatory functions (Eyster 2007; Goetzl 
et al. 1995; Needleman et al. 1986; Piomelli 1993). The cyclooxygenases (COXs) and 
lipoxygenases (LOXs), specific oxidoreductases, produce eicosanoids known as 
prostaglandins, and leukotrienes, respectively (Murakami and Kudo 2006; Poff and 
Balazy 2004). While COXs and LOXs both convert arachidonic acid to eicosanoids, they 
also generate significant amounts o f ROS as byproducts (Eyster 2007; Farooqui et al. 
2007). In addition, arachidonic acid acts as a key component o f membrane microdomains 
containing various enzymes, including members of the NADPH oxidase (NOX) family. 
Arachidonic acid has been linked as both a membrane anchor for NOX components, and 
as a cofactor to the NOX-proton channel (Bedard and Krause 2007; Groemping and 
Rittinger 2005; Lowenthal and Levy 1999; Mankelow et al. 2003; Quinn and Gauss
2004).
In this study, we investigated the role of CerK as a key mediator of NOX activity and 
eicosanoid biosynthesis in neuronal cells. We utilized both pharmacological and 
molecular approaches to demonstrate that TNFa-stimulated NOX activity and eicosanoid 
biosynthesis were dependent on CerK. Altogether, this study demonstrated, for the first 
time, that CerK was necessary for inflammatory-stimulated neuronal NOX activity, in 
addition to enhanced neuronal activities of CPLA2 , COX-2, and 5-LOX.
4.3: Materials and Methods
Reagents
Recombinant human tumor necrosis factor alpha (TNFa) was purchased from Millipore 
(Temecula, CA). DMEM and Penicillin/Streptomycin solution were obtained from 
Mediatech (Herndon, VA). Solutions of GlutaMAX-1 and trypsin/EDTA, as well as 
fluorescent siRNA, were from Invitrogen (Carlsbad, CA). The siRNA directed against
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CerK, and non-targeting siRNA was from Dharmacon (Lafayette, CO). The Mg2f- 
nSMase inhibitor GW4869, and the CerK inhibitor K l, were from EMD Biosciences 
(San Diego, CA). VECTASHIELD hard set mounting medium with 4,6-diamidino-2- 
phenylindole (DAPI) was purchased from Vector Laboratories (Burlingame, CA). Fetal 
bovine serum was received from Atlanta Biologicals (Atlanta, GA). The COX assay kit 
was from Cayman (Ann Arbor, MI). The XTT cell proliferation kit was from Trevigen 
(Gaithersburg, MD). 3H-arachidonic acid was from American Radiolabeled Chemicals 
(St. Louis, MO). All other lipids were from Avanti Polar Lipids (Alabaster, AL). A 
polyclonal rabbit anti-human CerK antibody was from Exalpha (Shirley, MA). A 
polyclonal goat anti-human phospho-cPLA2 antibody, a polyclonal goat anti-human 
phospho-p40phox antibody, a polyclonal rabbit anti-human GAPDH antibody, a polyclonal 
rabbit anti-human p67phox antibody, a monoclonal mouse anti-human (3-actin antibody, 
and corresponding horseradish peroxidase-conjugated secondary antibodies were from 
Santa Cruz (Santa Cruz, CA). Streptavidin-agarose beads, sulfo-NHS-biotin, protease 
inhibitor cocktail (PIC), a Pico Super Signal chemoluminescent kit, and a BCA protein 
assay kit were obtained from Pierce (Rockland, IL). A polyclonal rabbit anti-human 
phospho-5-LOX antibody and all other reagents were purchased from Sigma (St. Louis, 
MO).
Cell Culture
Human SH-SY5Y neuroblastoma cells were grown in 100 mm dishes (Falcon) in 
medium composed of DMEM, 10% fetal bovine serum (FBS), 1% Glutamax, 100 U/ml 
Penicillin and 100 U/ml Streptomycin (humidified atmosphere, 5% C02,37°C). For re­
plating, cells were treated with trypsin (0.5 mg/ml)/EDTA (0.2mg/ml) (5 min), washed 
with PBS, centrifuged (200 x graax, 2 min), and seeded onto 100 mm tissue culture dishes 
(2xl07 cells per dish), 6-well tissue culture plates (5xl06 cells per well), or 96-well tissue 
culture plates (5xl03 to 5xl04 cells per well).
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Cationic Nanoliposome Formation and siRNA Loading
Aliquots o f l,2-dioleoyl-2-trimethylammonium-propane (DOTAP), 1,2-distearoyL.sw- 
glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] (PEG2Q00- 
DSPE), and l,2-dioleoyl-.s7?-glycero-3-phosphoethanolamine (DOPE), suspended in 
chloroform, were made in a 4.75:0.5:4.75 molar ratio, or alternatively, aliquots of 
DOTAP, PEG2000-DSPE, DOPE, and lissamine rhodamine B-labeled DOPE were made 
in a 4.75:0.5:4.7025:0.0475 molar ratio. Lipids were dried to a film under a stream of 
nitrogen, then hydrated by addition o f 0.9% NaCl to a final lipid concentration of 25 
mg/ml. Solutions were wrapped in parafilm, heated at 60°C (60 min), and subjected to 
vortex mixing and sonicated until light no longer diffracted through the suspension. The 
lipid vesicle-containing solution was quickly extruded at 60°C by passing the solution 10 
times through 100 nm polycarbonate filters in an Avanti Mini-Extruder (Avanti Polar 
Lipids, Alabaster, AL). Nanoliposome solutions were stored at 4°C until use, protected 
from light when necessary. To prepare siRNA-loaded cationic nanoliposomes, siRNA 
was aliquoted into 0.9% NaCl, and nanoliposomes were added in a 10:1 weight ratio to 
siRNA. The solution was allowed to incubate overnight at room temperature prior to use. 
The RNA interference sequence was previously published by the Chalfant group 
(UGCCUGCUCUGUGCCUGUAdTdT and UACAGGCACAGAGCAGGCAdTdT) 
(Lamour et al. 2007).
Confocal Microscopy
Two-day old SH-SY5Y cultures (6-well plates, 5xl06 cells per well) were maintained in 
regular growth media, and transfected with 200 nM FITC-labeled, non-targeted, siRNA 
loaded into Rhodamine-labeled cationic nanoliposomes. After 24 h, the cells were 
detached with trypsin (0.5 mg/ml)/EDTA (0.2mg/ml), and re-plated onto poly-D-lysine 
(50 pg per cm2) coated glass cover slips. Following an additional 24 h growth period in 
regular media, the cells were washed three times in PBS, and fixed for 15 min at room 
temperature in 2% paraformaldehyde in PBS, pH 7.0. The cover slips were mounted onto 
glass slides with DAPI-containing mounting medium. Images were acquired using a
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Leica (TCS SP2 AOBS) scanning confocal microscope (Bannockburn, IL), and filter 
combinations for FITC, rhodamine, and DAPI.
Ceram ide Kinase Assay
Two-day old SH-SY5Y cultures (6-well plates, 5x106 cells per well) were stimulated 
with 100 ng/ml TNFa for 30 min after a 60 min pre-incubation with 10 pM GW4869. 
Cells were washed, scraped into PBS, and sonicated. Samples containing 5 pg total 
protein (BCA protein assay) were added to ceramide kinase buffer (150 pL final volume) 
containing 20 mM HEPES (pH 7.2), 50 mM NaCl, 50% glycerol, 1 mM dithiothreitol,
IX PIC and 500 pM ATP. Reactions were commenced by addition of 50 pL lipid 
solution containing 150 pM NBD-C12 ceramide 1% (v/v) Triton X-100, and 2% (w/v) 
BSA and incubated at 37°C (1 h). After termination with 100 pL dichloromethane 
Followed by a Bligh-Dyer extraction, lipids were separated by thin layer chromatography 
(dichloromethane/acetone/methanol/acetic acid/water at 10:4:3:2:1), and NBD-ceramide- 
1-phosphate was quantified using a GE Healthcare Typhoon Imager (Piscataway, NJ) 
with ImageQuant software.
Cellular Viability Assay
SH-SY5Y cells were seeded in 96-well tissue culture dishes (5xl03 cells per well), and 
grown for 48 hours. Cultures were transfected with siRNA 48 h prior to other treatments. 
Following TNFa exposure (100 ng/ml, 48 h), XTT reagent prepared according to the 
manufacturer (Trevigen, Gaithersburg, MD,) was added and allowed to incubate for 4 
hours. Viability was determined by absorbance at 490 nm (650 nm reference), using a 
Beckman Coulter Multimode DTX 880 microplate reader ((Fullerton, CA).
Cyclooxygenase Assay
Two-day old SH-SY5Y cultures (6-well plates, 5x106 cells per well) were stimulated 
with 100 ng/ml TNFa for 30 min after a 60 min pre-incubation with 10 pM GW4869, or 
alternatively, cultures were exposed to 10 pM of C8-ceramide-l-phosphate for 30 min.
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SH-SY5Y cells were harvested in cold PBS and sonicated. Quantitative measurement of 
COX activity was performed in cell lysates containing equal amounts of total protein 
(BCA protein assay) using a COX enzyme assay kit according to the manufacture’s 
instruction (Cayman, Ann Arbor, MI).
Arachidonic Acid Release Assay
Two-day old SH-SY5Y cultures (6-well plates, 5x106 cells per well) were incubated with 
0.5 pCi/mL (5 nM) 3H-arachidonic acid. Following overnight incubation, cells were 
rinsed two times with PBS, and incubated with media containing 1 mg/mL BSA (bovine 
serum albumin) for 10 minutes to remove unincorporated radioactivity, followed by PBS 
rinse. Regular growth media was replaced and cells were stimulated with TNFa (100 
ng/ml). Alternatively, cells were pre-incubated with the Mg2+-nSMase inhibitor GW4869 
(10 pM, 60 min), the CerK inhibitor K1 (10 pM, 60 min), or pre-transfected with either 
siRNA targeting CerK, or non-targeting siRNA (200 nM, 48 h). Pre-incubations and 
transfection spanned the 3FI-arachidonic acid labeling time. Aliquots of media were 
removed at various time points, centrifuged (10,000 x gmax, 10 min), and 200 pL of the 
supernatant was measured in a scintillation counter to determine the relative amount of 
arachidonic acid metabolites released from the cells. Counts were adjusted based on the 
total cellular protein determined for each experimental condition (BCA protein assay).
Quantification of Reactive Oxygen Species Production
SH-SY5Y cells were seeded in 96-well tissue culture dishes (5x10s cells per well) and 
grown for 48 hours. Cultures were incubated with 50 pM of the oxidation-sensitive 
fluorescent indicator 2’, 7 ’-dihydrodichlorofluorescein diacetate (H2 DCFDA) for one 
hour in the presence or absence of pharmacological inhibitors. H2 DCFDA is de- 
acetylated in the cytosol to dihydro-dichlorofluorescein and increases in fluorescence 
upon oxidation by H2 O2 to dichlorofluorescein (DCF). Following exposure to stimuli, 
cultures were washed with PBS, agitated in lysis buffer (2M Tris-Cl pH 8.0, 2% w/v 
SDS, 1 mM NajVOQ, and total DCF fluorescence intensity was quantified in 100 pi of
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sample cell lysates (equal amount of protein) using a Beckman Coulter Multimode DTX 
880 microplate reader (Fullerton, CA) with a 495 nm excitation filter and a 525 emission 
filter.
Membrane Translocation of p67phox
Plasma membrane proteins were prepared by biotinylation and streptavidin-affmity 
chromatography as described by Li and Shah with minor modifications (Li and Shah 
2002). SH-SY5Y neuroblastoma cells were grown in 6-well plates (5xl06 cells per well) 
for 48 h. Following transfection with either siRNA targeting CerK, or non-targeting 
siRNA (200 nM, 48 h), cultures were treated with TNFa (100 ng/ml, 15 min). After 
washing with HBSS-CM (IX  HBSS, 0.1 g/1 CaCl2, 0.1 g/1 MgCl2, pH 7.5), cultures were 
incubated with 0.5 mg/ml sulfo-NHS-biotin (prepared in 20 mM HEPES, HBSS-CM, pH 
8.0) for 40 min on ice, and excess sulfo-NHS-biotin was neutralized with 50 mM glycine 
(prepared in HBSS-CM) on ice for 15 min. Cells were scraped into HBSS-CM, 
centrifuged (200 x gmax, 2 min), re-suspended in 500 pL loading buffer (20 mM HEPES 
pH 7.5, HBSS, 1% Triton X-100, 0.2 mg/ml saponin, 1% PIC), and sonicated. 
Streptavidin-agarose beads (25 pL) were added to the cell lysates (2 h, 4°C). Beads were 
collected (2,500 x gmax, 2 min), re-suspended in 150 pL of loading buffer, and heated (5 
min, boiling water bath). Supernatants were obtained by centrifugation (2,500 x gmax, 2 
min), and total cellular protein content was determined (BCA protein assay).
Western Blotting
Two-day old SH-SY5Y cultures (6-well plates, 5x106 cells per well) were stimulated 
with 100 ng/ml TNFa for 15 min after a 60 min pre-incubation with 10 pM GW4869, or 
alternatively, cultures were exposed to 10 pM of C2-ceramide, C2-ceramide-l- 
phosphate, or C2-dihydroceramide for 15 min. Cells were lysed (2 M Tris-Cl pH 8.0, 2% 
SDS, 1 mM NajVCL) and following centrifugation (3,000 x gmax, 4°C, 20 min), 
supernatants collected. Alternatively, lysates from siRNA-transfected cells or biotin- 
labeled cells were collected. Equal amounts of total protein (5-50 pg, BCA protein assay)
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were separated by SDS -polyacrylamide (10-15%) gel electrophoresis (125 volts, 50 
watts, 75 mA) and proteins transferred onto nitrocellulose or PVDF membranes (2.5 
hours, 50 volts, 50 watts, 250 mA) according to Towbin and co-workers (Towbin et al. 
1992). Following transfer, membranes were blocked with TBST-BSA (5 mg/ml BSA, 50 
mM Tris-Cl pH 7.4, 150 mM NaCl, 0.1% Tween-20), and probed overnight with the 
appropriate primary antibody (1 pg/pl in TBST). Following incubation with a 
corresponding horseradish peroxidase-conjugated secondary antibody (0.2 pg/pl in 
TBST, 45 min), immune-reactivity was detected by chemoluminescence and quantified 
using a GE Healthcare Typhoon Imager (Piscataway, NJ) running ImageQuant software. 
Alternatively, immune-reactivity was detected by film exposure, followed by NIH 
ImageJ analysis (Bethesda, MD).
Statistical Analysis
One-way or two-way analysis of variance (ANOVA) or t-tests were used to determine 
statistically significant differences between treatments (p<0.05). At least three 
independent experiments were performed for each condition. Post hoc comparisons of 
specific treatments were performed using a Bonferroni test or a Dunette’s test. All error 
bars represent standard error of the mean (SEM). All statistical analyses were carried out 
using GraphPad Prism 4 software (La Jolla, CA).
4.4: Results
Neuronal ROS production was stimulated by TNFa.
Oxidative stress is a hallmark of acute, chronic, and psychiatric pathologies of the CNS 
and accompanies inflammatory processes (Block et al. 2007; Fetler and Amigorena
2005). Numerous studies, including our own (Chapter 2) (Barth et al. 2009), have 
demonstrated that TNFa causes oxidative stress in many non-neuronal and neuronal cell 
types both in vivo and in vitro (Block et al. 2007; Eyster 2007). We assessed in human 
SH-SY5Y neuroblastoma cells whether TNFa mediated the formation of ROS (oxidative
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stress), and whether this was attributable to NOX, COX-2, or 5-LOX, three 
oxidoreductases commonly associated with inflammatory responses. In order to quantify 
intracellular ROS production, SH-SY5Y cells were loaded with the redox-sensitive 
fluorescent indicator 2 ’, 7’-dihydrodichlorofluorescein (DCF). Within 15 min of acute 
exposure to 100 ng/ml TNFa, DCF-fluorescence intensity significantly increased (1.31 ± 
0.04, *p<0.001, n=3), indicative of a generation of intracellular ROS (control: 1.03 + 
0.01, n=3) (Fig. 4.1). Pre-treatment for 60 min with the non-specific NOX inhibitor 
diphenylene iodonium (DPI, 10 pM), the specific COX-2 inhibitor indomethacin (IDM, 
10 pM), the 5-LOX activator-protein inhibitor MK-886 (MK, 10 pM), or the antioxidant 
N-acetyl-L-cysteine (NAC, 5 mM), completely abrogated TNFa-stimulated intracellular 
ROS formation (TNFa + DPI: 1.00 ±  0.02, n=3; TNFa + IDM: 1.03 ±  0.01, m=3; TNFa 
+ MK: 0.99 + 0.04, n=3, TNFa + NAC: 0.92 + 0.01, n=3) (Fig. 4.1 A). These findings 
revealed that ROS formation in neuronal cells in response to TNFa arose from at least 
NOX, COX-2, and 5-LOX activity.
We further chose to evaluate a role for ceramide metabolites in response to 
inflammatory stimuli in neuronal cells. The generation of ceramide in response to various 
stimuli, including pro-inflammatory cytokines, has been documented and linked to 
cellular stress (Hannun and Luberto 2000). In our study, we found that blocking the 
hydrolysis of sphingomyelin to ceramide, by pre-treating with the selective Mg2+-nSMase 
inhibitor GW4869 (10 pM), negated TNFa-stimulated intracellular ROS formation (1.07 
+ 0.01, n=3) (Fig. 4. IB). We also found that exogenously added short-chain ceramide 
analogs alone (10 pM each, 15 min), caused significant ROS production in SH-SY5Y 
cells as demonstrated for C2-ceramide (CER; 1.23 ± 0.03, *p<0.001, n=4), C2-ceramide- 
1-phosphate (C1P; 1.33 + 0.01, *p<0.001, n=4), or C2-dihydroceramide (DHCER; 1.24 + 
0.02, *p<0.001, n=4). These results implied that ceramide metabolites could play a 
profound role in the modulation of oxidative stress. Furthermore, while many researchers 
consider dihydroceramide to be an ‘inactive’ form of ceramide, these findings supported 
recent studies demonstrating that dihydroceramides are important bioactive mediators of 
cellular stress and death pathways (Wang et al. 2008; Zahlten et al. 2007).
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Figure 4.1. TNFa stimulates neuronal ROS production. The production o f intracellular ROS was quantified using 
the oxidation-sensitive fluorescent indicator 2 ’, 7 ’-dihydrodichlorofluorescein (DCF). Human SH-SY5Y 
neuroblastoma cells were loaded with 50 pM o f the indicator, +/- inhibitors, 60 min prior to treatment. (A) SH-SY5Y 
cells were treated with T N Fa (TNF, 100 ng/ml, 15 min), +/- 10 uM o f the NOX inhibitor diphenylene iodonium (DPI), 
10 uM o f the COX-2 inhibitor indomethacin (IDM), 10 pM o f the 5-LOX activator-protein inhibitor MK-886 (MK), or 
5 mM of the antioxidant N-acetyl-L-cysteine (NAC). (B) SH-SY5Y cells were treated with TN Fa, +/- 10 pM o f the 
Mg2+-nSMase inhibitor GW4869 (GW). Alternatively, cells were treated for 15 min with 10 pM o f  short-chain 
ceramide analogs (C2-ceramide, CER; C2-ceramide-l-phosphate, C1P; C2-dihydroceramide, DHCER). Data represent 
means +/- SEM o f at least three independent experiments (1-way ANOVA, *p<0.001, compared to control: CON).
CerK and COX-2 activity were stimulated by TNFa.
To evaluate the link between ceramide metabolism and inflammatory stress, we measured 
the activities of CerK and COX-2. Our study revealed that TNFa-stimulated intracellular 
ROS formation was prevented by inhibition of the ceramide-generating Mg -nSMase, or 
COX-2 (Fig. 4.1), and indeed we had found that TNFa stimulated Mg2+-nSMase activity 
in both SH-SY5Y neuroblastoma cells and primary cortical neurons (data not shown). 
However other researchers have linked the production of ceramide-1 -phosphate, 
generated by CerK, to the production of prostaglandins by COX enzymes in non­
neuronal cells (Subramanian et al. 2005; Subramanian et al. 2007). In this study, we 
found that TNFa (100 ng/ml, 30 min) stimulated significant CerK activity in SH-SY5Y 
cells (2.06 ±0.13, *p<0.001, n=3), compared to the control (1.00 ±  0.08, n=3) (Fig.
4.2A). Intriguingly, TNFa-stimulated CerK activity was completely blocked by 60 min
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pre-treatment with 10 uM of the Mg2+-nSMase inhibitor GW4869 (0.34 + 0.02, n=3).
The efficacy of GW4869 towards CerK was either due to CerK-inhibition, or simply by 
preventing the generation of the substrate ceramide by Mg2+-nSMase. We also found that 
TN Fa (100 ng/ml, 30 min) stimulated significant COX-2 activity (pU/pg total protein) in 
SH-SY5Y cells (278 + 9, *p<0.001, n=3), compared to the control (33 ± 1, n=3), that was 
also blocked by 60 min pre-treatment with 10 pM GW4869 (51 + 2 , n=3) (Fig. 5.2B). As 
expected, COX-2 activity was also stimulated by 30 min treatment with 10 pM of the 
short-chain C8 analog o f ceramide-1-phosphate alone (C8-C1P: 151+5, *p<0.001, n=3). 
These findings demonstrated that TNFa-stimulated CerK activity, subsequently 
generating ceramide-1 -phosphate, contributed to enhanced COX-2 activity in neuronal 
cells.
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Figure 4.2. T N Fa stim ulates neuronal C erK  and COX-2 activity. CerK and COX-2 activity was evaluated in 
human SSH-SY5Y neuroblastoma cells. (A) CerK activity was quantified by measuring the conversion of the 
fluorescent NBD-ceramide to NBD-ceramide-1-phosphate. SH-SY5Y cells were exposed to T N Fa (TNF, 100 ng/ml, 
30 min), +/- 60 min pre-treatment with 10 pM of the Mg2+-nSMase inhibitor GW4869 (GW). (B) COX-2 activity was 
measured by using an enzyme assay kit according to the manufacturer’s instructions (Cayman Chemical, Ann Arbor, 
MI, USA). SH-SY5Y cells were exposed to T N Fa (100 ng/ml, 30 min), +/- 60 min pre-treatment with 10 pM 
GW4869, or alternatively for 30 min with 10 pM o f the short-chain C8 analog o f ceramide-1 -phosphate (C8-C1P). 
Data represent means +/- SEM o f at least three independent experiments (1-way ANOVA, *p<0.001, **p<0.01, 
compared to control: CON).
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Phosphorylation of CPLA2 , 5-LOX, and p40phox were stim ulated by TN Fa. 
Phosphorylation of CPLA2 , an enzyme responsible for the production of arachidonic acid, 
causes conformational changes that reveal lipid-binding domains essential towards 
enzyme activation (Ghosh et al. 2006; Kudo and Murakami 2002). We measured 
activation o f CPLA2 by quantifying phosphorylation of the enzyme. We found in SH- 
SY5Y cells that phosphorylation of CPLA2 increased significantly following acute (15 
min) addition of 100 ng/ml TNFa (2.77 + 0.28, *p<0.01, n=3), compared to the control 
(1.00 + 0.24, n=3) (Fig. 4.3A). Notably, phosphorylation was blocked by 60 min pre­
treatment with 10 pM GW4869 (1.33 + 0.27, n=3). However, all three short-chain 
analogs of ceramides (10 pM each, 15 min) did not significantly increase the 
phosphorylation of CPLA2 (C2-ceramide: 1.49 + 0.27, n=3; C2-ceramide-l-phosphate: 
1.73 + 0.14, n=3; C2-dihydroceramide: 1.32 ± 0.25, n=3).
Phosphorylation also plays a prominent role in the activation o f NOX enzymes. 
The assembly of cytosolic subunits with the membrane-bound subunits is regulated in 
part by phosphorylation. PX (Phox homology) domains play a key role in enabling the 
interaction of cytosolic subunits p47phox and p40phox with target membranes, bringing 
these subunits into position to interact with the membrane-bound subunits. These PX 
domains are revealed only after phosphorylation induces conformational changes that 
release auto-inhibitory regions (Bedard and Krause 2007; Groemping and Rittinger 2005; 
Quinn and Gauss 2004). Therefore, we analyzed NOX stimulation by quantifying 
changes in the phosphorylation o f the p40phox subunit. TNFa exposure (100 ng/ml, 15 
min) of SH-SY5Y cells substantially increased phosphorylation of p40phox (1.65 + 0.12, 
*p<0.01, n=3), compared to the control (1.02 + 0.05, n=3) (Fig. 4.3B), while pre­
incubation of SH-SY5Y cultures for 60 min with 10 pM GW4869 completely abolished 
phosphorylation (1.19 + 0.04, n=3) (Fig. 3B). Exposure for 15 min to of exogenous short- 
chain ceramide or ceramide-1-phosphate did not stimulate significant p40phox 
phosphorylation (C2-ceramide: 1.30 + 0.06, n=3; C2-ceramide-1 -phosphate: 1.42 + 0.10, 
n=3), while dihydroceramide did (C2-dihydroceramide: 1.86 ±  0.10, *p<0.001, n=3).
R e p ro d u ce d  with perm ission  o f the copyright ow ner. Further reproduction  prohibited w ithout perm ission .
145
This later result further substantiates dihydroceramide ’ s ability to stimulate intracellular 
ROS production.
Next, we evaluated phosphorylation of 5-LOX at Ser , an event that has been 
suggested to regulate the localization of the enzyme (Luo et al. 2005; Radmark and 
Samuelsson 2007). Acute addition of 100 ng/ml TNFa (15 min) to SH-SY5Y cultures 
significantly increased phosphorylation of 5-LOX (1.73 + 0.09, *p<0.05, n=3), compared 
to the control (1.02 + 0.07, n=3) (Fig. 4.3C). Phosphorylation was significantly reduced, 
although only partially, after a 60 min pre-treatment with 10 pM GW4869 (1.37 + 0.08, 
n=3). As with CPLA2 , phosphorylation of 5-LOX was not significantly stimulated by 
exposure for 15 min with 10 pM of short C2-chain analogs of ceramides (C2-ceramide: 
1.43 ±  0.17, n=3; C2-ceramide-l-phosphate: 1.36 + 0.13, n=3; C2-dihydroceramide: 1.49 
+ 0.15, n=3).
R e p ro d u ce d  with perm ission  o f the copyright ow ner. Further reproduction  prohibited w ithout perm ission .
146
Figure 4.3. T N F a stim ulates phosphorylation of ePLA2, 5-LOX, and  p40pho\  Phosphorylation o f cPLA2, p40phox, 
and 5-LOX was evaluated by western blotting. Human SH-SY5Y neuroblastoma cells were treated with T N Fa (TNF, 
100 ng/ml, 15 min), +/- 60 min pre-treatment with 10 pM o f the Mg2+-nSMase inhibitor GW4869 (GW). Alternatively, 
cells were treated for 15 min with 10 pM of short-chain ceramide analogs (C2-ceramide, CER; C2-ceram ide-l- 
phosphate, C1P; C2-dihydroceramide, DHCER). Following treatments, cells were lysed and western blotting was used 
to determine phospho-cPLA2, phospho-p40phox, or phospho-5-LOX levels in samples containing equal total cellular 
protein. (A) Quantified cPLA2 phosphorylation. (B) Quantified p40phox phosphorylation. (C) Quantified 5-LOX 
phosphorylation. Data represent means +/- SEM o f at least three independent experiments (1-way ANOVA, *p<0.05, 
compared to control: CON).
Blocking CerK prevented TNFa-stimulated neuronal NOX activity.
Since our study ascribed an important role in neuronal cells for ceramide species as 
mediators of TNFa-stimulated ROS production, and showed that TNFa could stimulate 
CerK activity in neuronal cells, it became important to evaluate the role of CerK and 
ceramide-1-phosphate in regulating NOX in response to inflammatory stimuli. We used
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siRNA to knockdown the activity of CerK using a sequence established by the Chalfant 
group (Lamour et al. 2007). To transfect SH-SY5Y cells with siRNA, we utilized a novel 
cationic nanoliposome formulation. Compared to other transfection systems, this 
formulation was specifically designed to be non-toxic and compatible for in vivo systemic 
delivery (Tran et al. 2008). To validate the delivery of siRNA to SH-SY5Y cells, we 
employed both fluorescently labeled siRNA and fluorescently labeled nanoliposomes 
(Fig. 4.4A). We observed incorporation o f the liposome components into the plasma 
membranes o f cells (red fluorescence), as well as siRNA uptake into perinnuclear and 
cytoplasmic regions of the cells (green fluorescence). The efficiency of siRNA 
transfection delivered by cationic nanoliposome (200 nM, 48 h) was determined to be 
73%. We utilized Western blotting to evaluate the knockdown of CerK by siRNA (siCK, 
200 nM, 48 h) as compared to non-targeted siRNA (siSCR), and found significant 
knockdown of CerK levels (siCK: 25% + 9%, *p<0.01, n=3; siSCR: 100% ± 13%, n=3) 
(Fig. 4.4B).
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Figure 4.4. C ationic nanoliposom es effectively deliver C erK  siRNA. Human SH-SY5Y neuroblastoma cells were 
transfected with siRNA targeting CerK. Cells were transfected with 200 nM siRNA for 48 hours in the presence of 
serum using a cationic nanoliposomal formulation. (A) Laser scanning confocal microscopy was used to evaluate 
uptake o f siRNA. 24 hours following transfection, cells were re-plated onto poly-D-lysine-coated glass coverslips and 
maintained for an additional 24 hours before fixation, mounting, and microscopy. Cellular nuclei were stained with 
DAPI (blue), the liposome contained a rhodamine-labeled lipid (red), and the RNA was fluorescein-labeled (green) 
BLOCK-iT Fluorescent Oligo (Invitrogen, Carlsbad, CA). (B) Knockdown o f CerK by targeted siRNA (siCK) 
compared to non-targeted siRNA (siSCR), was validated by Western blotting and quantified by image analysis o f band 
density. Images are representative o f three independent experiments, while data represent means +/- SEM o f at least 
three independent experiments (t-test, *p<0.01).
We next began to evaluate the cellular role for CerK in SH-SY5Y cells in 
response to TNFa. Initially, we evaluated TNFa-stimulated intracellular ROS 
production, which we earlier showed was due in part to the activation of NOX, COX-2, 
and 5-LOX. In this study, we observed that TNFa (100 ng/ml, 60 min) stimulated 
significant ROS production (1.94 + 0.19, *p<0.01, n=4), compared to the control (1.00 + 
0.13, n=4), which was blocked by 60 min pre-treatment with 10 pM GW4869 (0.98 ± 
0.12, n=4). The knockdown of CerK by siRNA (200 nM, 48 h) effectively blocked 
TNFa-stimulated intracellular ROS production (1.05 + 0.1, n=4), whereas non-targeted 
siRNA did not (1.68 + 0.08, *p<0.05, n=4) (Fig. 4.5A). This finding in neuronal cells is 
consistent with previous studies showing regulation of CPLA2 by CerK (Balsinde et al.
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2000; Pettus et al. 2004; Subramanian et al. 2005; Subramanian et al. 2007), considering 
cPLAi’s pivotal role in regulating NOX, COX-2, and 5-LOX through its production of 
arachidonic acid. To more closely evaluate the functionality of NOX, we next evaluated 
the translocation of the cytosolic subunit p67phox to the plasma membrane in response to 
TNFa (Fig. 4.5B). As expected, a significant translocation of p67phox to the plasma 
membrane occurred in response to 15 min treatment with 100 ng/ml TNFa (2.26 + 0.16, 
*p<0.01, n=3), compared to the control (1.00 + 0.04, n=3). Furthermore, specifically 
targeting CerK with siRNA (200 nM, 48 h), but not non-targeted siRNA, blocked TNFa- 
stimulated p67phox translocation (TNFa + siCK: 1.23 + 0.19, n=3; TNFa + siSCR: 2.12 
+ 0.19, *p<0.01, n=3). Altogether, these results demonstrate that CerK plays an essential 
role as a mediator of TNFa-stimulated neuronal NOX activity.
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Figure 4.5. B locking C erK  prevents T N Fa-stim ulated  neuronal NOX activity. The role o f CerK regulation of 
NOX was examined in human SH-SY5Y neuroblastoma cells by evaluating intracellular ROS production and 
translocation o f the p67phox cytosolic subunit o f NOX to the plasma membrane. Cells were pre-treated siRNA targeting 
CerK (siCK, 200 nM, 48 h), or non-targeting siRNA (siSCR, 200 nM, 48 h), followed by stimulation with T N Fa (TNF, 
100 ng/ml, 60 min). Alternatively, cells were pre-treated with the Mg2+-nSMase inhibitor GW4869 (GW, 10 pM, 60 
min). (A) The production of intracellular ROS was quantified by loading the cells 60 min before T N Fa treatment with 
50 pM of the oxidation-sensitive fluorescent indicator 2 ’, 7 ’-dihydrodichlorofluorescein (DCF). (B) The translocation 
ofp67phox to the plasma membrane was monitored following T N Fa exposure (100 ng/ml, 15 min) by biotinylating 
membrane proteins, separation by streptavidin-conjugated beads, and Western blot. All data represent means +/- SEM 
o f at least three independent experiments (1-way ANOVA, *p<0.05, compared to control: CON, **p<0.05 compared to 
TNF + siCK).
R e p ro d u ce d  with perm ission  o f the copyright ow ner. Further reproduction  prohibited w ithout perm ission .
150
Blocking C erK  prevented TN Fa-stim ulated neuronal arachidonic acid release. 
Eicosanoid biosynthesis is an important part of many inflammatory processes (Eyster 
2007; Farooqui et al. 2007). The COX and LOX oxidoreductases produce ROS and are 
also responsible for the oxygenation of arachidonic acid, the initial step in the production 
of eicosanoids. Production of eicosanoids is rapidly followed by their release from the 
cell, and for this reason, we chose to monitor the release o f eicosanoids as an indirect 
means of measure eicosanoid synthesis. We incubated SH-SY5Y neuroblastoma cells 
with 3H-labeled arachidonic acid, allowing its overnight incorporation into the cells. 
Following exposure to 100 ng/ml of TNFa, we collected aliquots of growth media at 
various time points and quantified arachidonic acid metabolite release by liquid 
scintillation counting (Fig. 4.6). We found that cells treated with TNFa alone, or cells 
transfected with non-targeted siRNA prior to TNFa-treatment, released a significantly 
greater amount of arachidonic acid metabolites over a six hour time course (TNFa-6 h: 
482 + 46, *p<0.001, n=3; TNFa + siSCR-6 h: 525 + 50, *p<0.001, n=3) compared to the 
control (6 h: 223 + 24, n=3). We further found that siRNA directed against CerK (200 
nM, 48 h), 60 min pre-treatment with 10 pM of K l, an inhibitor of CerK, or 60 min pre­
treatment with 10 pM of GW4869, a Mg2+-nSMase inhibitor, all prevented TNFa- 
stimulated arachidonic acid metabolite release (TNFa + siCK-6 h: 176 + 23, n=3; TNFa 
+ K l-6 h: 274 ± 25, n=3; TNFa + GW4869-6 h: 291 ±  35, n=3).
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Figure 4.6. Blocking C erK  prevents T N Fa-stim ula ted  neuronal arachidonic acid release. Human SH-SY5Y 
neuroblastoma cells were labeled with 3H-arachidonic acid overnight prior to exposure to TN Fa (TNF, 100 ng/ml), +/'- 
pre-treatment with the Mg2+-nSMase inhibitor GW4869 (GW, 10 pM, 60 min), the ceramide kinase inhibitor K1 (10 
pM, 60 min), siRNA directed specifically against CerK (siCK, 200 nM, 48 h), or non-targeting siRNA (siSCR, 200 
nM, 48 h).The release o f  arachidonic acid or arachidonic acid metabolites was monitored by scintillation counting of 
the growth media and 3H-counts were adjusted based on total cellular protein (determined by a protein assay). All data 
represent means +/- SEM of at least three independent experiments. Boxes denote significantly different values 
between treatments at a time point (2-way ANOVA, *p<0.01), including the control (CON), **p<0.01 compared to all 
treatments except TNF + K l).
Blocking CerK prevented TNFa-stimulated loss of neuronal viability.
To conclude our study, we evaluated how blocking CerK activity affected the viability of 
SH-SY5Y neuroblastoma cells exposed to TNFa (Fig. 4.7). As anticipated, we observed 
a significant decrease in cellular viability when SH-SY5Y cells were treated with 100 
ng/ml TNFa for 48 h (67% + 2%, *p<0.001, n=12), compared to the control (100% +
4%, n=12). Intriguingly, co-treatment with 10 uM GW4869 did not restore viability (63% 
± 2%, *p<0.001, n=10). However, siRNA directed against CerK (200 nM, 48 h) 
effectively prevented TNFa-induced loss of cellular viability (85% + 3%, **p<0.001, 
n=8), whereas non-targeted siRNA did not (68% ± 2%, *p<0.001, n=8). Most
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interestingly, the deleterious effects of TNFa on SH-SY5Y cellular viability could be 
restored, despite CerK inhibition by siRNA, with the addition of exogenous short-chain 
C8-ceramide-l-phosphate (73% + 2%, #p<0.01, n=8).
#
Figure 4.7. Blocking C erK  prevents T N F a-stim ulated  loss of neuronal viability. Viability o f  human SH-SY5Y 
neuroblastoma cells was evaluated 48 hours after exposure to T N Fa (TNF, 100 ng/ml), +/- co-incubation with the 
Mg2+-nSMase inhibitor GW4869 (GW, 10 pM), siRNA directed specifically against CerK (siCK, 200 nM), or non­
targeting siRNA (siSCR, 200 nM). Cationic nanoliposomes were used to deliver siRNA to cells 48 hours prior to 
treatment in regular growth media. Alternatively, the short-chain C8 analog o f ceramide-1 -phosphate (C8-C1P) was 
used to counter the effects o f CerK down-regulation by siRNA. Cellular viability was determined by XTT assay and 
values were normalized, and expressed as a percentage of the values obtained under control conditions (CON). All data 
represent means +/- SEM o f at least eight independent experiments (1-way ANOVA, *p<0.01, compared to control: 
CON, **p<0.01 compared to TNF + siCK; t-test, #p<0.01 comparing TNF + siCK to TNF + siCK + C8-C1P).
4.5: Discussion
Bioactive sphingolipids have been shown to regulate a diversity of cellular processes 
including survival, growth, cellular stress, and inflammation (Eyster 2007; Hannun 1996; 
Hannun and Luberto 2000). Recently, ceramide-1-phosphate, the product o f CerK
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activity, was shown to directly interact with CPLA2 and stimulate its activity by 
enhancing its association with target membranes (Subramanian et al. 2005; Subramanian 
et al. 2007). This finding implicated ceramide-1-phosphate as a key sphingolipid 
mediating inflammatory responses, as CPLA2 catalyzes the rate limiting step in 
eicosanoid biosynthesis (Eyster 2007; Lamour et al. 2007). Importantly, protein kinase 
activity is required to activate cPLA2 because phosphorylation induces a conformational 
change exposing lipid-binding domains (Ghosh et al. 2006; Kudo and Murakami 2002). 
In a similar manner, phosphorylation o f 5-LOX, and NOX subunits, other enzymes 
playing crucial roles in inflammation, results in changes in cellular localization, which 
regulate their activity (Bedard and Krause 2007; Eyster 2007; Farooqui et al. 2007). 
Interestingly, ceramide, another bioactive sphingolipid linked primarily to cellular stress, 
has been shown to regulate protein kinase C t, (PKCQ (Bourbon et al. 2000; Bourbon et 
al. 2002; Fox et al. 2007), CPLA2 (Huwiler et al. 2001), and NOX (Cacicedo et al. 2005; 
Yi et al. 2007). Ceramide has been shown to activate PK.CC, by direct binding, while 
PKC^ has been shown to strongly activate NOX (Fontayne et al. 2002). We have 
established ceramide, generated by TNFa-stimulated Mg2+-nSMase activity, as a key 
mediator of NOX in both primary neurons and the SH-SY5Y neuroblastoma cell line 
(data not shown). However, in this study we specifically evaluated the role of CerK and 
its product, ceramide-1-phosphate, as a mediator of TNFa-stimulated neuronal NOX 
activity (Fig. 4.8). This research is significant because it not only is the first to establish 
CerK as a regulator of NOX, but it also describes a route, independent of PKCt, 
activation, by which ceramide, through conversion to ceramide-1-phosphate, can regulate 
NOX. This study also expanded into neuronal cells, previous research linking CerK to 
eicosanoid biosynthesis.
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T N F a
N O X C O X 2 5 LO X
Figure 4.8. C erK  m ediates T N F a-stim ula ted  neuronal NOX activity and  eicosanoid biosynthesis. TN Fa evokes 
an increase in ceramide metabolites through two principal activities: 1) Mg2+-nSMase activity, hydrolyzing 
sphingomyelin to ceramide (CER), and 2) CerK activity, converting ceramide to ceramide-1-phosphate (C1P). Both 
ceramide and ceramide-1-phosphate stimulate CPLA2 activity, and thus increase arachidonic acid (AA) production. 
Ceramide metabolites in conjunction with arachidonic acid, mediate the formation o f ROS and eicosanoids in neuronal 
cells by stimulating the oxidoreductases: NADPH oxidase (NOX), cyclooxygenase-2 (COX-2), and 5-lipoxygenase (5- 
LOX).
We initially demonstrated that TNFa-stimulated intracellular ROS production in SH- 
SY5Y neuroblastoma cells was sensitive to pharmacological inhibition of COX, LOX, 
and NOX. These enzymes are all important oxidoreductases found throughout the body, 
including in the CNS (Bedard and Krause 2007; Eyster 2007; Farooqui et al. 2007). 
Arachidonic acid serves as a substrate for both LOXs and COXs, and has been linked to 
activity of NOXs through interactions with both membrane-bound and cytosolic subunits 
(Bedard and Krause 2007; Eyster 2007; Farooqui et al. 2007; Groemping and Rittinger 
2005; Quinn and Gauss 2004). We further showed that ROS production was sensitive to 
pharmacological inhibition of Mg2+-nSMase and was mimicked by exogenous short- 
chain analogs of ceramide, ceramide-1-phosphate, and dihydroceramide. We next 
investigated COX-2, and found that its activity was stimulated by TNFa in a manner that 
was sensitive to Mg2+-nSMase inhibition. Since exogenous short-chain ceramide-1-
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phosphate also stimulated COX-2 in our model, and ceramide-1 -phosphate-dependent 
CPLA2 generates the substrate for COX-2, we speculated, and found, that TNFa 
stimulated CerK activity. Interestingly, this CerK activity was blocked by inhibition of 
Mg2+-nSMase, corroborating our pharmacological findings suggesting Mg2+-nSMase 
involvement in TNFa-stimulated ROS production.
To more specifically evaluate CerK, and its role in TNFa-stimulated neuronal NOX 
activity, we employed siRNA directed against CerK. To deliver siRNA, we utilized a 
novel cationic nanoliposome, which was designed specifically for in vivo applications 
(Tran et al. 2008). It was important to utilize a delivery system suited for in vivo 
applications, and therefore adequate for translational research. We found that knockdown 
of CerK prevented TNFa-stimulated ROS production, as well as 3H-labeled arachidonic 
acid-metabolite release, a measure of eicosanoid biosynthesis and release. Both ROS and 
eicosanoids are neurotoxic, and so it was not surprising that knockdown of CerK 
prevented TNFa-induced loss of SH-SY5Y cell viability. Since we had earlier shown that 
ROS are generated by multiple oxidoreductases, it became important to directly evaluate 
NOX activation. The production of ROS by NOX requires both the phosphorylation and 
translocation of cytosolic subunits to membrane microdomains (Bedard and Krause 2007; 
Groemping and Rittinger 2005; Quinn and Gauss 2004). By monitoring the movement of 
the p67phox subunit to the membrane, we determined that CerK, and therefore ceramide-1- 
phosphate, was necessary for TNFa-stimulated NOX assembly and activity. The precise 
role for ceramide-1-phosphate-regulation of NOX may lie in its ability to stimulate 
CPLA2 activity, and therefore the production of arachidonic acid. However, while 
arachidonic acid has been suggested to be a component of NOX subunit-targeted 
membranes, it has also been suggested to activate a proton channel that comprises a 
portion of the gp91phox membrane-bound subunit (Lowenthal and Levy 1999; Mankelow 
and Henderson 2001; Mankelow and Henderson 2003; Mankelow et al. 2003; Mankelow 
et al. 2004). Therefore, while our findings that CerK regulates p67phox membrane 
translocation are explained through activation of CPLA2 in the former case, the later
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would suggest that our findings support a more direct role for CerK in the regulation of 
NOX. Perhaps ceramide-1-phosphate serves as a key component o f membranes targeted 
by NOX subunits.
Altogether, our study demonstrated that TNFa induced a profound generation of ROS in 
human SH-SY5Y neuroblastoma cells by activating three oxidoreductase activities, 
namely COX, LOX, and NOX, all under the regulation of ceramide metabolites. 
Oxidative stress is an important biological consequence of acute and chronic pathologies 
of the CNS, as well as psychiatric disorders, and is a primary effect of the associated 
inflammatory components (Block et al. 2007; Farooqui et al. 2007). In the CNS, the pro- 
inflammatory cytokine TNFa is released by activated microglia and astrocytes, and its 
accumulation is highly neurotoxic, inducing oxidative stress and apoptosis. Importantly, 
for the first time, our study showed that CerK played an essential role in regulating NOX 
activity, and therefore oxidative stress, in addition to regulating COX- and LOX- 
mediated eicosanoid biosynthesis in neuronal cells. Targeting CerK could potentially 
open new therapeutic strategies to alleviate neurodegeneration and improve neuronal 
survival and connectivity.
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Chapter 5: Inhibition of NADPH oxidase by glucosylceramide confers 
chemoresistance4
5.1: Introductory Paragraph
The bioactive sphingolipid ceramide induces oxidative stress by disrupting 
mitochondrial function and stimulating NADPH oxidase (NOX) activity, both of which 
stimulate apoptosis 1_5. Many anticancer chemotherapeutics (anthracyclines, Vinca 
alkaloids, paclitaxel, and fenretinide), as well as physiological stimuli such as tumor 
necrosis factor a  (TNFa), enhance ceramide accumulation through de novo synthesis, 
degradation of complex sphingolipids, or inhibition of ceramide catabolism, all of which 
increase oxidative stress in malignant cells 5'7. Consequently, ceramide metabolism in 
malignant cells has gained considerable interest as key to combating chemoresistance, in 
particular the up-regulation of glucosylceramide synthase (GCS) 6’8,9. We hypothesized 
that impeding TNFa- or chemotherapy-stimulated NOX activity by GCS could represent 
an important mechanism o f resistance. Utilizing neuroblastoma and glioblastoma cell 
lines, we determined that GCS activity blocked NOX activity, ultimately contributing to 
increased malignant cell survival. We also demonstrated a direct resistance mechanism 
where glucosylceramide, the product of GCS activity, interfered with NOX assembly. 
Collectively, our findings indicated that pharmacological or molecular inhibition of GCS 
using non-toxic nanoliposome delivery systems was able to augment NOX activity and 
improved the efficacy of chemotherapy.
4 Brian M. Barth, Sally J. Gustafson, Megan M. Young, Sriram S. Shanmugavelandy, 
James M. Kaiser, Todd E. Fox, Myles C. Cabot, Mark Kester, and Thomas B. Kuhn 
Prepared for submission as a Letter to Nature Cell Biology.
I, Brian Barth, affirm my contributions to the work outlined in this chapter. I contributed 
to the conceptualization and experimental design of the study, worked directly on all 
aspects of the study, coordinated collaborations, and prepared the manuscript, all under 
the supervision, mentorship, and advisement of Dr. Thomas Kuhn. Please see section 5.5 
on page 189 for the contributions of the other authors.
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5.2: M ain Text
The primary goal of chemotherapy is to induce cell death in malignant cells. Most 
chemotherapeutics target cellular processes associated with survival or growth. Recently, 
it has become apparent that many chemotherapeutics and endogenous stimuli such as 
TNFa, stimulate ceramide accumulation which increases oxidative stress and induces 
apoptosis of tumor cells l’5’7. Previously, we had demonstrated that TNFa stimulated 
NOX activity in SH-SY5Y neuroblastoma cells l0. Ceramide, a bioactive sphingolipid 
shown to be generated in response to numerous stimuli including TNFa, has been widely 
implicated as a modulator o f cellular stress and death 4 ,n’12. Not surprisingly, many 
chemotherapeutics have also been shown to induce oxidative stress 13’14. In our study, we 
evaluated several chemotherapeutic agents for their ability to stimulate the production of 
intracellular reactive oxygen species (ROS) in human SH-SY5Y neuroblastoma cells 
(Fig. 5.1). We utilized diphenylene iodonium (DPI), an inhibitor of NOX enzymes , to 
demonstrate that chemotherapeutic-stimulated intracellular ROS production was due in 
part, to NOX activity.
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Figure 5.1: Chemotherapeutics stimulate NOX-dependent intracellular ROS production. The production of 
intracellular ROS was evaluated using the redox-sensitive indicator H2DCFDA in human SH-SY5Y neuroblastoma 
cells. Diphenylene iodonium (DPI, 10 pM, 60 min pre-treatment), an inhibitor o f NOX, was utilized to demonstrate the 
NOX-dependence o f ROS production in response to various chemotherapeutics. (a) Doxorubicin (DOXO, 8.6 uM , 90 
min). (b) Paclitaxel (PCT, 100 nM, 60 min). (c) 4-hydroxy tamoxifen (40HT, 7.4 pM, 90 min). (d) Methotrexate 
(MTX, 1 pM, 60 min). (e) Gemcitabine (GEM, 1 pM, 120 min). (f) Fenretinide (4HPR, 1.5 pM, 60 min). (g) Empty 
(ghost) nanoliposomes (lipGFl, 60 min). (h) Nanoliposomes containing 5 pM C6-ceramide (lipC6, 60 min). (i) 
Nanoliposomes containing both 5 pM C6-ceramide and 5 pM PDMP (lipC6/PDMP, 60 min). Fluorescence, 
corresponding to ROS, was normalized to the average fluorescence of the control (relative DCF-fluorescence). Data 
represent the mean +/- SEM o f four independent experiments; * p < 0.05, ** p < 0.01, or *** p < 0.001, as determined 
by 1-way ANOVA.
In our study, we found that significant NOX-dependent intracellular ROS 
production was stimulated in response to the anthracycline doxorubicin (Fig. 5.1a), the
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mitotic inhibitor paclitaxel (Fig. 5.1b), the estrogen receptor antagonist 4-hydroxy 
tamoxifen (Fig. 5.1c), the anti-metabolite methotrexate (Fig. 5. Id), the nucleoside analog 
gemcitabine (Fig. 5.1e), and the retinoid derivative fenretinide (Fig. 5. If). Interestingly, 
tamoxifen has also been found to inhibit p-glycoprotein, and therefore glucosylceramide 
synthase by product inhibition, leading to an accumulation of ceramide. Additionally, 
fenretinide has been shown to stimulate serine palmitoyltransferase and therefore de novo 
synthesis of ceramide, as well as to block dihydroceramide desaturase, leading to 
accumulations of dihydroceramide 15,16. Our results not only tied the generation of 
intracellular ROS by these compounds to NOX, but also confirmed that known 
generators o f ceramides stimulate NOX-derived intracellular ROS production.
In addition to these more-well known agents, we evaluated three nanoliposomal 
formulations designed by our laboratory (Supplementary Information, Table 5.SI). One 
formulation, termed the ghost, is a control formulation that does not contain any 
ceramide. As expected, the ghost formulation did not stimulate the production of 
intracellular ROS (Fig. 5.1g). The other nanoliposome formulations contained the C6-, 
short-chain, analog of ceramide, which has demonstrated in vivo efficacy in treating 
rodent models of breast cancer and melanoma 17,18. Furthermore, the C6-ceramide 
nanoliposomal formulation has been extensively characterized by the Nanotechnology 
Characterization Laboratory of the National Cancer Institute, and most importantly, was 
shown to be free of toxic side effects associated with other anti-neoplastic agents 19. The 
second nanoliposomal formulation, in addition to C6-ceramide, also contained D-threo-1- 
phenyl-2-decanoylamino-3-morpholino-l-propanol (PDMP), an inhibitor of GCS, the 
enzyme that converts ceramide to glucosylceramide 8’9. We observed significant NOX- 
dependent production of intracellular ROS in response to treatment with the C6-ceramide 
formulation (Fig. 5.1h), and more so with the formulation combining C6-ceramide and 
PDMP (Fig. 5. li). This later finding, showing over 40% greater ROS production (p = 
0.0136, unpaired t-test), demonstrated that blocking GCS significantly improved the 
efficacy of nanoliposomal C6-ceramide-stimulated NOX-dependent intracellular ROS 
production in neuroblastoma cells.
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Figure 5.2: G lucosylceram ide blocks agonist-stim ulated NOX activity, (a) Basal activities o f catalase (CAT), 
superoxide dismutase (SOD), and glucosylceramide synthase (GCS) were compared between human SH-SY5Y 
neuroblastoma, U-87 MG glioblastoma, and LN-18 glioblastoma cells. Activities were normalized to the average 
activities o f SH-SY5Y cells. Data represent the mean +/- SEM of at least three independent experiments; * p < 0.05, as 
determined by 1-way ANOVA. (b) The redox-sensitive indicator H2DCFDA was used to compare production of 
intracellular ROS between SH-SY5Y, U-87 MG, or LN-18 cells in response to doxorubicin (8.6 pM). Fluorescence, 
corresponding to ROS, was normalized to the average 0-min fluorescence of the respective cell line (relative DCF- 
fluorescence). Data represent the mean +/- SEM o f three independent experiments; * p < 0.05, as determined by 2-way 
ANOVA, comparing SH-SY5Y response to both U-87 MG and LN-18 response, (c) Translocation of p67phox to the 
plasma membrane was evaluated as an indication o f NOX assembly. SH-SY5Y cells were exposed to T N Fa (TNF, 100 
ng/ml, 15 min) +/- 60 min pre-treatment with exogenous C8-glucosylceramide (GluCer, 10 pM). Translocation was 
normalized to the average translocation of the control. Data represent the mean +/- SEM of three independent 
experiments; * p < 0.01, as determined by 1-way ANOVA. (d) Intracellular ROS production was evaluated in SH- 
SY5Y cells exposed to T N Fa (TNF, 100 ng/ml, 60 min) +/- 60 min pre-treatment with GluCer (10 pM), or the 
antioxidant N-acetyl-L-cysteine (NAC, 5 mM). Data represent the mean +/- SEM o f three independent experiments; * p 
< 0.01, as determined by 1-way ANOVA.
A major problem in the treatment of cancer is that o f multi-drug chemoresistance. 
In some circumstances, a diagnosed cancer may already display chemoresistance prior to
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chemotherapy, as is the case with some glioblastomas 20’21, while in other cases a cancer 
may develop resistance, or relapse with resistance, to the chemotherapeutic(s) used 
during treatm ent9. In addition to research identifying increased ceramide metabolism in 
chemoresistant cancers, reports have also emerged documenting increased antioxidant 
defenses in radio- and chemoresistant glioblastomas 21. In our study, we compared the 
activities of catalase and superoxide dismutase, primary antioxidant enzymes, and the 
activity of GCS between human SH-SSY5Y neuroblastoma cells, human U-87 MG 
glioblastoma cells, and human LN-18 glioblastoma cells (Fig. 5.2a). We found that the 
activities of these enzymes were all significantly greater in both glioblastomas when 
compared to those observed in the neuroblastoma cell line. In context with these findings, 
we also found that SH-SY5Y neuroblastoma cells responded to doxorubicin with a robust 
increase in intracellular ROS production, whereas U-87 MG and LN-18 glioblastoma 
cells did not (Fig. 5.2b). We then evaluated a possible link between increased GCS 
activity and decreased agonist-stimulated intracellular ROS production.
Intriguingly, a genetic deficiency in cerebrosidase termed Gaucher’s disease (type
22I), results in the accumulation of glucosylceramide, that is unable to be degraded . A 
phenotype of this cerebrosidase deficiency, monocyte dysfunction, is strikingly similar to 
that of chronic granulomatous disease, a genetic deficiency in one or more of NOX 
subunits 2,22. From these similarities, it has been speculated that glucosylceramide could 
interfere with NOX; an idea initially tested with success in crude cell-free systems 22,23.
In our study, we speculated that agonist-stimulated NOX activity could be impeded 
directly by GCS’s production of glucosylceramide. Indeed, we found that the addition of 
exogenous glucosylceramide to SH-SY5Y neuroblastoma cells prevented TNFa- 
stimulated NOX activity. NOX activity is regulated in part by the movement of cytosolic 
subunits, such as p67phox, to the membrane where they complex with membrane-bound 
subunits to form the active enzym e2. We found that glucosylceramide blocked TNFa- 
stimulated p67phox translocation to the plasma membrane (Fig. 5.2c). This finding was 
critical because it showed, in a cellular system, that glucosylceramide itself blocked an 
important step in the assembly of the functional NOX. As expected, we further observed
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that TNFa-stimulated intracellular ROS production was abrogated by exogenous 
glucosylceramide (Fig. 5.2d).
Notably, GCS has been identified as a primary enzyme up-regulated in many 
cases of chemoresistance 5’8’9. Our findings in this study showing that numerous 
chemotherapeutics induced NOX-dependent intracellular ROS production, combined 
with those that showed that glucosylceramide blocks NOX assembly and activity, argue 
that GCS’s role in chemoresistance is more profound than previously thought. GCS was
8 9understood to drive chemoresistance by neutralizing ceramide ’ , which could also 
indirectly impede NOX, as ceramide has been shown to be a regulator of NOX-activity 3. 
We speculated that blockading of GCS activity would prevent its inhibition of NOX 
activity, and improve the efficacy of chemotherapy. Indeed we found that the 
pharmacological agent PDMP augmented doxorubicin-induced intracellular ROS 
formation in SH-SY5Y neuroblastoma cells, and even restored the effect in U-87 MG and 
LN-18 glioblastoma cells (Fig. 5.3a-c). We also observed that 3-amino-1,2,4-triazole 
(3 AT), an inhibitor of the antioxidant enzyme catalase, augmented doxorubicin-induced 
intracellular ROS accumulation in SH-SY5Y neuroblastoma cells, and restored the effect 
in U-87 MG and LN-18 glioblastoma cells (Fig. 5.3a-c). Furthermore, both PDMP and 
3AT improved doxorubicin-induced cell death in the neuroblastoma and glioblastoma 
cell lines (Fig. 5.3d-f).
The use of pharmacological agents has drawn some criticism due to issues with 
solubility, specificity, or toxicity, so we employed the more direct approach of molecular 
targeting utilizing siRNA directed against glucosylceramide synthase 19. An important 
aspect of our approach was the use of a non-toxic cationic nanoliposomal delivery 
method. Typical cationic transfection reagents are impractical for in vivo use due to their 
severe toxicity. However, our laboratory designed and tested a unique formulation that 
has shown promise in animal studies, both as an efficacious and non-toxic delivery 
system 24. In this study, we demonstrated that siRNA directed against GCS significantly 
augmented doxorubicin-induced intracellular ROS production in SH-SY5Y 
neuroblastoma cells, while a non-targeted siRNA did not (Fig. 5.3a). Likewise,
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significant doxorubicin-induced intracellular ROS production was restored in both U-87 
MG and LN-18 glioblastoma cells when targeted by siRNA directed against GCS, but not 
a non-targeted siRNA (Fig. 5.3b-c). Furthermore, by targeting GCS with specific siRNA, 
but not non-targeted siRNA, we demonstrated a significant decrease in cell viability 
induced by doxorubicin in the neuroblastoma and glioblastoma cell lines (Fig. 5.3d-f). 
These results showed that targeting GCS, the enzyme responsible for neutralizing 
ceramide and synthesizing NOX-impeding glucosylceramide, augmented chemotherapy- 
stimulated intracellular ROS production and cell death.
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Figure 5.3: In terference w ith GCS augm ents in tracellu lar ROS production and im proves chem otherapy-induced 
cell death. Cells were exposed to doxorubicin (DOXO, 8.6 pM) +/- 2 hour pre-treatment with the GCS inhibitor PDMP 
(10 pM), or the catalase inhibitor 3-amino-l,2,4-triazole (3AT, 1 mM). Alternatively, cells were transfected with 200 
nM siRNA directed against GCS (siGCS), or non-targeted siRNA (siSCR), 48 hours prior to treatment. The production 
o f intracellular ROS was examined after 90 min treatment in human SH-SY5 Y neuroblastoma, U-87 MG glioblastoma, 
or LN-18 glioblastoma cells, using the redox-sensitive indicator H2DCFDA, while cellular viability was determined 
after 48 hour treatment by XTT assay. Fluorescence, corresponding to ROS, was normalized to the average 
fluorescence of the control (relative DCF-fluorescence). (a) ROS in SH-SY5Y cells, (b) ROS in U-87 MG cells, (c) 
ROS in LN-18 cells, (d) Viability o f SH-SY5Y cells, (e) Viability ofU -87 MG cells, (f) Viability o f LN-18 cells. Data 
represent the mean +/- SEM o f four independent experiments; * p < 0.05 compared to control (CON), ** p < 0.05 
compared to DOXO, *** p < 0.05 compared to DOXO + PDMP, as determined by 1-way ANOVA.
Overall, our studies revealed that the SH-SY5Y neuroblastoma cell line was 
relatively more sensitive to agonist-stimulated NOX activity, compared to the U-87 MG 
and LN-18 glioblastoma cells lines tested. So while inhibiting GCS activity augmented 
doxorubicin-induced NOX activity and neuroblastoma cell death, we also evaluated how 
overexpression of GCS affected the cell line. Transfection of SH-SY5Y neuroblastoma 
cells with a plasmid encoding FLAG-tagged GCS significantly blocked TNFoc-
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stimulated intracellular ROS production (Fig. 5.4a) and doxorubicin-stimulated 
intracellular ROS production (Fig. 5.4b). Furthermore, overexpression of GCS 
completely, and significantly, blocked the TNFa-stimulated decrease in SH-SY5Y cell 
viability (Fig. 5.4c), and also modestly, yet significantly, blocked doxorubicin-stimulated 
SH-SY5Y cell viability loss (Fig. 5.4d). GCS overexpression likely does not completely 
block the doxorubicin-stimulated decrease in SH-SY5Y cell viability due to the 
concurrent induction of other pathways by doxorubicin that do not involve ceramide or 
NOX. Lastly, we demonstrated that overexpression o f GCS inhibited TNFa-stimulated 
assembly of NOX in neuroblastoma cells. Overexpression of GCS blocked TNFa- 
stimulated p67phox translocation to the plasma membrane, while siRNA directed against 
GCS, but not non-targeted siRNA, augmented TNFa-stimulated p67phox translocation 
(Fig. 5.4e).
R e p ro d u ce d  with perm ission  o f the copyright ow ner. Further reproduction  prohibited w ithout perm ission .
DOXO DOXO+GCS
D O X O  D O X 0 + & C 5
Figure 5.4: Overexpression of GCS blocks NOX and improves survival. Human SH-SY5Y neuroblastoma cells 
were transfected with 3 pg/ml of a GCS-expressing plasmid, 200 nM siRNA directed against GCS (siGCS), or non­
targeted siRNA (siSCR), 48 hours prior to treatment. The production of intracellular ROS was evaluated using the 
redox-sensitive indicator H2DCFDA, while cellular viability was determined by XTT assay. Fluorescence, 
corresponding to ROS, was normalized to the average fluorescence of the control (relative DCF-fluorescence). (a) ROS 
in cells exposed to T N Fa (TNF, 100 ng/ml, 60 min). (b) ROS in cells exposed to doxorubicin (DOXO, 8.6 pM, 90 
min). (c) Viability o f cells exposed to TN Fa (TNF, 100 ng/ml, 48 h). (d) Viability o f cells exposed to doxorubicin 
(DOXO, 8.6 pM, 48 h). Data represent the mean +/- SEM o f four (viability), or five (ROS), independent experiments; * 
p < 0.05, as determined by 1-way ANOVA. (e) Translocation of p67phox to the plasma membrane was evaluated as an 
indication o f  NOX assembly. Translocation was normalized to the average translocation o f  the control, and represent 
the mean +/- SEM o f three independent experiments; * p < 0.05 compared to control (CON), ** p < 0.01 compared to 
TNF + siGCS, as determined by 1-way ANOVA.
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Only recently, functional NOX (NOX1-5) activities, similar to the well- 
documented NOX2 in phagocytes, were identified in many non-phagocytic cell types 
(microglia, astrocytes, neurons) as a source of ROS production in response to stimuli 
such as TN Fa 2. Several lipids including arachidonic acid or anionic phospholipids are 
critical in the activation mechanism of NOX enzymes 2’25. A recent study also 
demonstrated that ceramide synthesized de novo from the saturated fat palmitate induced 
the activation of NOX in retinal pericytes 3. Therefore, it became important to evaluate 
the role of chemoresistant pathways that metabolize ceramide, such as GCS, in the 
regulation of NOX activity. Many chemotherapeutics, as well as endogenous stimuli such 
as TNFa, stimulate ceramide accumulation with a goal to stimulate apoptosis o f tumor 
cells 5’n ’12. Mechanisms of chemoresistance have therefore developed to evade the toxic 
effects of ceramide, by neutralization, degradation, or conversion to pro-mitogenic and 
pro-survival metabolites 5. Moreover, oxidative stress resistance of tumor cells has also
recently been described in the form of increased catalase activity in rat glioblastoma cells
21
While manipulating GCS activity by various methods suggested that ceramide 
neutralization impeded NOX, exogenous glucosylceramide-driven impediment of NOX 
activity was not explained. Important to understanding this phenomenon is the fact that 
while GCS resides on the cytosolic leaflet of the Golgi apparatus, glucosylceramide is 
promptly re-located to the luminal side 26. For this reason, natural glucosylceramide is 
found predominantly on the extracellular leaflet of the plasma membrane, the same 
location as exogenously added glucosylceramide. Furthermore, glucosylceramide does 
not laterally diffuse within the plasma membrane due to the hydrophilicty of its head 
group 26. Therefore, we speculated that glucosylceramide interfered with NOX assembly 
via a biophysical mechanism. By studying liposome models of the plasma membranes, 
we observed that the addition of glucosylceramide significantly decreased the size of 
these vesicles (Fig. 5.5a). The size of a vesicle is a measure of curvature (equal to the 
reciprocal of the radius), in that a smaller vesicle is more curved. Therefore, we
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postulated that glucosylceramide interferes with NOX by inducing positive curvature, 
which restricts subunit-subunit and subunit-membrane interactions (Fig. 5.5b).
Many advanced CNS tumors, such as glioblastomas, respond poorly to 
chemotherapeutic and radiation therapies, while in comparison, resistance in 
neuroblastomas is less com m on20,21. Complicating matters, and driving the demand for
new and better therapeutics, is the fact that glioblastoma multiform, the most common
20primary brain tumor, has one of the worst survival rates among all cancers . 
Accordingly, our research implicating GCS in the depletion o f ceramide and 
glucosylceramide in inhibiting NOX assembly by glucosylceramide, offers important 
advances to the understanding of glioblastomas, and the design of better therapeutics. On 
the other hand, it is worth noting that degenerative pathologies, including acute and 
chronic CNS disorders as well as psychiatric disorders, exhibit oxidative stress as a major 
component of their pathologies 28’29. This is important because in contrast to the goals of 
cancer therapy, the goals in the treatment of degenerative disorders are to improve the 
survival and function of normal cells. While ceramide neutralization and degradation are 
hallmarks of chemoresistance, ceramide accumulation is characteristic of degenerative 
disorders4’11’12’29
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Figure 5.5: Glucosylceramide prevents NOX activity by altering membrane curvature. Liposomes were prepared 
as a model o f the plasma membrane, and the effect on membrane curvature with glucosylceramide addition was 
evaluated, (a) Liposomes composed o f phospholipids, cholesterol, and sphingomyelin (basic formulation), with or 
without ceramide, were compared to equivalent counterparts containing glucosylceramide. Size o f liposomes, related to 
curvature (curvature = 1 /radius), was determined by light scattering. Data represent the mean o f three independent 
experiments. Significance (* p < 0.05) was determined by unpaired t-test o f the mean diameter o f respective liposomes, 
(b) Model depicting the addition of glucosylceramide inducing positive membrane curvature, which restricts the ability 
of NOX cytosolic components to interact with essential membrane lipids (phospholipids: blue; essential interacting 
membrane lipids: purple; sphingomyelin: orange; cholesterol: yellow; ceramide: small red circles; glucosylceramide: 
dark red hexagons; gp91phcx: grey trans-membrane domains; p22phox: olive green trans-membrane domains; p40phox: 
light green crescent; p67phox: dark green oval; p47phox: light blue crescent), (c) Schematic depicting that TN Fa, or 
chemotherapeutics, stimulates NOX through ceramide generation, and that neutralization to glucosylceramide directly 
blocks NOX while also depleting ceramide.
In summary, ceramide neutralization through the formation of glucosylceramide 
not only decreases the pro-apoptotic stimulus ceramide, but also abolishes NOX
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assembly and activity (Fig. 5.5c), and in conjunction with increased antioxidant enzyme 
activities, greatly alleviates cell death-inducing oxidative stress associated with 
chemotherapy or physiological agonists. Consequently, pharmacological inhibition of 
antioxidant enzymes, such as catalase, or pharmacological or molecular inhibition of 
GCS restored doxorubicin-toxicity, offering promise as a useful therapeutic avenue for 
the treatment of advanced cancers of the CNS. While treatment of patients with siRNA is 
currently not possible due to toxicity associated with delivery systems, our non-toxic 
cationic nanoliposomal formulation is designed specifically to overcome this hurdle. 
Additionally, our nanoliposomal formulation combining C6-ceramide and PDMP 
overcomes the current hurdle to clinical delivery of the GCS inhibitor PDMP associated 
with its low solubility. Nano-scale delivery systems further offer considerable clinical 
potential in the delivery of lower, yet more concentrated, therapeutic doses 19,30. 
Altogether, nano-encapsulated pharmacological or molecular agents targeting GCS offer 
exceptional promise in the treatment of chemoresistant CNS cancers. Specifically so, 
because interference with GCS overcomes the tumor’s ability to neutralize ceramide and 
block NOX, ultimately restoring the ability to produce ROS and induce tumor cell death.
5.3: Methods
Reagents
DMEM and Penicillin/Streptomycin solution were obtained from Mediatech (Herndon, 
V A ).). Solutions of GlutaMAX-1 and trypsin/EDTA, Hank’s Balanced Salt Solution 
(HBSS), and Amplex Red reagent, as well as fluorescent siRNA, were from Invitrogen 
(Carlsbad, CA). Fetal bovine serum was received from Atlanta Biologicals (Atlanta, GA). 
The ON-TARGET plus SMART pool siRNA directed against GCS, and non-targeting 
siRNA was from Dharmacon (Lafayette, CO). GCS cDNA (Gene: UGCG; Accession: 
BC038711), was purchased from Thermo Fisher Scientific (Huntsville, AL). 
Streptavidin-agarose beads, sulfo-NHS-biotin, protease inhibitor cocktail (PIC), a Pico 
Super Signal chemoluminescent kit, and a BCA protein assay kit were obtained from
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Pierce (Rockland, IL). Polyclonal rabbit anti-GCS, rabbit anti-FLAG, rabbit anti- 
GAPDH, and p67phox antibodies, and corresponding horseradish peroxidase-conjugated 
secondary antibodies were from Santa Cruz (Santa Cruz, CA). An XTT cell proliferation 
assay kit was obtained from Trevigen (Gaithersburg, MD). VECTASHIELD hard set 
mounting medium with 4,6-diamidino-2-phenylindole (DAPI) was purchased from 
Vector Laboratories (Burlingame, CA). Recombinant human tumor necrosis factor alpha 
(TNFa) was purchased from Millipore (Temecula, CA). 2’, 7 ’-
dihydrodichlorofluorescein diacetate, doxorubicin, paclitaxel, methotrexate, fenretinide, 
and 4-hydroxy tamoxifen were from EMD Biosciences (San Diego, CA). Gemcitabine 
was a gift from Dr. Yixing Jiang. D-threo-l-Phenyl-2-decanoylamino-3-morpholino-l- 
propanol (PDMP) was purchased from Biomol (Plymouth Meeting, PA). All other lipids 
were from Avanti Polar Lipids (Alabaster, AL). All other reagents were purchased from 
Sigma (St. Louis, MO).
Cell Culture
Human SH-SY5Y neuroblastoma cells, human U-87 MG glioblastoma cells, and human 
LN -18 glioblastoma cells were grown in DMEM medium supplemented with 10% fetal 
bovine serum, 100 U/ml penicillin, and 100 U/ml streptomycin (humidified atmosphere, 
5% CO2 ,37°C) in 100 mm tissue culture dishes (Falcon). For amplification, cells were 
washed off into PBS (phosphate buffer saline) after treatment with 0.5 mg/ml trypsin and
0.2mg/ml EDTA (5-15 min), centrifuged (200 x gmax, 2 min) and plated in 100 mm tissue 
culture dishes (2xl07 cells per dish), 6-well tissue culture plates (5xl06 cells per well), or 
96-well tissue culture plates (5xl03 to 5xl04 cells per well).
Liposome Preparation and Cellular Transfection
Aliquots of lipids were made at appropriate ratios (Supplementary Information, Table 
5.SI), and dried to a film under a stream of nitrogen, then hydrated by addition of 0.9% 
NaCl to a final lipid concentration of 25 mg/ml. Solutions were wrapped in parafilm, 
heated at 60°C (60 min), and subjected to vortex mixing and sonicated until light no
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longer diffracted through the suspension. The lipid vesicle-containing solution was 
quickly extruded at 60°C by passing the solution 10 times through 100 nm polycarbonate 
filters in an Avanti Mini-Extruder (Avanti Polar Lipids, Alabaster, AL). Nanoliposome 
solutions were stored at 4°C until use, protected from light when necessary. To prepare 
siRNA- or plasmid-loaded cationic nanoliposomes, siRNA, or plasmid DNA, was 
aliquoted into 0.9% NaCl, and nanoliposomes were added in a 10:1 weight ratio to 
nucleic acid. The solution was allowed to incubate overnight at room temperature prior to 
use. The RNA interference sequences utilized (Supplementary Information, Table 5.S2), 
were from the ON-TARGET plus SMART pool product line of Dharmacon (Lafayette, 
CO). Confocal microscopy, and Western blotting, was used to validate transfection, 
knockdown, and overexpression (Supplementary Information, Fig. 5.SI).
Liposome Size Determ ination
Liposome suspensions were diluted 1:10 in 0.9% NaCl prior to size determination. Light 
scattering was used to quantify the size of liposomes using a Malvern Instruments 
Zetasizer Nano (Malvern, Worcestershire, United Kingdom).
Glucosylceramide Synthase C onstruct Generation
Glucosylceramide synthase cDNA (Gene: UGCG; Accession: BC038711) was 
transferred by PCR sub-cloning into the mammalian expression vector pcDNA3.1 
(Invitrogen, Carlsbad, CA). The construct was sequence-verified by the Molecular 
Genetics Core Facility at the Pennsylvania State University College of Medicine.
Plasma M em brane Translocation of p67phox
Plasma membrane proteins were prepared by biotinylation and streptavidin affinity 
purification as previously described 10. SH-SY5Y cells grown in 6-well plates for 
transfected with siRNA or plasmid (200 nM, or 3 ug/ml, respectively, 48 h), or C8- 
glucosylceramide (10 pM, 60 min), prior to TNFa stimulation (100 ng/ml, 15 min). Next, 
cultures were washed with HBSS pH 7.5 containing 0.1 g/1 CaCl2 and 0.1 g/1 M gCf
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(HBSS-CM), incubated with 0.5 mg/ml sulfo-NHS-biotin (20 mM HEPES in HBSS-CM 
pH 8.0, 40 min, on ice), and excess sulfo-NHS-biotin was neutralized with 50 mM 
glycine (HBSS-CM, on ice, 15 min). Cells were scraped into HBSS-CM, centrifuged 
(200 x gmax, 2 min), lysed in 500 pL loading buffer (20 mM HEPES in HBSS pH 7.5, 1% 
Triton X-100, 0.2 mg/ml saponin, 1% PIC), and after brief sonication, incubated with 
streptavidin-agarose beads (25 pi, 2 h, 4°C). Beads were collected by centrifugation 
(2,500 x gmax, 2 min), and re-suspended in 150 pi of loading buffer (5 min, boiling water 
bath) to release bound protein. Supernatants were obtained by centrifugation (2,500 x 
gmax, 2 min), and analyzed by Western blotting (Supplementary Methods).
Quantification of Reactive Oxygen Species Production
SH-SY5Y, U-87 MG, or LN-18 cells were seeded in 96-well tissue culture dishes (5xl04 
cells per well) and grown for 48 hours. Cultures were incubated with 50 pM of the 
oxidation-sensitive fluorescent indicator 2’, 7 ’-dihydrodichlorofluorescein diacetate 
(H2DCFDA) for one hour in the presence or absence of pharmacological inhibitors, N- 
acetyl-L-cysteine (5 mM), or C8-glucosylceramide (10 pM). Alternatively, cells were 
transfected with siRNA (200 nM), or plasmid (3 pg/ml), 48 h prior to exposure, the last 
hour of which included H2DCFDA loading. H2DCFDA is de-acetylated in the cytosol to 
dihydro-dichlorofluorescein and increases in fluorescence upon oxidation by H2Q2 to 
dichlorofluorescein (DCF). Following exposure to stimuli, cultures were washed with 
PBS, agitated in lysis buffer (2M Tris-Cl pH 8.0, 2% w/v SDS, 1 mM NasVCfi), and total 
DCF fluorescence intensity was quantified in 100 pi of cell lysates using a Beckman 
Coulter Multimode DTX 880 microplate reader (Fullerton, CA) with a 495 nm excitation 
filter and a 525 emission filter. All DCF fluorescence data were normalized to the 
average DCF fluorescence under control conditions (relative DCF-fluorescence values).
Glucosylceramide Synthase Activity
Generation of fluorescent NBD-glucosylceramide was quantified as follows. Samples of 
whole cell lysates containing 5 pg of total protein (BCA protein assay) were reacted with
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100 pM NBD-ceramide in 5 mM MnCl2 pH 7.2, 30 mg/ml BSA, and 1 mM UDP-glucose 
(100 pi reaction volume, 60 min, 37°C). After termination of the reaction (100 pi 
dichloromethane), lipids were extracted (Bligh-Dyer), and separated by thin layer 
chromatography (chloroform/acetone/methanol/acetic acid/water at 10:4:3:2:1). NBD- 
glucosylceramide was quantified using a GE Healthcare Typhoon Imager (Piscataway, 
NJ) running ImageQuant software.
Superoxide Dismutase Activity
Interference o f ferricytochrome reduction by superoxide was measured as an indication 
o f superoxide dismutase (SOD) activity. Samples o f whole cell lysates containing 5 pg o f 
total protein (BCA protein assay) were added to a solution of 50 pM hypoxanthine, 6 nM 
xanthine oxidase, 100 pM EDTA, and 10 pM ferricytochrome c in a 50 mM potassium 
phosphate pH 7.8 (100 pi reaction volume, 30 min, 25°C), and ferricytochrome reduction 
was quantified using a Beckman Coulter Multimode DTX 880 microplate reader 
(Fullerton, CA), reading absorbance at 550 nm.
Catalase Activity
Interference of horseradish peroxidase-mediated formation of the fluorescent resorufin 
from Amplex Red was quantified as an indication of catalase activity. Samples of whole 
cell lysates containing 5 pg of total protein (BCA protein assay) were mixed with 0.1 M 
Tris-Cl pH 7.4 and 10 mM Mg CI2 (volume of 75 pi) prior to incubation with 10 pM 
H2 O2 (25 pi) for 30 min at 37°C. Next, an equal volume (100 pi) of horseradish 
peroxidase (2 U/ml) and Amplex Red (100 pM) was added to the reaction mixture, and 
resorufin fluorescence was quantified using a Beckman Coulter Multimode DTX 880 
microplate reader (Fullerton, CA), with a 530 nm excitation filter and a 590 emission 
filter.
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Cellular Viability Assay
SH-SY5Y, U-87 MG, or LN-18 cells were seeded in 96-well tissue culture dishes (5xl03 
cells per well), and grown for 48 hours. Cultures were co-incubated with pharmacological 
inhibitors, and either 100 ng/ml TNFa, or 5 [xg/ml doxorubicin, for 48 hours. 
Alternatively, cells were transfected with siRNA (200 nM), or plasmid (3 pg/ml), 48 h 
prior to TNFa or doxorubicin exposure. XTT reagent prepared according to the 
manufacturer (Trevigen, Gaithersburg, MD) was added and allowed to incubate for 4 
hours. Viability was determined by absorbance at 490 nm (650 nm reference), using a 
Beckman Coulter Multimode DTX 880 microplate reader ((Fullerton, CA). All values 
were normalized to the average values under control conditions.
Statistical Analysis
One-way, or two-way, analysis of variance (ANOVA), were used to determine 
statistically significant differences between treatments (p<0.05). At least three 
independent experiments were performed for each condition. Post hoc comparisons of 
specific treatments were performed using a Bonferroni test. Unpaired t-tests were used to 
directly compare mean diameters of respective liposome formulations. All error bars 
represent standard error of the mean (SEM). All statistical analyses were carried out 
using GraphPad Prism 4 software (La Jolla, CA).
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5.7: Supplem entary Inform ation
Figure 5.S1: T ransfection of cells w ith siRNA. Human SH-SY5Y neuroblastoma cells were grown in normal growth 
medium, and transfected with 200 nM siRNA loaded into cationic nanoliposomes. For confocal microscopy, the DOPE 
of the cationic formulation contained one molar percentage o f  lissamine rhodamine B-labeled DOPE. 24 hours 
following transfection, cells were re-plated onto poly-D-lysine-coated glass coverslips, and maintained for an 
additional 24 hours before fixation, mounting, and microscopy, (a) Green fluorescent non-targeting siRNA (BLOCK-iT 
Fluorescent Oligo; Invitrogen, Carlsbad, CA). (b) Cellular nuclei stained with DAPI (blue), (c) Liposome component 
rhodamine-DOPE (red), (d) Merged image.
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Formulation • ' :■ Lipids . ■• ■■■■ . : • ' . . 7 ■ Moiaf Ratio . . '
Cationic DOTAP; PEG2GGQ-DSPE: DOPE 4.75:0.5:4.75
Ghost DSPC: DOPE: PEG20Q0-D5PE 5. W: 2.87:1.47
Ceiratnkle DSPC: DOPE: PEG2030-DSPE: PEG75Q-C8CER: C6CER 3.75:1.75:8.75: 0.75:3
Ceramide*'PDMP DSPC:DOPE: PEG2000-D5PE.PEG750-C3CER: 3.75:1.75:0.75s 0.75:1.5:
C6CER:PDMP 1.5
Basic DSPC: DOPC: DOPE: PS: SM; CH 0,8:0.Si 1: 0:4:1: 4
BasieCer DSPC: DOPC: DOPE: PS; SM: CH:C3CER
SasioGluCer DSPC: DOPC: DOPE: PS; SM: CH: GLUCER 0.8:0.0:1: 0.4:1:4:1
BasicCerGluCer DSPC: DOPC: DOPE: PS: SM: CH:C8CER:GLUCER 0.8:0.8:1: 0 :4:1:4:1:1
Table 5.S 1: N anoliposom e form ulations. Liposome formulations were prepared from specific lipids, at particular 
molar ratios, prior to nano-sizing. l,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC), l,2-distearoyl-sn-glycero-3- 
phosphocholine (DSPC), 1,2-diolcoyl-i-«-glycero-3-phosphoethanolaminc (DOPE), 1,2-distearoyl-.v«-glycero-3- 
phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] (PEG2000-DSPE), l,2-dioctanoyl-s«-glycero-3- 
phospho-L-serine (PS), l,2-dioleoyl-3-trimethylammonium-propane (DOTAP), C6-ceramide (C6CER), C8-ceramide 
(C8CER), C8-ceramide-l-succinyl[methoxy(polyethylene glycol)-750] (PEG750-C8CER), C8-g!ucosylceramide 
(GLUCER), Cl 8-sphingomyelin (SM), cholesterol (CH), and D-threo-l-phenyl-2-decanoylamino-3-morpholino-l- 
propanol (PDMP).
'I-D-# •'/ . ' ; Target Sequence • -7 ■
J -006441 -05 GCGAAUCCAUGACAAUAUA
J -006441 -06 GGACCAAACUACGAAUUAA
J -008441 -07 GAUCCUAACUUAAUCAACA
J -006441 -OS GGAAUGUCUUGUUUAAU GA
Table 5.S2: T arget sequences fo r siRNA. ON-TARGET plus SMART pool siRNA was obtained from Dharmacon 
(Lafayette, CO). Four separate sequences within the human glucosylceramide synthase gene (Gene: UGCG; Accession: 
BC038711) were targeted.
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Supplem entary M ethods 
Confocal M icroscopy
Two-day old SH-SY5Y cultures (6-well plates, 5x106 cells per well) were maintained in 
regular growth media, and transfected with 200 nM FITC-labeled, non-targeted, siRNA 
loaded into Rhodamine-labeled cationic nanoliposomes. After 24 h, the cells were 
detached with trypsin (0.5 mg/ml)/EDTA (0.2mg/ml), and re-plated onto poly-D-lysine 
(50 pg per cm2) coated glass cover slips. Following an additional 24 h growth period in 
regular media, the cells were washed three times in PBS, and fixed for 15 min at room 
temperature in 2% paraformaldehyde in PBS, pH 7.0. The cover slips were mounted onto 
glass slides with DAPI-containing mounting medium. Images were acquired using a 
Leica (TCS SP2 AOBS) scanning confocal microscope (Bannockburn, IL), and filter 
combinations for FITC, rhodamine, and DAPI.
W estern Blotting
Equal amounts of total protein (BCA protein assay) were separated by SDS- 
polyacrylamide (10%) gel electrophoresis (125 Y, 50 Watts, 75 mA). After transfer of 
proteins onto nitrocellulose membranes (2.5 h, 50 V, 50 Watts, 250 mA), membranes 
were blocked with TBST-BSA (50 mM Tris-Cl pH7.4, 150 mM NaCl, 0.1% Tween-20,
5 mg/ml BSA), and probed overnight with a polyclonal rabbit anti-p67phox antibody (1 
pg/pl in TBST), a polyclonal rabbit anti-FLAG antibody (1 pg/pl in TBST), a polyclonal 
rabbit anti-glucosylceramide synthase antibody (1 pg/pl in TBST), or a polyclonal rabbit 
anti-GAPDH antibody (1 pg/pl in TBST). Following incubation with a horseradish 
peroxidase-conjugated anti-rabbit secondary antibody (0.2 pg/pl in TBST, 45 min), 
immune-reactivity was detected by chemoluminescent exposure followed by ImageJ 
analysis (NIH, Bethesda, MD).
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C hapter 6: W ild A laskan blueberry extracts inhibit a magnesium -dependent neutral 
sphingomyelinase activity in neurons exposed to TN Fa5
6.1: A bstract
The proinflammatory cytokine tumor necrosis factors a  (TNFa) is key to initiating and 
orchestrating inflammation, which substantially contributes to the progression of many 
chronic and acute CNS pathologies. TNFa can stimulate a magnesium (Mg2+)-dependent 
neutral sphingomyelinase (nSMase) resulting in the accumulation of ceramide, a lipid 
messenger implicated in oxidative stress and apoptosis. Dietary polyphenols were shown 
to alleviate CNS inflammation largely attributed to their antioxidant properties. We found 
that preincubation of human SH-SY5Y neuroblastoma cells with organic or aqueous 
extracts prepared from Alaska wild bog blueberries completely negated Mg2+-nSMase 
activation upon TNFa exposure. This specific and potent inhibition of Mg2+-nSMase 
activity was non-antioxidant in nature. This study demonstrated for the first time that 
Alaska wild bog blueberries harbor the capacity to interfere with a key step in the
•j j
progression of inflammation in neuronal cells, the activation of Mg -nSMase, providing 
further evidence for the therapeutic potential of blueberries.
5 Brian M. Barth*, Sally J. Gustafson*, Colin M. McGill, Thomas P. Clausen & Thomas 
B. Kuhn. Authors contributed equally. Published in Current Topics in Nutraceutical 
Research (2007), Volume 5, Issue 4, pages 183-188.
I, Brian Barth, affirm my contributions to the work outlined in this chapter. I contributed 
to the conceptualization and experimental design of the study, worked directly with Sally 
Gustafson during the course of the study, and helped in the preparation of the manuscript, 
all under the supervision, mentorship, and advisement of Dr. Thomas Kuhn. Please see 
section 6.7 on page 207 for the contributions of the other authors.
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6.2: Introduction
The pro-inflammatory cytokine tumor necrosis factor alpha (TNFa) exhibits pleiotropic 
effects in the developing, adult, and injured central nervous system (Allan and Rothwell 
2001; Merill 1992; Vitkovic et al. 2000; Viviani et al. 2004). TNFa affects neuronal 
survival, contributes to the formation, repair and maintenance of synaptic connectivity, 
modulates outgrowth o f neuronal processes, stimulates gene expression, and regulates 
neuronal redox-state. TNFa plays a key role in the initiation and orchestration of 
inflammation in many chronic neurodegenerative diseases (Alzheimer’s disease, 
Parkinson’s disease, Amyotrophic Lateral Sclerosis), acute CNS injuries (stroke, 
traumatic injuries), and even psychiatric disorders (autism, schizophrenia) (Fontaine et al. 
2002; Keane et al. 2006; Lucas et al. 2006; Vargas et al. 2005). Reactive microglia and 
astroglia cells, which are both prevalent in most CNS pathologies as well as in the aging 
CNS, persistently secrete TNFa at high levels (Block et al. 2007). Interactions of TNFa 
with the TNF receptors type I and II activates numerous cellular signal transduction 
pathways leading to stress kinase activation, oxidative stress, caspase activation, 
ceramide production, and ultimately apoptosis of neuronal cells (Locksley et al. 2001).
Sphingolipids are highly prevalent in neuronal plasma membranes and serve as 
precursors for various lipid second messengers (Futerman and Hannun 2004). For 
instance, ceramide is cytotoxic for most neuronal cell types and implicated in oxidative 
stress and apoptosis. Ceramide can be either synthesized de novo from the palmitic acid 
or rapidly formed by hydrolysis of sphingomyelin via a TNFa-sensitive magnesium 
(Mg2+)-dependent neutral sphingomyelinase (nSMase). So far, three mammalian Mg2+- 
nSMases have been characterized, with Mg2+-nSMase 2 specifically expressed in 
mammalian brain (Clarke et al. 2006). Inhibiting Mg2+-nSMase 2 activity with GW4869 
or via siRNA attenuated TNFa-stimulated apoptosis and generation of reactive oxygen 
species, demonstrating the vital role of Mg2+-nSMase 2 in apoptosis and inflammatory 
processes as well as in cell growth and differentiation (Clarke et al. 2006). Diets rich in 
fruits and vegetables are long known for their benefits to our health (Joseph 2002). In 
particular, dietary intake of blueberries was shown to alleviate cognitive decline in
R e p ro d u ce d  with perm ission  o f the copyright ow ner. Further reproduction  prohibited w ithout perm ission .
193
animal models and decrease ischemia-induced brain damage (Joseph et al. 2003; Mattson 
et al. 2002; Sweeney et al. 2002). The active ingredients are largely attributed to the 
family of polyphenols, which act in vitro as highly effective antioxidants and reduce the 
progression of CNS inflammation (Ramassamy 2006). However, many polyphenols are 
barely detectable in the CNS after dietary consumption, implying the presence of 
compounds with non-antioxidant properties serving as potent inhibitors in adverse 
inflammatory signaling pathways. We investigated whether Wild Alaskan bog 
blueberries ( Vaccinium uliginosum) interfere with TNFa-stimulated inflammatory 
signaling pathways by inhibiting Mg2+-nSMase activity in neuronal cells.
6.3: M aterials and M ethods
Reagents: Recombinant human TNFa and an MTT (3-(4,5-dimethylthiazol-2-yl)-2,5- 
diphenyl tetrazolium bromide) Cell Growth assay kit were purchased from Millipore 
(Temecula, CA). DMEM and Penicillin/Streptomycin solution were obtained from 
Mediatech (Herndon, VA). GlutaMAX-1, trypsin/EDTA solution, and an Amplex Red 
Sphingomyelinase assay kit were from Invitrogen (Carlsbad, CA). Fetal bovine serum 
was received from Atlanta Biologicals (Atlanta, GA). All other reagents were purchased 
from Sigma (St. Louis, MO).
Cell culture: SH-SY5Y human neuroblastoma cells were grown in DMEM medium 
supplemented with 10% fetal bovine serum, 100 U/ml Penicillin and 100 U/ml 
Streptomycin (humidified atmosphere, 5% C02>37°C) in 100 mm dishes (Falcon). Cells 
were harvested after incubation with trypsin (0.5 mg/ml)/EDTA (0.2mg/ml), briefly 
triturated, and plated into 6 well or 96 well tissue culture plates (200,000 cells per well or 
60,000 cells per well, respectively). Prior to treatments, SH-SY5Y cells in 6 well pates 
were grown for 72 h whereas SH-SY5Y cells in 96 well plates were grown for 48 h.
Blueberry extract preparation: Wild Alaskan bog blueberries ( Vaccinium uliginosum) 
were harvested in the interior of Alaska at three distinct geographical locations (Lake
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Minchumina, Fox, and Fairbanks) and stored frozen at -20°C. Blueberries were 
lyophilized, crushed to a powder, and then extracted without hydrolysis using either an 
organic solvent or water. To obtain an organic blueberry extract (OBBX), 3.0 g of 
powdered blueberries were extracted with 20 ml 70% acetone/30% water for 15 minutes 
with frequent agitation whereas an aqueous blueberry extract (ABBX) was prepared 
using deionized (18 mf>) water. Insoluble material was removed by filtration and extracts 
were roto-vaporized at 40°C prior to lyophilizing. The resulting powder was stored at 
-20°C. OBBX or ABBX were reconstituted either in 70% acetone/30% water or 
deionized (18 mO) water followed by a 1:20 dilution with 18 mO water immediately 
before addition to SH-SY5Y cells.
Magnesium (Mg2+)-dependent neutral sphingomyelinase assay (Mg2+-nSMase): 
Subconfluent cultures of SH-SY5Y cells were pretreated with 5 |xg/ml OBBX or ABBX 
for 2 h. Then, SH-SY5Y cells were exposed to TNFa (100 ng/ml) for 15 min, harvested
2_j_
in cold phosphate buffered saline and sonicated. Quantitative measurement of Mg - 
nSMase activity was performed in cell lysates containing equal amounts of total protein 
(BCA assay, Pierce, Rockland, IL) and using an enzyme coupled Amplex Red 
fluorescence assay kit (Invitrogen, Carlsbad, CA). Briefly, Mg2+-nSMase activity in 
samples generates ceramide and phosphocholine. Next, choline is liberated by alkaline 
phosphatase and converted to betaine and peroxide by choline oxidase. In the last step, in 
the presence o f horseradish peroxidase (HRP), hydrogen peroxide with Amplex Red to 
form the highly fluorescent product resorufin measured at 590 nm using a Beckman 
Coulter Multimode DTX 880 microplate reader.
Choline Oxidase Assay: Addition of choline to a mixture of choline oxidase, HRP, and 
Amplex Red results in the formation of peroxide and subsequently the fluorescent 
product resorufin. In the absence of choline, the above mixture was preincubated with 
OBBX (5 pg/ml), ABBX (5 pg/ml and 75 jxg/ml), 5 mM N-acetyl-L-cysteine, or 2000 
U/ml catalase for 15 min. The reaction was initiated by adding 50 |xM choline. After 15
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min incubation period (37°C), resorufm fluorescence was measured at 590 nm using a 
Multimode DTX 880 microplate reader.
Cytotoxicity Assay: Briefly, cultures of SH-SY5Y cells were serum deprived overnight 
and then supplement with blueberry extracts (5 pg/'ml or 75 pg/ml) for 48 h. Cytotoxicity 
was determined using an MTT cell viability assay according to manufacture’s 
instructions (Chemicon). Formazan generation was measured using a Multimode DTX 
880 microplate reader.
Statistical Analysis: Analysis of variance (ANOVA) was used to determine statistically 
significant differences between treatments (p>0.05). Post hoc comparisons of specific 
treatments were performed using a Scheffe test to determine statistical significance based 
on the calculated ANOVA data. A Dunette’s test was used for multiple comparisons 
between treatments and a single control. All error bars represent standard deviations.
6.4: Results
In various cell types, TNFa stimulates a magnesium (Mg2+)-dependent neutral 
sphingomyelinase (nSMase) activity, which generates ceramide by hydrolyzing 
sphingomyelin in neuronal plasma membranes, a key step in the progression of 
inflammation. Dietary consumption of blueberries was shown to alleviate adverse effects 
o f CNS inflammation. Thus, we tested whether organic or aqueous extracts obtained 
from wild Alaskan bog blueberries (OBBX or ABBX, respectively) interfered with 
TNFa-stimulated activation of Mg2+-nSMase in SH-SY5Y human neuroblastoma cells. 
Mg2+-nSMase activity was quantified utilizing an enzyme assay coupling ceramide 
generation in cell lysates to Amplex Red fluorescence. As show in Figure 6.1, SH-SY5Y 
cells revealed a dramatic increase in Mg2+-nSMase activity (1.76+0.2, n=7, *p<0.05) 
upon a 15 min exposure to 100 ng/ml TNFa compared to control cultures (1.00+0.16, 
n=8). In contrast, the presence of OBBX or ABBX (5 pg/ml each) negated TNFa- 
stimulated activation of Mg2+-nSMase. The most potent inhibition of Mg2+-nSMase
R e p ro d u ce d  with perm ission  o f the copyright ow ner. Further reproduction  prohibited w ithout perm ission .
196
activity was achieved with OBBX or ABBX from blueberries collected at Lake 
Minchumina (LM; 1.14+0.09, n=3, p<0.05 and 1.16+0.12, n=3, p<0.05, respectively). In 
comparison, inhibition of Mg2+-nSMase was less pronounced but still significant using 
OBBX and ABBX prepared from blueberries collected in Fox (FX; 1.3+0.2, n=3, p<0.05 
and 1.37+0.22, n=3, p<0.05, respectively) or Fairbanks (FB; 1.12+0.18, n=3, p<0.05 and 
1.31+0.03, n=3, p<0.05, respectively). Taken together our findings suggested that wild 
Alaskan bog blueberries contain a potent inhibitor against Mg2+-nSMase activity in 
human neuronal cells.
2.0  *
T
LM  FX FB
Treatments
Figure. 6.1: Extracts o f wild Alaskan bog blueberries inhibit Mg2+-nSMase activity in neuronal cells. Blueberries were 
harvested at three different locations in the interior o f Alaska: Lake Minchumina (LM), Fox (FX), and Fairbanks (FB). 
Both organic (70% acetone/30% water) and aqueous extracts were prepared (OBBX and ABBX, respectively) as 
described in materials and methods. Mg2+-nSMase activity was quantitatively measured in lysates o f human SH-SY5Y 
neuroblastoma cells (equal amount o f total soluble protein) using an enzyme assay coupled to Amplex Red 
fluorescence. All values are normalized to control condition. Exposure o f SFLSY5Y cells to 100 ng/ml T N Fa for 15 
min (T) significantly stimulated Mg2+-nSMase activity (filled bar). In contrast, preincubation of SF1-SY5Y cells with 5 
pg/ml o f OBBX (open bars) or ABBX (hatched bars) for 2 h prior to T N Fa stimulation abolished Mg2+-nSMase 
activity and was indistinguishable from our control (C; gray bar). Error bars represent standard deviations o f three 
independent experiments and statistical significance was determined at *p<0.05 (ANOVA and post hoc Scheffe test, 
Dunette’s test for multiple comparison o f means).
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Since quantitative measurements of Mg2+-nSMase activity in cell lysates relied on 
the formation of peroxide, inhibition of Mg2+-nSMase in our experimental paradigm 
could have resulted from simple peroxide scavenging. Blueberries in general and wild 
Alaskan blueberries in particular exhibit some of the highest antioxidant capacities 
measured (Prior 1998). We controlled for this alternative taking advantage of a direct 
choline oxidation assay. Addition of choline to a mixture of choline oxidase, HRP, and 
Amplex Red results in the formation of fluorescent resorufin. As shown in Figure 6.2, 
neither addition of ABBX nor OBBX interfered with peroxide production in the direct 
choline oxidation assay at a concentration (5 ug/ml) shown to completely inhibited Mg2+- 
nSMase activity. However, increasing concentrations by 15 fold (75 qg/ml ABBX) 
revealed strong peroxide scavenging activity (FX; 66±4% , n=8, *p<0.05). As expected, 
addition of 5 mM N-acetyl-L-cysteine (51+3%, n=8, p<0.05) or 2000 U/ml Catalase 
(51+2%, n=8, p<0.05) to the direct choline oxidation assay abolished peroxide 
generation. These findings suggest the non-antioxidant nature of Mg2+-nSMase inhibition 
in our blueberry extracts at low concentrations.
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Figure 6.2: Inhibition o f Mg2+-nSMase activity results from non-antioxidant compounds in wild Alaskan bog blueberry 
extracts. In a direct choline oxidation assay, peroxide generation was quantitatively measured via Amplex Red 
fluorescence through the conversion of choline to betaine and peroxide via choline oxidase. All values were normalized 
to choline oxidation, our control (C; solid bar). Neither OBBX nor ABBX exhibited peroxide scavenging capacity at a 
concentration o f 5 pg/ml (open bars and hatched bars, respectively), which was shown to potently inhibit Mg2+-nSMase 
activity. As expected, addition o f 5 mM N-acetyl-L-cysteine (NAC) and 2000 U/ml catalase (CAT) significantly 
interfered with peroxide generation (grey bars). Moreover, addition o f 75 pg/ml ABBX to the direct choline oxidation 
assay also exhibited strong antioxidant capacity (grey bar). Omitting choline in our assay resulted in virtually no 
fluorescence (no Choi). Error bars represent standard deviations from six independent experiments and statistical 
significance was determined at *p<0.05 (ANOVA and post hoc Scheffe test). Extracts were prepared from wild 
Alaskan bog blueberries harvested at Lake Minchumina (LM), Fox (FX), and Fairbanks (FB).
We further determined viability o f human SH-SY5Y neuroblastoma cells upon 
prolonged exposure to blueberry extracts to verify the specificity of blueberry extracts in 
inhibiting Mg2+-nSMase activity. Figure 6.3 demonstrates that neither OBBX nor ABBX 
(5 [ig/ml each) compromised SH-SY5Y cell viability over a 48 h time period compared 
to control, however, when increasing concentrations of extracts 15 fold (75 pg/'ml ABBX, 
FX) cell viability was significantly diminished. As expected, UV irradiation of SH- 
SY5Y cells for 20 min caused a drastic reduction in cell viability (positive control). This 
result demonstrates that blueberry extracts (5 fxg/ml) did not compromise SH-SY5Y cell 
viability at concentrations that negated Mg2+-nSMase activation by TNFa.
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Figure 6.3: Extracts o f  wild Alaskan bog blueberries are not cytotoxic. Serum free cultures o f SH-SY5 Y cells were 
supplemented with OBBX and ABBX (5 pg/ml each) and maintained for 48 h prior to measuring cell viability (MTT 
assay). All values were normalized to control (C; grey bar). Neither OBBX (open bars) nor ABBX (hatched bars) 
compromised cell viability at concentrations (5 ng/ml) shown to inhibit Mg2+-nSMase activity. In contrast, cell 
viability was significantly compromised when increasing ABBX to 75 pg/ml, a 15 fold excess (ABBX-75, FX, solid 
bar). As a positive control, UV exposure (20 min) o f SH-SY5Y cells dramatically reduced cell viability (UV; solid 
bar). Error bars represent standard deviations o f at least four independent experiments and statistical significance was 
determined at *p<0.05 (ANOVA and post hoc Scheffe test). We tested blueberries harvested from Lake Minchumina 
(LM), Fox (FX), and Fairbanks (FB).
6.5: Discussion
We demonstrated for the first time that wild Alaskan bog blueberries have the capacity to 
inhibit Mg2+-nSMase activity in human neuronal cells upon exposure to the 
proinflammatory cytokine TNFa (Fig. 6.1). Moreover, our findings strongly suggest that 
Mg2+-nSMase inhibition was non-antioxidant in nature (Fig. 6.2), extractable in either an 
organic solvent or water only, and benign to viability of neuronal cells over a sustained 
time period. So far, three distinct Mg2+-nSMases have been characterized in eukaryotes. 
Relevant to our study, Mg2+-nSMase 2 is predominantly expressed in the mammalian 
CNS (Hofmann et al. 2000), and our experimental approach confirmed specificity of the 
blueberry extract inhibitory affect towards this SMase. First, experiments were
performed in the cholinergic and dopaminergic SH-SY5Y neuroblastoma cell line
2+ .
derived from a human CNS tumor. Second, this Mg -nSMase was stimulated upon 
exposure of SH-SY5Y cells to TNFa (Fig. 6.1) as reported for the mammalian CNS 
Mg2+-nSMase 2. Third, our assay conditions were specific for Mg2+-nSMase activity.
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Fourth, the pharmacological compound GW4869 inhibited TNFa-stimulated activation 
of Mg2+-nSMase in SH-SY5Y cells (data not shown) in accordance with Luberto et al. 
(Luberto et al. 2002).
The capacity to inhibit Mg2+-nSMase activity was present in both organic and 
aqueous extracts of wild Alaskan bog blueberries harvested at three distinct locations 
(Lake Minchumina, Fox, Fairbanks). Although statistically not significant, organic or 
aqueous extracts prepared from Lake Minchumina blueberries consistently contained 
higher potency in inhibiting Mg2+-nSMase compared to either extracts prepared from 
Fairbanks blueberries or Fox blueberries. These observed differences could arise from 
extracts not standardized according to a series of phytomarkers or actual distinct 
compositions of blueberries due to factors such as soil composition, water availability, or 
sun exposure despite all three blueberry harvest locations lie within 200 miles o f each 
other in the interior of Alaska. Clearly, future studies need to include a standardized 
comparison among wild Alaskan blueberries as well as blueberries from other US
2_|_
locations to determine whether significant differences in the potency of inhibiting Mg - 
nSMase activity exist. The health benefits of a high dietary consumption of blueberries 
and many other fruits and vegetables are largely attributed to polyphenolic compounds 
with antioxidant properties and, in particular, wild Alaskan blueberries exhibit one of the 
highest antioxidant capacities measured (Wu 2004). Thus, it was crucial to determine 
whether our blueberry extracts actively suppressed peroxide production since peroxide 
production was an integral step in our Mg2+-nSMase activity assay. Regardless of the 
harvest location, we detected no measurable peroxide scavenging capacity in our direct 
choline oxidation assay supplemented either with organic or aqueous blueberry extracts 
at 5 [ig/ml, a concentration sufficient to abolish Mg2+-nSMase activity. Moreover, this 
finding is critical since Mg2+-nSMase is redox sensitive and activated by peroxide (Won 
and Singh 2006). Furthermore, aqueous or organic blueberry extracts inhibited Mg2+- 
nSMase activity in a direct assay using a fluorescent nSMase substrate (data not shown). 
Nevertheless, addition of aqueous and organic blueberry extracts at 15 fold higher 
concentrations significantly suppressed peroxide production indicative of their
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antioxidant properties. In conclusion, inhibition of Mg2+-nSMase derives from a non­
antioxidant compound present in wild Alaskan bog blueberries.
Finally, inhibition of Mg2+-nSMase activity could also be accounted for by an 
inherent cytotoxic effect of our blueberry extracts on SH-SY5Y cells. Some residual cell 
death is expected to occur under serum free conditions for 48 h even in controls. 
Interestingly, both aqueous and organic blueberry extracts showed a strong tendency to 
increase cell viability compared to our control. Potentially, the high antioxidant 
properties of blueberry extracts were beneficial for cell viability analogous to B 29 
supplementation of cultured hippocampal neurons.
Activation of Mg2+-nSMase and subsequent generation of ceramide is key to the 
progression o f inflammation and increased oxidative stress in the CNS common to many 
chronic neurodegenerative pathologies, acute CNS injuries, and even psychiatric 
disorders. Thus, Mg2+-nSMase represents a pivotal target for therapeutic intervention.
2_j_
The fact that wild Alaskan bog blueberries contain a potent Mg -nSMase inhibitor 
further substantiates the benefits of dietary consumption o f blueberries to alleviate 
inflammation in the CNS (Noyan-Ashraf et al. 2005; Wu et al. 2004).
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C hapter 7: Conclusions and Future Perspectives 
7.1: The mechanism
This thesis research focused on a biochemical pathway central to the progression and 
potentially initiation of inflammation in the CNS. Neuroinflammation is prevalent 
following acute CNS trauma, in chronic CNS diseases, and in some psychiatric disorders, 
and is accompanied by signs o f severe oxidative stress (Block et al. 2007; Fetler and 
Amigorena 2005; Nimmerjahn et al. 2005). The guiding hypothesis of this study 
attributed a key role to the bioactive lipid ceramide, and to a neuronal NOX, in the 
underlying molecular mechanism of neuroinflammation. Several important studies 
provided strong support for this hypothesis.
First, this research identified a neuronal NOX as the principal source of ROS production 
that was activated by the pro-inflammatory cytokine TNFa, one of the earliest mediators 
of neuroinflammation. 5-LOX and COX-2 (two oxidoreductases) also contributed to 
oxidative stress in addition to the action of the neuronal NOX. The NOX is speculated to 
rely on the omega-6 polyunsaturated fatty acid arachidonic acid by two different 
hypotheses. One describes arachidonic acid as an indispensable membrane anchor for 
some cytosolic subunits of the NOX (Groemping and Rittinger 2005; Quinn and Gauss 
2004; Ueyama et al. 2007). The other describes arachidonic acid as a regulator o f a 
proton pump contained within the large membrane-bound subunit of the NOX 
(Lowenthal and Levy 1999; Mankelow and Henderson 2001; Mankelow and Henderson 
2003; Mankelow et al. 2003; Mankelow et al. 2004). This research supported both 
possible hypotheses, showing that TNFa-stimulated neuronal NOX activity was critically 
dependent on the activity of CPLA2 , an enzyme responsible for the production of 
arachidonic acid.
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Second, we demonstrated that TNFa, or the soluble toxic amyloid beta fragment A p1'42, 
induced a Mg2+-nSMase activity in both human SH-SY5Y neuroblastoma cells and 
primary cortical neurons obtained from brains of 7-day old chick embryos. Mg2+- 
nSMase, like other sphingomyelinases generates ceramide from the hydrolysis of 
sphingomyelin, a complex lipid prevalent in neuronal plasma membranes (Clarke et al. 
2006; Farooqui et al. 2007; Marchesini and Hannun 2004). Ceramide is also well known 
to evoke cellular stress responses and oxidative stress (Hannun 1996; Hannun and 
Luberto 2000).
Third, we demonstrated that ceramide accumulation resulted in an activation of the 
neuronal NOX: 1) through the action o f Mg2+-nSMase, 2) by exogenous addition of a 
short-chain ceramide analog, 3) by inhibiting ceramide degradation, and 4) by stimulating 
de novo ceramide biosynthesis. Moreover, the ceramide metabolite ceramide-1-phosphate 
could also induce NOX activity. This finding is important because ceramide-1-phosphate 
has recently emerged as a potent regulator o f CPLA2 activity through direct interaction 
with the enzyme itself (Pettus et al. 2004; Subramanian et al. 2005; Subramanian et al. 
2007). In our experimental system we determined that TNFa also stimulated CerK 
activity, phosphorylating ceramide to produce ceramide-1-phosphate. CerK activity was 
highly sensitive to inhibition of Mg2+-nSMase thereby placing it downstream of Mg2+- 
nSMase in the neuroinflammatory pathway. Furthermore, inhibition of CerK by RNA 
interference prevented TNFa-stimulated NOX activity and restored cellular viability.
Fourth, oxidative stress was found to disrupt many cellular functions. We identified actin 
as one target o f neuroinflammatory-stimulated ROS. Irreversible oxidative damage 
(carbonylation) to actin severely disrupts actin dynamics in neuronal cells. Proper actin 
cytoskeletal dynamics are essential for fundamental cellular processes such as gene 
expression, motility, plasticity, vesicular transport and more (Formigli et al. 2007; 
Gourlay and Ayscough 2005; Lanzetti 2007; Maloney and Bamburg 2007). SphKl 
emerged as a second target of ROS damage associated with neuroinflammation.
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Sphingosine-1-phosphate, the product of SphKl activity, is implicated in mechanisms 
underlying cell survival, cell proliferation, cell motility, and angiogenesis (Alemany et al. 
2007). Irreversible oxidative damage to SphKl and loss of sphingosine-1-phosphate 
production therefore has severe consequences for cell survival.
Fifth, glucosylceramide was identified as an inhibitor of NOX. Glucosylceramide is the 
product of glucosylceramide synthase and therefore is a direct product of ceramide 
neutralization (Gouaze-Andersson and Cabot 2006; Liu et al. 2001). RNA interference 
directed against glucosylceramide synthase augmented TNFa- or doxorubicin-stimulated 
NOX activity, while overexpression of glucosylceramide synthase had the opposite 
effect. Additionally, addition of exogenous glucosylceramide blocked NOX activity. 
These results suggested that glucosylceramide synthase may inhibit NOX activity either 
by depleting ceramide, an essential lipid activator, or by direct inference by 
glucosylceramide, or both.
Altogether, these studies conclusively showed that neuroinflammation could mediate 
NOX-dependent oxidative stress by modulating ceramide metabolism (Fig. 7.1). It is 
important to keep in mind that these studies also described a positive, yet detrimental 
feedback mechanism, involving the oxidation of actin and SphKl, which ultimately 
impedes neuronal survival and perpetuates the progression of CNS pathologies.
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Figure 1: Ceramide metabolism mediates inflammatory-stimulated NADPH oxidase activity in neurons. TN Fa 
(or A ft1'42) stimulated Mg2+-nSMase activity generating ceramide. In addition to ceramide, CerK activity (producing 
ceramide-1-phosphate) mediated the activity o f cPLA2 and a neuronal NADPH oxidase (NOX). Alternatively 
glucosylceramide, the product o f ceramide neutralization by glucosylceramide synthase (GlCerSN), blocked NOX 
activity. Intriguingly NOX activity impeded actin and SphKl via oxidation; a positive feedback pathway impeding 
neuronal survival.
7.2: Neuroprotection and wild Alaskan bog blueberries
Foods rich in antioxidants as well as those with high omega-3 polyunsaturated fat content 
have been shown to improve CNS health (Galli et al. 2002). Alaskan salmon has one of 
the highest omega-3 contents of salmon in the entire world; particularly important 
because these fats impede inflammatory responses including those that occur in the CNS 
(Farooqui et al. 2007). Likewise, Alaskan blueberries have one o f the highest anti oxidant 
capacities o f any fruit, which can combat oxidative stress associated with aging as well as 
with degenerative pathologies (Ramassamy 2006). Unfortunately, antioxidant 
compounds such as polyphenols rarely accumulate to efficacious levels in the CNS 
following dietary consumption (Joseph et al. 2003; Noyan-Ashraf et al. 2005;
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Ramassamy 2006; Wu et al. 2004). Rather, beneficial effects from consumption of 
blueberries and other fruits and vegetables may arise from other naturally occurring 
compounds that antagonize specific biochemical pathways.
This thesis research evaluated crude extracts obtained from wild Alaskan bog blueberries 
for their potential to interfere with Mg2+-nSMase-mediated neuroinflammation. It was 
determined that components are present in wild Alaskan bog blueberries, independent of 
antioxidants, that block TNFa-stimulated Mg2+-nSMase activity in neuronal cells.
2_|_
Preliminary evidence from fractionated extracts (data not shown) suggested that Mg - 
nSMase-inhibitory effects arose from highly lipophilic fractions. These findings may 
indicate that the inhibitory effect observed might be due to a compound acting in 
competition with the lipid substrate (sphingomyelin), or by a biophysical effect on the 
membrane where the Mg2+-nSMase is localized. Additionally, a lipophilic compound 
could make an ideal therapeutic to treat CNS pathologies due to the probability of 
crossing the blood-brain-barrier. Altogether, this research showed that wild Alaskan bog 
blueberries contain components, in addition to antioxidants, with therapeutic potential for 
the treatment o f acute CNS trauma, chronic CNS disease, or psychiatric disorders.
7.3: Implications for neurodegeneration
Neuroinflammation is a response associated with many acute and chronic pathologies of 
the CNS, as well as with psychiatric disorders (Block et al. 2007; Fetler and Amigorena 
2005; Nimmerjahn et al. 2005). The inflammatory response in the CNS is similar to that 
found outside the CNS in that it targets pathogens, toxins, and other insults in order to 
eliminate their threat (Block et al. 2007; Sawada et al. 1989; Town et al. 2005). 
Unfortunately, inflammatory responses can have dramatic and unintended consequences 
in the CNS; in particular the damage to processes key to neuronal function and survival. 
Ceramide accumulation and oxidative stress are prevalent in many, if  not all 
neurodegenerative pathologies (Farooqui et al. 2007). Ceramide is a bioactive
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sphingolipid that has been implicated as a regulator of a variety of events including 
cellular stress, oxidative stress, and apoptosis (Hannun 1996; Hannun and Luberto 2000). 
In this study, activation of Mg2+-nSMase by TNFa (or A p1"42) resulted in the generation 
o f ceramide, and further metabolism by CerK produced ceramide-1-phosphate. Both 
ceramide and ceramide-1-phosphate are potent inducers of ROS accumulation and thus 
oxidative stress.
The mechanism elucidated in this thesis research described inflammatory-regulation of a 
neuronal NOX unique from that documented in microglia, the immune cell of the CNS. 
The NOX, an enzyme responsible for the production of superoxide anion, mediated 
oxidative damage to key neuronal components in response to inflammatory stimuli. Two 
specific neuronal targets of oxidative modification were identified as actin and SphKl. 
Actin and SphKl are both important for neuronal survival, actin specifically through 
structure and dynamic cytoskeletal processes (Fiala et al. 2002; Maloney and Bamburg 
2007), and SphKl through production of the pro-survival and pro-growth lipid 
sphingosine-l-phosphate (Alemany et al. 2007; Mizugishi et al. 2005). Disruption of 
actin and SphKl via NOX-dependent oxidation represents a profound finding of this 
research, namely a pathway of positive feedback where neuronal survival is jeopardized, 
exacerbating inflammation and leading to neurodegeneration.
Loss of neuron functionality including synaptic plasticity, vesicular trafficking, and 
neurotransmission, and ultimately neuronal death reflect the cellular correlate of 
degenerative CNS disorders. The identification of Mg2+-nSMase, CerK, and a neuronal 
NOX as integral components of a pathway linking neuroinflammation to oxidative stress, 
and ultimately to neurodegeneration, provides new molecular targets for 
pharmacotherapy designed to treat acute CNS trauma, chronic CNS disease, and 
psychiatric disorders and ultimately improve neuronal functionality and survival.
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7.4: Implications for cancer
The CNS, like other organs, is susceptible to malignant tumors arising from any of its 
three cell types (neurons, astrocytes, and microglia). Cancers of the CNS are particularly 
problematic due to the sensitive nature of the CNS, frequently rendering the tumors 
inoperable (Belda-Iniesta et al. 2006; Castel et al. 2007). An unfortunate addition to the 
problem of CNS cancer is the often-unresponsive nature to chemotherapy and radiation 
therapy. In responsive cancers, both chemotherapy and radiation are shown to induce 
ceramide accumulation as a mechanism important to the cytotoxic effect of the treatment 
(Ogretmen and Hannun 2004; Senchenkov et al. 2001; Zheng et al. 2006). Like other 
ceramide-mediated pathways that stimulate oxidative stress, the ceramide-mediated NOX 
pathway described in this thesis research is also targeted by chemotherapeutics such as 
doxorubicin. Although not a specific goal of chemotherapeutics, the onset of oxidative 
stress is an important mechanism that assists in destroying the targeted cancer while also 
affecting neighboring cells through a bystander effect (Ozben 2007; Wang and Yi 2008).
Several highly invasive cancers, such as brain and breast cancer, display increased 
activities of sphingosine kinase-1, acid ceramidase, and glucosylceramide synthase 
(Gouaze-Andersson and Cabot 2006; Ogretmen and Hannun 2004; Senchenkov et al. 
2001). Acid ceramidase and glucosylceramide synthase regulate the clearance of 
ceramide, and therefore counteract the effects of chemotherapy, as well as radiation. 
Sphingosine kinase-1, on the other hand, phosphorylates the ceramide-metabolite 
sphingosine to produce the pro-survival and pro-growth lipid sphingosine-1-phosphate 
(Alemany et al. 2007; Ogretmen and Hannun 2004). Altogether, these enzymes confer 
the ability to resist chemotherapy and radiation in cancers where they are upregulated. 
Recent studies have demonstrated that inhibitors of these enzymes restore the sensitivity 
of resistant cancers to chemotherapy and radiation (Gouaze-Andersson and Cabot 2006; 
Ogretmen and Hannun 2004; Senchenkov et al. 2001; Wang et al. 2008).
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In addition to increased glucosylceramide synthase activity, this thesis research revealed 
that glioblastomas, highly invasive and drug-resistant brain cancers, possessed increased 
superoxide dismutase and catalase activities. These enzymes are important for 
eliminating ROS and decreasing oxidative damage to cellular components, ultimately 
protecting the glioblastomas from chemotherapy-stimulated oxidative stress. Intriguingly, 
it was determined that glucosylceramide also inhibited NOX, demonstrating a feedback 
effect where ceramide neutralization serves to protect cells from ceramide-stimulated 
oxidative stress. Since numerous chemotherapeutics have been shown to increase 
ceramide levels, it is reasonable to speculate that NOX activity may also increase. Drug- 
and radiation-resistant cancers that up-regulate ceramide clearance pathways may also, 
via this feedback mechanism, reduce ceramide-stimulated NOX activity and therefore 
oxidative stress. Combined with an increased capacity to eliminate ROS, these advanced 
cancer cells posses the ability to evade treatment, survive, and grow despite 
chemotherapy or radiation.
7.5: Future Perspectives
This thesis research lays the foundation for a variety o f further studies. An important 
advance is the validation, via genetic studies (RNA interference), of pharmacology
utilized to evaluate components of the neuroinflammatory pathway studied in this thesis
2+ .
research. In particular, validation of studies performed with the Mg -nSMase inhibitor 
GW4869, and the NOX inhibitor DPI. Studies of NOX are limited by the lack of specific 
inhibitors. Genetic studies (including real-time PCR) also provide a means to evaluate 
specific isoforms o f NOX that are prevalent in neurons and stimulated by inflammation. 
Different neuronal isoforms may be localized in differing regions of the cell, which is 
deserving of study. Localization may regulate the diversity of activities observed with 
NOX, including responses to inflammatory stimuli, growth factor signaling, as well as 
ever-changing demands in neuronal plasticity. Additionally, more studies of how 
neuronal NOX is regulated are needed. Activation of the oxidase requires
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phosphorylation and subunit assembly at membranes, events regulated by protein kinases 
and the Rac GTPase (Groemping and Rittinger 2005; Quinn and Gauss 2004; Ueyama et 
al. 2007). In light of this study’s implication of ceramide as a key stimulator of the NOX, 
protein kinase C £ (PKCQ should be closely evaluated. PKC^ interacts directly with, and 
is activated by ceramide (Bourbon et al. 2000; Bourbon et al. 2002; Fox et al. 2007). 
Likewise, ceramide or ceramide-1-phosphate interactions with the NOX deserve future 
evaluation. The PX domains of the p47phox and p4Qphox subunits bind to arachidonic acid, 
phosphoinositides, and anionic phospholipids (Groemping and Rittinger 2005; Quinn and 
Gauss 2004; Ueyama et al. 2007), a phenomenon also observed with cPLA2 (an enzyme 
that interacts directly with ceramide-1-phosphate) (Pettus et al. 2004; Subramanian et al. 
2005; Subramanian et al. 2007). Future studies should also identify targets of NOX- 
mediated oxidation. Oxidation of specific amino acids may impact proteins differently by 
regulating function, localization, or trafficking.
Lastly, complete characterization of the components o f wild Alaskan bog blueberries, as 
well as other natural products, may reveal compounds that protect neurons by 
antagonizing components of neuroinflammatory pathways. Altogether, future studies 
should seek to more clearly define the precise links between neuroinflammation, 
oxidative stress, and neurodegeneration, and ultimately lead to the development of better 
therapeutic strategies to treat inflammatory-mediated pathologies of the CNS.
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